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xABSTRACT
The milk fat globule membrane (MFGM) that surrounds fat globules in
milk is a natural source of sphingolipids, phoshpholipids and proteins with
defined anticancer properties. Dairy processing operations can affect the structure
and composition of MFGM, potentially influencing its anticancer activity. The
aim of this project was to determine if anticancer activity can be attributed to
sweet and fermented buttermilks which contain fragments of MFGM and examine
if different milk processing operations (separation, washing, heating and drying)
may influence the antiproliferative activity of resultant buttermilks. After 3 days
of incubation sweet pasteurized buttermilk at the concentration of 0.38 mg total
solids/ml significantly (P ≤ 0.001) inhibited growth of SW480 human colon
cancer cells by 97.5% but had no toxic effect on FHC human normal colon cells
as determined by the acid phosphatase cytotoxicity assay. Antiproliferative
activity was lost after spray drying of buttermilk but was retained after heat
treatment and freeze and spin drying. In contrast to natural buttermilks, fermented
buttermilks inhibited growth to a lesser extent. Analysis of mitochondrial
permeability and phoshatidylserine exposure in cells using flow cytometry
suggest induction of apoptosis as a biological mechanism involved in the
inhibitory effect exerted by buttermilk fractions on cancer cell growth.
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were washed and subjected to In-Cell Western analysis using specific antibody
against phosphorylated p38 protein.
6.15. Changes in phosphorylated JNK protein in SW480 colon cancer cells after 24h
and 48h (as indicated) of buttermilk treatment at different concentrations. SW480
cells were either left untreated or exposed to buttermilk at indicated times and
concentrations. SW480 cells were additionally treated with 5 mM NaBut, which
served as positive control. After the indicated times, treatment was removed, cells
were washed and subjected to In-Cell Western analysis using specific antibody
against phosphorylated JNK protein.
6.16. Confocal immunofluorescent examination of endonuclease G in SW480 cells.
SW480 cells were either untreated (control, C-) and treated with 0.2 mg total
solids/ml (B2). SW480 cells were also treated with 5 mM sodium butyrate (NaBut,
C+), which served as positive control. After 48h cells were washed and labelled with
endonuclease G antibody (green) (a). SW480 cells were also counterstained with
DRAG5 (b), which is fluorescent DNA dye to detect cells’ nuclei (blue). Merged
images (c) show nuclei of SW480 cells (blue) and endonuclease G (green).
6.17. Confocal immunofluorescent examination of AIF in SW480 cells. SW480 cells
were either untreated (control, C-) and treated with 0.2 mg total solids/ml (B2).
SW480 cells were also treated with 5 mM sodium butyrate (NaBut, C+), which
served as positive control. After 48h cells were washed and labelled with AIF
antibody (green) (a). SW480 cells were also counterstained with DRAG5 (b), which
is fluorescent DNA dye to detect cells’ nuclei (blue). Merged images (c) show nuclei
of SW480 cells (blue) and AIF (green).
206
207
209-212
213-215
xix
LIST OF TABLES
Chapter 1
1.1. The major proteins of the MFGM and their health benefits.
1.2. Relative lipid composition of the bovine MFGM.
9-10
11
Chapter 2
2.1. Compositional analysis of buttermilk samples. 69
Chapter 3
3.1. Compositional analysis of unwashed and washed buttermilk samples.
3.2. Phospho- and sphingolipid compositions of unwashed and washed buttermilk
samples.
98
99
Chapter 4
4.1. Compositional analyses of feed, retentate and permeate produced from unwashed
cream.
4.2. Phospho- and sphingolipid composition of feed, retentate and permeate produced
from unwashed cream.
4.3. Compositional analysis of feed, retentate, permeate produced from washed
cream.
4.4. Phospho- and sphingolipid composition of feed, retentate and permeate produced
from washed cream.
126
126
127
127
Chapter 5
5.1. Compositional analyses of feed, retentate and permeate produced from unwashed
cream.
5.2. Phospho- and sphingolipid composition of feed, retentate and permeate produced
156
xx
from unwashed cream.
5.3. Compositional analysis of feed, retentate, permeate produced from washed
cream.
5.4. Phospho- and sphingolipid composition of feed, retentate and permeate produced
from washed cream.
156
157
157
xxi
ABBREVIATIONS
ACF aberrant crypt foci,
ADRP adipocyte differentiation-related protein,
AIF apoptosis-inducing factor,
Alk-SMase alkaline sphingomyelinase,
AP acid phosphatase,
APC adenomatous polyposis coli,
APC (filter) allophycocyanin (filter),
apoB apolipoprotein B,
ATP adenosine triphosphate,
BNIP3 Bcl-2/E1B and 19K-interacting protein 3,
BRCA1 breast cancer type 1 susceptibility protein,
BRCA2 breast cancer type 2 susceptibility protein,
BSA bovine serum albumin,
BTN butyrophilin,
C1PP                ceramide-1-phosphate phosphatase,
CC buttermilk produced from commercial cream,
CCK cholecystokinin,
CDase ceramidase,
cDNA complementary deoxyribonucleic acid,
CDP-choline cytidine diphosphocholine,
Cer ceramide,
CEPT                CDP-ethanolamine:1,2 diacylglycerol ethanolaminephosphotransferase,
CHO chinese hamster ovary,
xxii
CK  ceramide kinase,
CLA conjugated linoleic acid,
CMC critical micellar concentration,
CMP cytidine 5'-monophosphate,
COX-2 cyclooxygenase-2,
cPLA2 cytosolic phospholipase A2,
CRS cerebrosidase,
CS ceramide synthase,
CSC buttermilk produced from centrifugally separated cream,
DAG 1,2-diacylglycerol,
DAGK diacylglycerol kinase,
DES dihydroceramide desaturase,
DHA docosahexaenoic acid,
DMEM Dulbecco’s Modified Eagle’s medium,
DNA deoxyribonucleic acid,
DNase deoxyribonuclease,
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine,
EAE experimental allergic encephalomyelitis,
ECACC European Collection of Cell Cultures,
ECT CTP:phosphoethanolamine cytidylyltransferase,
EK ethanolamine kinase,
EndoG endonuclease G,
EPA eicosapentaenoic acid,
ER endoplasmic reticulum,
ERK extracellular signal-regulated kinase,
xxiii
FA fatty acid,
FABP fatty acid binding protein,
FACE fast activated cell-based ELISA,
FACS fluorescence-activated cell sorting,
FAP familial adenomatous polyposis,
FBS fetal bovine serum,
FHC human fetal colon,
FITC fluorescein isothiocyanate,
G4SC buttermilk produced from gravitationally separated cream at 4°C,
GAIP Gα-interacting protein,
Gal galactose,
GC gas chromatography,
GC glucosylceramide,
GC–MS    gas chromatography-mass spectrometry,
GCS glucosylceramide synthase,
GIT gastrointestinal tract,
Glc glucose,
GLUT1 facilitated glucose transporter isoform 1,
GSK glycogen synthase kinase,
GTPases guanosine triphosphatase,
H&E haematoxylin and eosin,
haCER2 human alkaline ceramidase 2,
HEPES 4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid,
HPLC high-performance liquid chromatography,
IFNγ interferon-γ,
xxiv
IP3 inositol 1,4,5-trisphosphate,
JNK c-Jun N-terminal kinase,
KSR kinase suppressor of Ras
L-15 Leibovitz-15,
LAB lactic acid bacteria,
LC lactosylceramide,
LC3 light chain 3,
LDL low-density lipoprotein,
MAPK mitogen-activated protein kinase,
MDPC Moorepark Dairy Production Centre,
MEKK MAP/ERK kinase kinase,
MEM                Modified Eagle’s medium,
MFG-E8 lactadherin,
MFGM milk fat globule membrane,
MDF mucin-depleted foci,
Min mice multiple intestinal neoplasia mice,
MMP-7 matrix metalloproteinase-7,
mRNA messenger ribonucleic acid,
MS multiple sclerosis,
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium, inner salt,
MUC1 mucin 1,
MW molecular weight,
NaBut sodium butyrate,
NF-κB nuclear factor κB,
xxv
NGF nerve growth factor,
NL neutral lipids,
NMR nuclear magnetic resonance,
OD optical density,
PA phosphatidic acid,
PAF platelet activating factor,
PAP phosphatidic acid phosphohydrolase,
PARP poly(ADP-ribose) polymerase,
PAS6/7 lactadherin,
PBS phosphate buffered saline,
PC phosphatidylcholine,
PDK1 3-phosphoinositide-dependent protein kinase 1,
PE phosphatidylethanolamine
PEMT phosphatidylethanolamine N-methyltransferase,
PES phenazine ethosulfate,
PGE2 prostaglandin E2,
pI isoelectric point,
PI phosphatidylinositol,
PI(3,4,5)P3 phosphatidylinositol 3,4,5-trisphosphate,
PI(4,5)P2 phosphatidylinositol-4,5-bisphosphate,
PI3K phosphatidylinositol-3-kinase,
PKB protein kinase B,
PKCα                protein kinase C α,
PL polar lipids,
PLA2 phospholipase A2,
xxvi
PLC phospholipase C,
PLD phospholipase D,
PMSF phenylmethanesulfonyl fluoride,
PP1 protein phosphatase 1,
PP2A protein phosphatase 2A,
PS phosphatidylserine,
PTP permeability transition pore,
PVDF polyvinylidene difluoride,
RA rumenic acid,
Rb (RB) retinoblastoma protein,
RNAi ribonucleic acid interference,
RNase ribonuclease,
ROS reactive oxygen species,
S1P sphingosine-1-phosphate,
S1PP sphingosine-1-phosphate phosphatase,
SB sodium bicarbonate,
SDS-PAGE sodium dodecyl sulphate-polyacrylamide gel electrophoresis,
shRNA short hairpin ribonucleic acid,
SK sphingosine kinase,
SK sphingosine kinase,
SM sphingomyelin,
SMase sphingomyelinase,
SMS sphingomyelin synthase,
SMUF simulated milk ultrafiltrate,
Sph sphingosine,
xxvii
SK1-S1P sphingosine kinase 1-sphingosine-1-phosphate,
TBS tris-buffered saline,
TC sodium taurocholate,
TCF T-cell factor,
TEER transendothelial electrical resistance,
TLC thin layer chromatography,
TMRE tetramethylrhodamine ethyl ester perchlorate,
TNFα tumour necrosis factor α,
TS total solids,
VDAC voltage-dependent anion channel,
VEGF vascular endothelial growth factor,
XO xantine oxidase,
TABLE OF CONTENTS
DECLARATION ii
ACKNOWLEDGEMENTS iv
AWARDS vi
COMMUNICATIONS vii
ORAL vii
POSTER viii
PUBLICATIONS (IN PREPARATION) viii
ABSTRACT x
LIST OF FIGURES xi
LIST OF TABLES xix
ABBREVIATIONS xxi
CHAPTER 1
LITERATURE REVIEW
Milk fat globule membrane – a source of polar lipids for colonic health?
1.1. Intestinal tract integrity and role of lipids 3
1.2. Milk fat globule membrane (MFGM) 6
1.2.1. Proteins and lipids of MFGM 8
1.2.2. Isolation and purification of MFGM 13
1.3. Profile of polar lipids present in gastrointestinal tract 15
1.3.1 Phosphoglycerides 15
1.3.1.1. Phosphatidylcholine 17
1.3.1.2. Phosphatidylinositol 20
1.3.2. Sphingolipids 22
1.3.2.1. Ceramide 25
1.3.2.2. Sphingosine 29
1.3.2.3. Sphingosine-1-phosphate 30
1.3.2.4. Ceramide-1-phosphate 33
1.3.3. Glycosphingolipids 34
1.3.3.1. Glucosylceramide 35
1.3.3.2. Lactosylceramide 35
1.4. Hydrolysis of sphingomyelin 36
1.4.1. Digestion of dietary sphingomyelin 36
1.4.2. Endogenous sphingomyelin 38
xxix
1.5. Dietary sphingolipids and colon cancer 40
1.5.1. Sphingomyelin digestion and colon cancer 40
1.5.1.1. Decreased alkaline sphingomyelinase activity in colon cancer 40
1.5.1.2. Dietary sphingomyelin reduces colon cancer 42
1.6. Summary and perspectives for future research. 43
1.7. Thesis objectives 45
CHAPTER 2
Selection of colorimetric assay and processing method for studying
antiproliferative activity of buttermilk samples in vitro.
2.1. Introduction 49
2.2. Materials and Methods 52
2.2.1. Materials 52
2.2.2. Preparation of buttermilk samples for antiproliferative studies 52
2.2.2.1. Cream preparation 52
2.2.2.2. Buttermilk preparation 53
2.2.3. Compositional analyses of buttermilk samples 53
2.2.4. Cell culture 54
2.2.5. Optimization of cell growth for different cell lines 54
2.2.6. Antiproliferative activity of commercial lipids: sphingosine, ceramide,
lactosylceramide, sphingomyelin and phosphatidylcholine 55
2.2.7. Lipid extraction and fractionation of buttermilk lipid classes 56
2.2.8. Preparation of micellar solutions 57
2.2.9. Antiproliferative activity of buttermilk fractions 57
2.2.10. Statistical analysis 58
2.3. Results 59
2.3.1. Optimization of 96-well plate cytotoxicity assays (MTS vs. acid
phosphatase) for evaluating effects of buttermilk on cell growth 59
2.3.2. Comparative analysis of effects of sphingosine and ceramide on
SW480 cell growth as determined by MTS and AP assays 62
2.3.3. Effect of commercial lipids: sphingomyelin, lactosylceramide and
phosphatidylcholine on growth of SW480 colon cancer cells 65
2.3.4. Compositional analyses of buttermilk samples 68
2.3.5. Fatty acids 69
2.3.6. Polar lipid fraction 72
2.3.7. Neutral lipid fraction 75
2.4. Discussion 81
2.5. Conclusions 87
xxx
CHAPTER 3
Effect of sweet and fermented buttermilk samples on growth of SW480
human colon cancer cells and FHC normal colon epithelial cells.
3.1. Introduction 90
3.2. Materials and methods 92
3.2.1. Preparation of buttermilk samples for antiproliferative studies 92
3.2.1.1. Cream preparation 92
3.2.1.2. Buttermilk preparation 93
3.2.1.3. Fermentation studies 93
3.2.2. Compositional analyses of buttermilk samples 93
3.2.2.1. Characterisation of MFGM phospho- and sphingolipid
component 94
3.2.3. Cell culture 95
3.2.4. Acid phosphatase activity assay 95
3.2.5. Statistical analysis 96
3.2.5.1. Compositional analyses of buttermilks 96
3.2.5.2. Cytotoxicity assays 96
3.3. Results 97
3.3.1. Compositional analyses of buttermilks 97
3.3.2. Cytotoxicity 100
3.3.2.1. Optimization of incubation time and concentration of buttermilk
for cytotoxicity assay using SW480 human colon cancer cells 100
3.3.2.2. Comparison of antiproliferative activity of buttermilk samples
produced from unwashed and washed creams 100
3.3.2.3. Comparison of influence of buttermilk on growth of SW480
colon cancer cells and FHC normal colon epithelial cells 102
3.3.2.4. Evaluation of influence of high heat treatment and spray
drying on antiproliferative activity of buttermilk 104
3.3.2.5. Antiproliferative activity of fermented buttermilk samples 105
3.4. Discussion 108
3.5. Conclusions 115
xxxi
CHAPTER 4
Effect of buttermilk samples produced at pilot scale on growth of SW480,
HT-29 and Caco-2 human colon cancer cell lines and HepG2 human
hepatocellular cancer cell line.
4.1. Introduction 118
4.2. Materials and methods 121
4.2.1. Buttermilk production 121
4.2.2. Cell culture 121
4.2.3. Acid phosphatase activity assay 122
4.2.4. Preparation of Caco-2 cells monolayer 123
4.2.5. Preparation of DMEM media for metabolism study 124
4.2.6. Statistical analysis 124
4.3. Results 125
4.3.1. Compositional analysis of buttermilks 125
4.3.2. Cytotoxicity 126
4.3.2.1. Antiproliferative activity of feed, retentate and permeate samples
produced from unwashed cream 126
4.3.2.2. Antiproliferative activity of feed, retentate and permeate samples
produced from washed cream 132
4.3.2.3. Evaluation of buttermilk treatment on growth of differentiated and
non differentiated Caco-2 cells 136
4.3.3. Analysis of influence of media components (glucose vs galactose) on
buttermilk’s antiproliferative activity 136
4.4. Discussion 142
4.5. Conclusions 148
CHAPTER 5
Effect of spray, freeze and spin drying of buttermilk on its antiproliferative
activity against SW480 human colon cancer cells.
5.1. Introduction 151
5.2. Materials and methods 153
5.2.1. Buttermilk production 153
5.2.2. Cell culture 153
5.2.3. Acid phosphatase activity assay 154
5.2.4. Statistical analysis 154
5.3. Results 155
xxxii
5.3.1. Compositional analysis of buttermilks 155
5.3.2. Cytotoxicity 158
5.3.2.1. Antiproliferative activity of concentrated buttermilk fractions
produced from unwashed and washed cream 158
5.3.2.2. Antiproliferative activity of buttermilk samples after spray,
freeze and spin drying 161
5.4. Discussion 165
5.5. Conclusions 169
CHAPTER 6
Analysis of antiproliferative mode of action of buttermilk on SW480 colon
cancer cells.
6.1. Introduction 172
6.2. Materials and Methods 175
6.2.1. Materials 175
6.2.2. Cell culture 175
6.2.3. Haematoxylin and eosin staining of cultured cells 176
6.2.4. Fluorescence methods for detection of apoptosis 177
6.2.4.1. Tetramethylrhodamine ethyl ester perchlorate (TMRE)
staining of cultured cells 177
6.2.4.2. Apoptosis and cell cycle analysis using propidium iodide
by flow cytometry 177
6.2.4.3. Apoptosis detection using Annexin-V-FLUOS staining 178
6.2.5. Determination of Akt using fast activated cell-based ELISA (FACE) 179
6.2.6. Analysis of β-catenin, ERK2, phosphorylated-ERK 1/2, c-myc,
phosphorylated p38, and phosphorylated JNK using In-Cell Western Assay 180
6.2.7. Western Blot analysis of caspase-9 and caspase-3 181
6.2.7.1 Harvesting the cells 181
6.2.7.2. Protein estimation 182
6.2.7.3. SDS-PAGE 182
6.2.7.4. Blotting and detection 183
6.2.8. Immunofluorescence analysis of cleaved PARP, apoptosis-inducing
factor (AIF) and endonuclease G 183
6.2.9. Statistical analysis 184
6.3. Results 185
6.3.1. Haematoxylin and eosin staining of cultured cells 185
6.3.2. Apoptosis detection using Annexin-V-FLUOS by FACS 187
6.3.3. Apoptosis detection using Anexin-V-FLUOS by fluorescence microscopy 190
xxxiii
6.3.4. Apoptosis and cell cycle analysis by FACS 192
6.3.5. Analysis of mitochondrial membrane depolarization 194
6.3.6. Analysis of cleavage of apoptotic biomarkers: caspase-3, caspase-9
and PARP 196
6.3.7. Efect of buttermilk on signalling molecules: Akt, ERK 1/2, β-catenin
and c-myc 200
6.3.8. Analysis of endonuclease G and AIF by immunofluorescence 207
6.4. Discussion 216
6.5. Conclusions 222
Final discussion 224
References 230
CHAPTER 1
Milk fat globule membrane – a source of polar lipids for colonic
health?
xxxv
The milk fat globule membrane (MFGM) surrounds fat globules, protects
it against lipolysis and disperses the milk fat in the milk plasma. Besides their
structural and emulsifying role, in vivo and in vitro studies have demonstrated that
phospholipids and sphingolipids of MFGM possess cancer risk-reducing
properties. Several reports attribute its chemopreventive activity to products of
sphingomyelin hydrolysis, which affect multiple cellular targets that control cell
growth, differentiation and apoptosis. With knowledge on the potential health
benefits of MFGM lipids and proteins dairy industries could in the future address
their research in developing new functional dairy products enriched in beneficial
MFGM components.
1.1. Intestinal tract integrity and role of lipids
Maintenance of gastrointestinal tract (GIT) integrity is vital for assimilation of
nutrients and elimination of waste. The small intestine in the human adult is
approximately 6 m in length and the large intestine (colon) approximately 1.5 m. A
monolayer of epithelial cells specialized for absorption of nutrients, water and
electrolytes lines the entire length of the intestine (Johnson, 2001). These cells also
constitute a mucosal barrier between the body and the lumen affording protection
from potentially hostile microorganisms and toxins. The most distinctive feature of
the small intestine is the presence of innumerable villi that extend into the lumen as
finger-like projections composed of columnar epithelial cells. Between the villi are
pit-like crypts that constitute the proliferative zone containing rapidly dividing,
undifferentiated epithelial cells that serve to replace cells that are continuously shed
into the gut lumen. In contrast, the mucosa of the colon has no villi and is flat. In both
small intestine and colon, cell proliferation is at a maximum near the base of the crypt
(Johnson, 2001). As cells divide one daughter cell retains its physical location and
continues to divide, whilst the other  enters a population of dividing transit cells that
migrate upward from the crypt base. Crypt-cell replication is balanced by exfoliation
and apoptosis. Growth signals, growth inhibiting signals and death signals under the
influence of intricate genetic control systems regulate the balance between cell birth
and cell death in the intestinal tract. Disturbances in this fine-regulated interaction can
lead to tumour formation in the gastrointestinal tract.
As a cell divides in two, it must make sufficient amounts of additional
membranes to accommodate the expansion of its surface area and internal organelles.
Generation of new cell membranes in the rapidly turning over mucosal cells of the
4human intestinal tract is as fundamentally important as protein synthesis or DNA
replication. The lipid components of membranes, principally phospholipids,
sphingolipids and sterols such as cholesterol, provide the basic structural and physical
properties for the new cells. Mucosal cells of the epithelium synthesize as well as
import these lipid molecules to varying degrees to form membranes.
Phosphoglycerides and sphingolipids are distributed asymmetrically within the
membrane surface of polarized intestinal cells as well as in the membranes of various
intracellular organelles (e.g. endoplasmic reticulum, Golgi, lysosome, mitochondria).
For instance, the apical membrane of intestinal epithelial cells is more enriched in
sphingolipids than the basolateral surface. Glycosphingolipid levels are higher in
epithelial cells than in non-epithelial cells of the small intestine and colon. An
analysis of sphingolipid profiles in intestinal cells by chromatographic techniques
(TLC, GC, and GC-MS) has revealed that sphingolipid biosynthesis and cellular
location are intimately linked to mucosal cell differentiation and maturation (reviewed
in Duan & Nilsson, 2009). Glycosphingolipid composition changed radically during
foetal and neonatal development of the digestive tract and during cell migration from
crypt to villus tip (Bouhours and Glickman, 1976). A high content of
glucosylceramide, synthesized by glucosylceramide synthase was observed during
cell differentiation; GM3, the most abundant ganglioside synthesised in the intestine
is located mainly in the apical membrane of villus cells where activity of CMP-sialic
acid:lactosylceramide sialyltransferase, the key enzyme regulating ganglioside
synthesis is high compared with crypt cells (Bouhours and Glickman, 1976).
Sphingomyelin (SM) and complex glycosphinglipids tend to be imported into
intestinal cells much more slowly than sphingosine, their simple sphingoid base.
5Instead, they (i.e. dietary sphingolipids) are metabolised in the gut lumen by
ectoenzymes expressed on the luminal surface of enterocytes. These include
sphingomyelinases which metabolise sphingomyelin to ceramide and ceramidases
which metabolise ceramide to sphingosine. Sphingomyelinases also act on
endogenous sphingomyelin occurring in the outer leaflet of absorptive cells.
Sphingosine is taken up by enterocytes and converted into sphingosine-1-phosphate
(S1P) by sphingosine kinase (SK). S1P may be rapidly recycled back to sphingosine
by phosphatases or irreversibly degraded by S1P lyase which converts S1P to palmitic
aldehyde and ethanolamine phosphate. The metabolites of sphingomyelin serve as
intermediates either in the conversion of sphingoid bases to palmitic acid for
incorporation into chylomicrons or in sphingolipid synthesis. Additionally, they may
serve as bioactive lipids that initiate signalling pathways. Expression levels of
sphingolipid metabolic enzymes in the intestinal tract and intracellular
compartmentation of ceramide, sphingosine and S1P determine their access to
signalling targets and ultimately their biological effects in the gut.
The last two decades have seen an explosion of interest in the regulatory roles
of sphingolipids in fundamental biological processes that are integral to cancer
pathogenesis. Although the risk of colon cancer is increased by age and certain
inherited genetic mutations, external hazards, such as smoking, industrial pollutants,
ultraviolet radiation and a diet rich in saturated fat cannot be excluded as risk factors.
The term chemoprevention, a strategy designed to block, reverse or delay
carcinogenesis prior to tumour invasion applies not only to pharmacological
components but also to nutritional agents (Hawk et al., 2004). There is an increasing
awareness that diet can influence colon cancer development and progression; hence
food science and new product development is focused on health aspects of particular
6food components. In recent years, dairy food research has yielded much evidence that
redresses the negative image of milk as an undesirable dietary source of saturated fat
and cholesterol, which were found to be responsible for coronary heart disease
(Kannel et al., 1971; Parodi, 2003). While much research has focused on the anti-
inflammatory, anti-atherogenic and anti-carcinogenic activities of esterified fatty acids
such as rumenic acid (RA) in milk fat globules (Parodi, 2003) there is now substantial
evidence that the cancer risk-reduction property resides also in the phospholipids,
sphingolipids and proteins of the MFGM that surrounds the lipid triglyceride core,
protecting it from enzymatic attack by lipases (Spitsberg, 2005; Dewettinck et al.,
2008). The MFGM is a rich source of phospholipids, sphingolipids and proteins that
are known to affect multiple cellular mechanisms, in particular cell proliferation and
apoptosis. This review focuses on the impact of lipid components of the milk fat
globule membrane on human health, particularly in relation to colorectal cancer.
1.2. Milk fat globule membrane (MFGM)
Milk has evolved as a complete food produced by mammary epithelial cells of
lactating female mammals to sustain immunologically immature neonates through a
period of intensive growth and development into maturity. Being the product of
mammalian genes, the rapidly expanding tools of biotechnology enable an
understanding of the variation in milk composition as a function of species, time and
physiology. Bovine milk contains hundreds of diverse components including proteins,
peptides, amino acids, triacylglycerides, diacylglycerides, saturated and
polyunsaturated fatty acids, phospholipids, lactose, vitamins and minerals (Fox and
McSweeney, 1998). Processing strategies are being developed to fractionate bovine
milk into constituent molecular components for structure function studies. Increasing
knowledge of the molecular structure and natural function of milk’s biomolecules has
7potential to inform development of novel foods with distinct characteristics that will
deliver health and well being to individual consumers.
As discussed above, lipids are a major structural element for cells. Lipid
biosynthetic pathways that form the myriad of lipids found in mammalian milks
evolved specifically to support growth and survival of neonates. Lipids are ‘old’
molecules with established roles in storing energy, building membranes, signalling
within and between cells, modifying proteins, forming permeability barriers and
protecting cells from reactive oxygen species. The new discipline of systems biology
aims to define the cellular lipidome, build a comprehensive picture of lipid metabolic
pathway interactions, discover new molecular lipid species and predict how lipids
modulate biological functions (Brown and Murphy 2009). The approach has
generated a lipid renaissance with potential to bring lipidomics into milk processing in
order to determine how milk lipids modulate health and disease in humans (Casado et
al., 2009).
Triglycerides comprise 98% of milk lipids (Lopez et al., 2011). Containing
over 400 different acylchains, milk lipids are the most mixed triglycerides found in
nature serving as a remarkable source of energy, fat-soluble nutrients and bioactive
lipids for mammals (German and Dillard, 2006). According to Mather and Keenan
(1998), MFGM is a tri-layer consisting of proteins and lipids from the endoplasmic
reticulum membrane and from the membrane of the mammary epithelial cells which
coats lipid droplets during their secretion. As it is derived from the cell membrane,
MFGM is naturally rich in important minor lipids (sphingomyelin,
phosphatidylserine, phosphatidylcholine) and glycoproteins that are exclusively found
in cell membranes of bovine mammary epithelial cells. MFGM shares the physical,
8chemical and functional features of the apical surface membrane from which it is
secreted, making it suitable as a vehicle for delivery of lipid components to
gastrointestinal cells.
1.2.1. Proteins and lipids of MFGM
Extensive proteomic studies have characterized the protein moiety of bovine
MFGM (Affolter et al., 2010; Fong et al., 2007; Fong and Norris, 2009; Reinhardt
and Lippolis, 2006). Bovine MFGM mainly consists of xanthine oxidase (155 kDa),
butyrophilin (67 kDa), glycoprotein B (48 kDa), mucin MUC1 (200 kDa), the redox
enzyme, CD36 (77 kDa), the adhesive glycoprotein, MFG-E8 (PAS-6/7), adipocyte
differentiation-related protein (ADRP) and fatty-acid binding protein (13 kDa) (Fox
and McSweeney, 1998; Mather and Keenan, 1998; reviewed by Dewettinck et al.,
2008). Recently, Fong et al. (2007) characterized some new minor proteins in bovine
MFGM which have not been reported previously: polymeric Ig receptor protein,
apolipoproteins E and A1, 71 kDa heat-shock cognate protein, clusterin,
lactoperoxidase, Ig heavy chain and peptidylprolyl isomerase A. Some of these
MFGM proteins were found to possess beneficial properties on human health, which
are briefly reviewed in table 1.1.
9Table 1.1. The major proteins of the MFGM and their health benefits (based on Dewettinck et al. 2008 and Riccio 2004).
Component
MW
(kDa)
pI Health aspects References
Fatty acid binding
protein  (FABP)
13 5-5.5 Cell growth inhibitor
Anticancer factor (FABP as selenium carrier)
Epidermal-FABP contributes to regulation of EAE
(experimental allergic encephalomyelitis, disease
induced in laboratory animals that displays clinical
characteristics similar to human multiple sclerosis, MS)
Spitsberg et al. 1995
Bansal et al. 1989
Li et al. 2009
Breast cancer type 1 susceptibility
protein (BRCA1)
Inhibition of breast cancer Brody and Biesecker 1998
Breast cancer type 2 susceptibility
protein (BRCA2)
Inhibition of breast cancer Vissac et al. 2002; Brody and Biesecker
1998
10
Xantine oxidase
(XO)
146
(300)
7.8 Bactericidal agent
Anti-inflammatory
Martin et al. 2004; Hancock et al. 2002;
Clare et al. 2008
Spitsberg 2005; Fong et al. 2007
Mucin 1 (MUC1) 160-
200
<4.5 Protective effect against rotavirus infection Kvistgaard et al. 2004; Peterson et al.
1998
Butyrophilin (BTN) 66-67 5.32 Suppression of multiple sclerosis (MS)
Induces or modulates experimental allergic
encephalomyelitis (EAE)
Influences pathogenesis of autistic behaviour
Mana et al. 2004
Johns and Bernard 1999; Stefferl et al.
2000
Vojdani et al. 2002
Lactadherin
(PAS6/7, MFG-E8)
47 6-6.6 Protective effect against rotavirus infection
Fusion with antigen promotes antigen-specific immune
responses, resulting in delayed tumor growth
Lactadherin promotes vascular endothelial growth factor
-dependent neovascularization
Kvistgaard et al. 2004; Peterson et al.
1998; Newburg et al. 1998
Zeelenberg et al. 2008; Liu et al. 2005
Silvestre et al. 2005
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MFGM contains approximately 0.5-1% of the total lipids in milk, of which the
majority are sphingolipids and phospholipids (phosphoglycerides) which show polar
properties as they are amphiphilic molecules with hydrophobic fatty acyl chains and a
hydrophilic organophosphate (choline, serine, ethanolamine or inositol) head group
(Dewettinck et al., 2008). Analysis of lipids is traditionally based on chromatographic
techniques such as TLC and HPLC with UV detection and on nuclear magnetic
resonance spectroscopy. Owing to overlap of individual lipid classes, these techniques
provide limited resolution for analysis of complex lipid mixtures as found in MFGM.
Mass spectrometry (MS) methods using electrospray ionization in combination with
HPLC separation has been successfully used to confirm the lipid composition profile
of bovine MFGM as determined by quantitative capillary GC (Fong et al., 2007).
Table 1.2 represents the relative lipid composition of bovine MFGM.
Table 1.2. Relative lipid composition of bovine MFGM  expressed as a percentage of
total lipid extracted (adapted from Fong et al. 2007)
Component % w/w
Triglyceride 56
Diglyceride 2.1
Monoglyceride 0.4
Free Fatty Acids 0.9
Phospholipids
Phosphatidylcholine
Phosphatidylserine
Phosphatidylinositol
Phosphatidylethanolamine
Sphingomyelin
Lactosylcerebroside
Glucosylcerebroside
40.6
31% (w/w) of phospholipids
5% (w/w) of phospholipids
7.1% (w/w) of phospholipids
30.5% (w/w) of phospholipids
19.9% (w/w) of phospholipids
3.4% (w/w) of phospholipids
0.3% (w/w) of phospholipids
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The fatty acid composition associated with the MFGM triglyceride was found
to contain higher proportions of palmitic and stearic acids and fewer unsaturated fatty
acids, such as C14:1, C16:1, C18:1 and conjugated C18:2, when compared with the
butter fat triglyceride (Fong et al., 2007). Relative phospholipid abundance of MFGM
was phosphatidylcholine > phosphatidylethanolamine > sphingomyelin >
phosphatidylinositol > phosphatidylserine > lactosylcerebroside >
glucosylcerebroside. In general, C18:1 and/or C18:2 were the predominant fatty acyl
chains in phospholipids contributing to MFGM fluidity and membrane protein
activity. Saturated sphingoid bases were associated with unsaturated or saturated
longer chain fatty acids while unsaturated sphingoid bases were associated with
saturated shorter chain fatty acids (Fong et al., 2007). In general, the acyl composition
of sphingomyelin differed from that of phosphoglycerides in containing significantly
higher proportions of long chain fatty acids with carbon chain length greater than 20,
particularly C22:0, C23:0 and C24:0. Conjugated C18:2 was observed in
sphingomyelin, but not in the phosphoglyceride fractions of MFGM. Dietary
supplementation of cow diet with polyunsaturated fatty acids increased the
unsaturated FA content and concentration of phospholipids and sphingomyelin in
bovine MFGM (Lopez et al., 2008). More recently, MFGM derived from small milk
fat globules contained significantly higher amounts of phosphatidylcholine and
sphingomyelin than MFGM from large milk fat globules (Lopez et al., 2011).
Confocal laser scanning microscopy and fluorescent probes showed that the bilayer of
the MFGM was characterized by distinct rigid liquid-ordered microdomains enriched
in sphingomyelin that were laterally segregated from liquid-disordered domains
enriched in glycerophospholipids in which proteins and glycosylated molecules were
dispersed (Lopez et al., 2011). A comprehensive analysis of the anti-cancer and health
13
beneficial properties of a wide range of MFGM components and other agents in milk
can be found in reviews by Spitsberg (2005) and Parodi (2001, 2003). A wide review
of the effects of CLA in vivo and in vitro was published by Wahle et al. (2004). The
health benefits of sphingolipids and phosphoglycerides, which are the major
components of MFGM are discussed further in the text.
1.2.2. Isolation and purification of MFGM
MFGM in milk enables milk fat to remain dispersed throughout the aqueous
phase. Ambient and physiological factors such as quality of milk, its age, temperature,
bacteriological content as well as stage of lactation and season can influence MFGM
structure and composition (Fox and McSweeney, 1998). Dairy processing operations,
such as homogenization, heating or drying as well as milk handling and transportation
may also affect release of MFGM. Buttermilk, a by-product of butter manufacture is
an ideal source of bovine MFGM material for compositional, structural and functional
studies (Astaire et al., 2003; Corredig et al., 2003; Dewettinck et al., 2008; Jinjarak et
al., 2006; Morin et al., 2006, 2007a, 2007b; Rombaut and Dewettinck, 2006;
Rombaut et al., 2006, Snow et al., 2010). Not only was it a traditional beverage for
the Irish population up to the middle of 20th century it was also used for the care of
patients with advanced cancer (Grant, 1969)
Traditionally, whole milk was left to sit to allow the cream to separate from
skimmed milk. Nowadays separation is quickened by mechanical centrifugation
which may cause some damage to MFGM. In traditional buttermilk wild strains of
lactic acid bacteria (LAB) acquired from the environment fermented the milk. It
lowered the pH of milk and gave a valuable product rich in lactic acid, a by-product
naturally produced by LAB while fermenting lactose. In the next step of buttermaking
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the cream is washed repeatedly 3-6 times with water. This can cause some damage to
the outer layers and also loss of small molecules (Fox and McSweeney, 1998). During
churning, as a result of mechanical treatment, the MFGM material is shed and
released into the aqueous phase, which is buttermilk. The lipid droplets are then
released from the stabilizing polar lipid envelope and aggregate into the fat grains.
The cream is split into two phases: a water-in-oil phase and an oil-in-water phase,
called buttermilk. In traditional churning, the buttermilk is drained off when fat grains
reach a certain size, but in modern buttermaking machines, buttermilk drainage is
continuous (Fox and McSweeney, 1998). The bacterial souring of buttermilk makes it
even more valuable and “gut-friendly” product, and also tolerable by lactose-
intolerant people.
Relative to other dairy products (butter, cheddar cheese, cream) buttermilk has
a high polar lipid content (2.03g / 100g dry matter and 33.05g / 100g total lipids) and
can be concentrated by removal of water by filtration, evaporation or drying
(Rombaut and Dewettinck, 2006). Strategies for purification of polar lipids employ a
combination of coagulation, filtration, centrifugation to remove lactose, whey proteins
and minerals. A phospholipid-rich retentate fraction was achieved upon cross flow
membrane filtration after casein membrane retention was reduced by acid and rennet
coagulation (Sachdeva and Buchhein, 1997). A combination of filtration and
supercritical CO2 removed neutral lipids present in microfiltered retentate and yielded
a purified polar lipid product that contained 83.15g on a total lipid basis (Astaire et
al., 2003). The properties, analysis and purification of milk polar lipids are reviewed
extensively (Dewettinck et al., 2008; Rombaut and Dewettinck, 2006). It is apparant
that standardisation and optimisation of processes for purification of polar lipids
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would improve the quality of MFGM for investigations of its potential health benefits
in the colon.
Potential roles for MFGM in the gastrointestinal tract of humans include
enhancing binding ability of probiotic bacteria to intestinal cells, inhibition of viral
infectivity (Jimenez-Flores and Brisson, 2008) and maintenance of colon health.
Recently, MFGM was shown to confer protection against colon carcinogenesis in an
animal model of experimental carcinogenesis. Rats fed a diet containing MFGM had
significantly fewer aberrant crypt foci compared to rats fed corn oil or anhydrous
milkfat (Snow et al., 2010). Sphingomyelin, which accounts for 19% of bovine
MFGM polar lipids, provides specific properties to the colon that need to be further
investigated. Although the structure-function relationship of individual sphingomyelin
species is not known, it has been shown that ceramides containing specific fatty acids
are involved in cell death and inhibit cell growth. C16 and C24 ceramide species
regulate apoptosis (Osawa et al., 2005; Seumois et al., 2007) whereas C18 ceramide
inhibits cancer cell growth (Koybasi et al., 2004) Thus, lipidomics approaches to
quantification of acyl composition of sphingmyelin will be of great importance in
delineating the precise role of bovine MFGM sphingolipids on colon health.
1.3. Profile of polar lipids present in gastrointestinal tract
1.3.1 Phosphoglycerides
Phosphoglycerides (also called glycerophospholipids) are derivatives of sn-
glycerol 3-phosphate containing two esterified fatty acyl chains and a polar head
group esterified to the phosphate (Fig. 1. 1). The fatty acids can vary in length and be
saturated (no double bonds) or unsaturated (one, two or three double bonds). In
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phosphatidylcholine (PC) the head group is choline. Fig. 1.1 shows the molecules
attached to the phosphate group in three other common phosphoglycerides:
phosphatidylethanolamine, phosphatidylserine and phosphatidylinositol.
Fig. 1.1. General structure and major classes of phosphoglycerides.
Lipids, lipid kinases and lipid phosphatases play as important role as proteins
in activating and mediating signal transduction pathways in cells (reviewed by Eyster,
2007). When cell-surface receptors are stimulated by extracellular signals, a number
of bioactive lipid mediators (e.g. 1,2-diacylglycerol (DAG), phosphatidylinositol-4,5-
bisphosphate, phosphatidic acid (PA), lysophospholipids and arachidonic acid) are
generated through the action of phospholipases C, D and A2 on specific cellular
phospholipids (Fig. 1.2). These second messenger products have been shown to
function as mediators of numerous cell responses including proliferation,
differentiation, migration and apoptosis resistance. Lysophospholipids are products of
phospholipase cleavage of phospholipids. Although present in biological membranes
in extremely low levels (less than 1% of all phospholipids), they are nevertheless
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considered potent endogenous growth factors causing various biological effects,
primarily cell proliferation (Rivera and Chun, 2008).
Fig. 1.2. Cleavage products of the action of phospholipases on polyphosphoinositides
and phosphatidylcholine. Abbreviations: DAG, diacylglycerol kinase; PA,
phosphatidic acid; PLA2, phospholipase A2; PLC, phospholipase C; PLD,
phospholipase D
1.3.1.1. Phosphatidylcholine
Phosphatidylcholine is the most prominent phospholipid in both healthy and
colorectal cancer cells (reviewed extensively by Cui and Houweling, 2002) and its
biosynthesis is greatly increased in colon cancer tissues, primarily due to decreased
activities of phospholipase C and D and enhanced activity of CTP:phosphocholine
cytidylyltransferase activity (Dueck et al., 1996).
Phosphatidylcholine is synthesized in the intestine by the cytidine
diphosphocholine (CDP-choline) pathway. Preformed choline is phosphorylated with
ATP by a choline kinase in the cytoplasm of the cell to phosphocholine, which reacts
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with cytidine triphosphate to form CDP-choline and pyrophosphate. CDP-choline:1,2-
diacylglycerol cholinephosphotransferase, a membrane-bound enzyme in the
endoplasmic reticulum catalyses the transfer of phosphocholine moiety of CDP-
choline to sn-1,2-diacylglycerol to form phosphatidylcholine (Fig. 1.3). The CDP-
choline to phosphatidylcholine pathway occurs in all cells containing a nucleus; an
alternative pathway called the phosphatidylethanolamine methylation pathway occurs
only in the liver and accounts for 20-30% of phosphatidylcholine synthesised there.
This reaction involves transfer of three methyl groups to the nitrogen of
phosphatidylethanolamine by S-adenosyl methionine.
Choline
CK
Phosphocholine
Cytidine diphodphocholine
Phosphatidylcholine
ATP
ADP
CTP
PPCT
CPT
DAG
CMP
Ethanolamine
Phosphoethanolamine
Cytidine diphosphoethanolamine
Phosphatidylethanolamine
EK
ECT
CEPT
PEMT
ATP
ADP
PP
CTP
CMP
DAG
+3CH3
tidine diphosphocholine
Fig.1.3. Pathways for the synthesis of phosphatidylcholine; it can be formed either
from choline (in the intestine) or from ethanolamine followed by methylation of
phosphatidylethanolamine (in the liver). Abbreviations: CEPT; CDP-
ethanolamine:1,2 diacylglycerol ethanolaminephosphotransferase; CK, choline
kinase; CPT, cholinephosphotransferase; CT, CTP:phosphocholine
cytidylyltransferase; DAG, diacylglycerol; ECT, CTP:phosphoethanolamine
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cytidylyltransferase; EK, ethanolamine kinase; PEMT, phosphatidylethanolamine N-
methyltransferase.
Increased expression of biosynthetic enzymes provides a pool of
phosphatidylcholine for enhanced membrane synthesis that is necessary for rapid
growth during tumour development. Microarray transcription profiling revealed
overexpression of lysophosphatidylcholine acyltransferase 1, the enzyme that converts
lysophosphatidylcholine into phosphatidylcholine in colorectal adenocarcinomas
compared to normal mucosas (Mansilla et al., 2009).
Phosphatidylcholine is not only a major structural component of cell
membranes but is also, along with sphingomyelin, a reservoir of lipid secondary
messengers, diacylglycerol and ceramide. Yen et al. (1999) reported that deficiency of
choline diminished membrane phosphatidylcholine and sphingomyelin levels in PC12
neuronal cells and that this was associated with accumulation of ceramide and
diacylglycerol, activation of caspases and induction of apoptosis. Although choline
deficiency in humans was associated with increased DNA damage and apoptosis in
lymphocytes compared with choline-sufficient humans (da Costa et al., 2006), a
recent epidemiological study involving 47,302 men showed that dietary intake of
choline was not associated with increased colorectal cancer risk (Lee et al., 2010).
Nuclear magnetic resonance (NMR)-based metabolomic studies of human
tumours identified elevated levels of phosphocholine relative to normal tissues
(Yalcin et al., 2010). Phosphocholine is a precursor metabolite synthesized by choline
kinase, which provides a ready supply of phosphatidic acid necessary for stimulating
cancer survival signalling pathways. Increased levels of choline kinase activity and
choline kinase mRNA levels have been found in rat 1,2-dimethylhydrazine-induced
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colon cancer and in human colon cancer (Nakagami et al., 1999a and 1999b).
Chemical inhibitors that target choline kinase activity and genetic approaches that
silence choline kinase by generation of an shRNA against the alpha isoform of choline
kinase have proven to be effective anti-tumoural strategies in vitro and in vivo
(Rodriguez-Gonzalez et al., 2004; Sanchez-Martin et al., 2005; Yalcin et al., 2010).
The specific depletion of the choline kinase alpha isoform induced apoptosis in
several tumour-derived cell lines from breast, bladder, lung and cervix carcinoma
tumours, while the viability of normal primary cells was not affected (Banez-Coronel
et al., 2008).
Signalling by phospholipids is also dependent on fatty acid composition. The
major fatty acid incorporated into phosphatidylcholine is arachidonic acid, which is a
precursor for prostaglandin formation through activation of COX-2, which leads to
cell proliferation and inflammation. The effects of marine phosphatidylcholine and
phosphatidylserine have been studied by Hossain et al. (2006). They found that
phosphatidylcholine and phosphatidylserine highly enriched in eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) increased the cytotoxic and pro-apoptotic
effect of sodium butyrate on Caco-2 cells.
1.3.1.2. Phosphatidylinositol
Other major membrane phospholipids that cause cell proliferation are
phosphatidylinositol and phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), its
phosphorylated derivative. The enzyme phosphatidylinositol-3-kinase (PI3K), when
recruited to the membrane by activated receptor tyrosine kinases, generates
phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3) (Fig. 1.4). The 3-phosphate
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added by this enzyme is a binding site for various signal transduction proteins, in
particular protein kinase B (PKB) also known as Akt.
Fig. 1.4. Phosphorylation of PI (4,5)P2 by PI3K and cleavage products from the action
of PLC on PI(4,5)P2: DAG and IP3. Abbreviations: DAG, diacylglycerol; IP3, inositol
trisphosphate; PI(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate; PI3K,
phosphatidylinositol-3-kinase; PI(4,5)P2, phosphatidylinositol-4,5-bisphosphate; PLC,
phospholipase C.
In resting cells, the level of PI-3-phosphates is low. Hormone stimulation
results in elevated PI-3-phosphate levels, PKB binding and localisation to the cell
surface membrane. Full activation of PKB requires two further site phosphorylations
by phosphoinositide-dependent protein kinase 1 (PDK1). Once fully activated, PKB
can dissociate from the plasma membrane and phosphorylate pro-apoptotic proteins,
such as Bad, thereby preventing activation of an apoptotic pathway leading to cell
death. Data accumulated in the last decade have established that this pathway plays a
key role in cancer development, progression and resistance to chemotherapy.
Therefore, drugs designed to specifically target this pathway are under development
to be used as a single agent and in combination to chemotherapy to overcome
therapeutic resistance.
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1.3.2. Sphingolipids
Sphingolipids represent a broad class of lipids naturally occurring in most
cellular membranes. They consist of a sphingoid base, a fatty acid tail and a
headgroup (Merrill et al., 1993; Merrill et al., 1997; Huwiler et al., 2000). The
sphingoid base on its own, sphingosine ((2S,3R,4E)-2-amino-1,3-dihydroxy-4-
octadecene) occurs in most mammalian cells while the most common sphingoid base
in yeasts and plants is phytosphingosine. Fig. 1.5 presents the chemical structure of
the most common sphingolipids, of which sphingomyelin, glucosylceramide and
lactosylceramide are found in dairy products.
Variations in the type, number and linkage of sugar residues in the
oligosaccharide chain give rise to a wide range of naturally occurring
glycosphingolipids. Also the lipid moiety can vary in terms of chain length of the fatty
acid and in the degree of saturation and hydroxylation of the sphingoid base.
Glycosphingolipids form a cell-type specific pattern, which changes with cell growth,
differentiation, viral transformation, ontogenesis and oncogenesis (Van Slambrouck
and Steelant, 2007; Hakomori, 2003).
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Sphingolipid Structure
D-erythro-C18-sphingosine
D-erythro-C16-ceramide
D-erythro-C16-sphingomyelin
D-erythro-C16-ceramide-1-phosphate
D-erythro-C16-sphingosine-1-phosphate
D-glucosyl-β1-11’-C16-ceramide
Fig. 1.5. Chemical structure of sphingolipids; sketched with C16 N-acyl chain,
commonly found in nature.
Sphingomyelin and glycosphingolipids undergo hydrolysis via the action of
mucosal alkaline sphingomyelinase and neutral ceramidase in the epithelial cells of
the intestine to form bioactive lipids, such as ceramide, sphingosine, ceramide-1-
phosphate or sphingosine-1-phosphate that mediate many signal transduction events
necessary for mammalian development. Their importance is evident in the
sphingolipidoses, a group of inherited diseases associated with high mortality caused
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by defects in lysosomal sphingolipid degradation. Niemann-Pick disease is
characterised by defective acid sphingomyelinase activity and excessive storage of
sphingomyelin (reviewed in Kolter and Sandhoff, 2006). A defect in acid ceramidase
and excessive storage of ceramide leads to Farber disease while Gaucher disease is
caused by defect in β-glucocerebrosidase and excessive storage of glucosylceramide
(reviewed by Huwiler et al., 2000). Both diseases are diagnosed in infants. Symptoms
of Farber disease may include moderately impaired mental ability and problems with
swallowing. Other symptoms may include vomiting, arthritis, swollen lymph nodes,
swollen joints, joint contractures (chronic shortening of muscles or tendons around
joints), hoarseness and xanthomas which thicken around joints as the disease
progresses. Most children with Farber disease die by age 2, usually from lung disease.
Gaucher disease is characterised by enlarged liver and spleen, osteoporosis,
yellowish-brown skin pigmentation and the rapid and premature destruction of blood
cells, leading to anaemia, neutropenia and thrombocytopenia.
Sphingomyelin hydrolysis starts with the action of sphingomyelinase on
phosphorylcholine headgroup (Spence, 1993) and formation of ceramide (Fig. 1.6),
which is either cleaved into sphingosine and a long-chain fatty acid by ceramidase
(Hassler and Bell, 1993) or phosphorylated to ceramide-1-phosphate by ceramide
kinase (Sugiura et al., 2002). Sphingosine is then phosphorylated at the hydroxyl
group by a sphingosine kinase to form sphingosine-1-phosphate. Ceramide can be
also glucosylated to form glucocerebrosides, such as glucosylceramide,
lactosylceramide and more complex gangliosides. Numerous studies have produced
experimental data as proof of their anti-cancer (ceramide, sphingosine), pro-cancer
(sphingosine-1-phosphate, ceramide-1-phosphate) or other properties which are
described in the following sub-sections. A delicate balance exists between these
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metabolites in human cells, the alterations of which may influence cell growth and the
process of carcinogenesis.
Ceramide
Sphingosine
Sphingosine-1-phosphate
Glucosylceramide
Lactosylceramide
Ceramide-1-phosphateDihydroceramide
Sphingomyelin
Glycosphingolipids
CDaseCS
S1PP SK
C1PP
CK
SMase
SMS
DES
CRS
GCS
Fig. 1.6. Pathways and products of ceramide metabolism. Abbreviations: C1PP,
ceramide-1-phosphate phosphatase; CDase, ceramidase; CRS, cerebrosidase; CK,
ceramide kinase; CS, ceramide synthase; DES, dihydroceramide desaturase; GCS,
glucosylceramide synthase; S1PP, sphingosine-1-phosphate phosphatase; SMS,
sphingomyelin synthase; SMase, sphingomyelinase; SK, sphingosine kinase.
1.3.2.1 Ceramide
Ceramide is composed of an N-acylated (14 to 26 carbons) sphingosine (18
carbons). A trans double bond across C4 and C5 of the sphingosine backbone is
important for its biological activity, such that dihydroceramide, which lacks this
double bond, is mainly biologically inactive (Ogretmen and Hannun, 2004). Ceramide
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was first isolated from bovine milk in the free form in 1972 by Fujino and Fujishima.
Sixteen component fatty acids were found, among which C23:0 (38.1%), C24:0
(29.5%), C22:0 (17.9%) and C16:0 (7.2%) were predominant. Seven component long-
chain bases were detected. The principal bases were C18-sphingosine (35.0%) and
C16-sphingosine (31.6%) (Fujino and Fujishima, 1972). Recently, Fong et al. (2007)
confirmed that in bovine milk the sphingoid base consisted predominantly of C16:1,
C17:1 and C18:1 fatty acids.
Ceramide is produced in response to a diverse range of stress stimuli including
toxic chemotherapeutic drug treatments, growth factor withdrawal, radiation, hypoxia,
hyperthermia and ischemia. Several direct targets of ceramide have been identified in
vitro and in vivo which tie ceramide to regulation of apoptosis, cell cycle arrest and
inhibition of proliferation (reviewed by Duan and Nilsson, 2009, Hannun and Obeid,
2008) (Fig. 1.7). They include KSR, cRAF, MEKK, cathepsin D and serine/threonine
protein phosphatases PP1 (protein phosphatase 1) and PP2A (protein phosphatase 2A)
(Wolff et al., 1994).
Ceramide
PP1
PP2ABcl-2
c-Jun
SB proteins RB
PKCαAkt/PKB
Cathepsin D
Bid
MEKK
cRAF
KSR
Fig. 1.7. Ceramide-regulated targets. Abbreviations: KSR, kinase suppressor of Ras;
MEKK, MAP/ERK kinase kinase; PP1, protein phosphatase 1; PP2A, protein
phosphatase 2A; RB, retinoblastoma protein.
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It is through the protein phosphatases that ceramide can induce apoptosis and
inhibit growth. Ceramide-activated protein phosphatase substrates include c-Jun, Bcl-
2, Akt/PKB, Rb, PKCα, and SR proteins (Pettus et al., 2002). Reyes and co-workers
(1996) showed that treatment with exogenous ceramide or TNFα, a ceramide-
generating agonist, led to time-dependent dephosphorylation of c-Jun in A431 cells.
Deng and co-workers (2009) reported increased mitochondrial PP2A activity and
specific dephosphorylation of mitochondrial Bcl-2 in response to ceramide. PP2A
dephosphorylated Bcl-2 leading to inactivation of its anti-apoptotic function (Ruvolo
et al., 1999; 2002) and it activated pro-apoptotic protein Bad (Chiang et al., 2001).
Several studies have demonstrated the ability of ceramide to induce
dephosphorylation of Akt/PKB with concomitant loss of function. Pre-treatment with
okadaic acid, a phosphatase inhibitor blocked the effect, demonstrating a role for
PP2A in regulating this activity. Lee and co-workers (2000) reported that PKCα, a
Bcl-2 kinase was dephosphorylated in response to exogenous ceramides in cells.
Based on inhibitor studies with fuminosin B1, PP2A was shown to be responsible for
the dephosphorylation of PKCα.
PP1 is also a ceramide-activated protein phosphatase enzyme. The
dephosphorylation of retinoblastoma protein (Rb) by PP1 following ceramide
treatment, which resulted in growth arrest was not affected by okadaic acid at
concentrations that specifically inhibit PP2A (reviewed by Pettus et al., 2002; Chao et
al., 1992). Inhibition of PP1 with phosphatidic acid blocked ceramide-induced
dephosphorylation of Rb and inhibited PARP cleavage, thus implicating PP1 in both
cell cycle arrest and apoptotic processes, respectively (Kishikawa, 1999).
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The dephosphorylation of SR proteins (SRp70, SRp55, SRp40, and SRp30)
provides further evidence of the importance of ceramide activation of PP1 in
apoptosis. SR proteins owe their nomenclature to the presence of sequences of
consecutive serine (S) and arginine (R) dipeptides. They are required for splicing pre-
mRNA prior to translation. Dephosphorylation of SR proteins by PP1 promoted the
generation of the pro-apoptotic splice variants (i.e. the dominant negative Bcl-XS and
caspase-9) at the expense of the anti-apoptotic splice variants (i.e. Bcl-XL and
caspase-9b) (Chalfant et al., 2002).
The role of ceramide in apoptosis is best illustrated in the case of TNF-induced
apoptosis. TNF induces activation of neutral sphingomyelinase and ceramide
formation. Ceramide activation of PP2A resulted in dephosphorylation of Bcl-2 as
well as the Bcl-2 kinase PKCα in mitochondria (Ruvolo et al., 1999; Lee et al., 2000).
The net effect was inhibition of the anti-apoptotic actions of Bcl-2. Since Bcl-2 and
Bcl-X inhibit mitochondrial cytochrome c release, their dephosphorylation may allow
cytochrome c release and downstream caspase-9 activation (Sawada et al., 2000).
As mentioned above, ceramide-induced apoptosis, cell cycle arrest and
inhibition of proliferation also involve direct activation of protein kinases. These
include kinase suppressor of Ras (KSR), cRAF and MEKK, a protein kinase that
phosphorylates one or more of the MEK enzymes on Ser or Thr.
KSR is a scaffold protein that regulates the specificity, efficiency and
amplitude of the MAP kinase (also referred to as extracellular signal-regulated protein
kinase or ERK) signalling cascade. KSR can mediate proliferative responses except
when the pro-apoptotic Bcl-2 family member, BAD, is present. In ceramide-treated
cells which express dephosphorylated Bad, KSR is involved in converting the
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normally proliferative mitogen-activated protein kinase (MAPK) cascade into a pro-
apoptotic signalling pathway (Basu et al., 1998)
Cathepsin D is an important target for ceramide generated endosomally by
acid sphingomyelinase. The interaction of ceramide with cathepsin D was shown to
induce the autocatalytic proteolysis of the 52-kDa pro-enzyme to form the active
48/32-kDa form of cathepsin D. Several studies have shown that activation of the pro-
apoptotic protein Bid, cytochrome c release and caspase-3 activation occur upon
translocation of cathepsin from the lysosome in response to oxidative stress (Kagedal
et al., 2001). Cathepsin D has also been implicated in mediating apoptosis in response
to diverse stress stimuli including TNFα, IFNγ, chemotherapeutic agents and serum
deprivation (Deiss et al., 1996; Wu et al., 1998; Shibata et al., 1998).
1.3.2.2. Sphingosine
Sphingosine is an 18-carbon amino alcohol with an unsaturated hydrocarbon
chain (2-amino-4-octadecene-1,3-diol) and is the major digestion product of complex
sphingolipids in the gastrointestinal tract (Schmelz et al., 2001). It possesses an effect
similar to ceramide on cancer cells and when supplied exogenously can inhibit
proliferation and induce apoptosis in many cancer cell types including colon cancer
cells (Matsubara and Ozawa, 2001). Schmelz and co-workers (2001) found that
sphingosine reduced cytosolic and nuclear β-catenin in SW480 and T84 human colon
cancer cells. β-catenin is an essential component of the Wnt signalling pathway which
is dysfunctional in colon cancer. Most Wnt-signalling dysfunctions lead to the nuclear
accumulation of -catenin where it associates with transcription factors to drive the
transcription of multiple target genes encoding proteins, such as c-myc, cyclin D1,
MMP-7, laminin-5γ2 implicated in proliferation, cell-cell attachment, and invasion
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(Martensson et al., 2007). An important regulator of Wnt signalling pathway is the
protein known as adenomatous polyposis coli (APC), the gene product of the tumour
suppressor gene APC. Together with axin and GSK, it binds to -catenin targeting it
for destruction. Thus, the reduction of cytosolic -catenin in sphingosine-treated
cancer cells maintains Wnt pathway in the OFF position. Defects in the APC/β-
catenin pathway are common in up to 60% of sporadic human colon cancers (Powell
et al., 1992) and are thought to predispose cells to additional mutations that proceed to
neoplasia (Polakis, 1999). It is apparent that dietary sphingolipids, presumably via
their digestion products, bypass or correct defects in the APC/-catenin regulatory
pathway.
1.3.2.3. Sphingosine-1-phosphate
The sphingolipid metabolite sphingosine-1-phosphate is a bioactive
lipoprotein-borne serum lipid formed by the phosphorylation of sphingosine by
sphingosine kinase. It has dual messenger functions acting as a first messenger
extracellularly and as a second messenger intracellularly. As a first messenger,
sphingosine-1-phosphate binds to a family of five specific G protein-coupled
receptors that are differentially expressed in different tissues and which regulate
diverse cellular actions, such as growth, differentiation, cell survival, angiogenesis
and cell migration (reviewed by Goetzl and An, 1998; Pyne and Pyne, 2000; Spiegel
and Milstien, 2003; Hla et al., 2001), immune function and lymphocyte trafficking
(Jolly et al., 2002; Mandala et al., 2002; Brinkmann et al., 2002). Its binding to S1P1
receptor and subsequent activation of a pertussis toxin-sensitive Gi protein is critical
for the formation and extension of new blood vessels. Activation of small GTPases
(e.g. Rac and Rho) that are linked to cytoskeletal rearrangements and motility, ERK,
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p38 mitogen-activated protein kinases, phospholipase D and Akt are further examples
of outside-in signalling conducted by sphingosine-1-phosphate.
Activation of membrane-bound growth factor receptors by platelet-derived
growth factor and epidermal growth factor leads to the formation inside the cell of
sphingosine-1-phosphate, which as a second messenger regulates target biomolecules
including COX-2, ERK, NF-κB, caspase-3 and Bax, vital for inhibition of apoptosis
and induction of proliferation.
Immunohistochemical evidence indicated higher levels of sphingosine kinase
mRNA and protein in human colon cancer cells when compared with their non-
cancerous (normal) cells, indicating a role for sphingosine-1-phosphate in cancer
pathogenesis and progression (Kawamori et al., 2009). Adenomas had higher
expression of sphingosine kinase 1 compared with normal mucosa, and colon cancers
with metastasis had higher expression of sphingosine kinase 1 than those without
metastasis. Enzymes that catabolize sphingosine-1-phosphate, such as sphingosine-1-
phosphate lyase and sphingosine-1-phosphate phosphatase were observed to be
present at higher levels in normal intestinal epithelial cells than in colon cancer cells,
suggesting that colon cancer cells manifest a block in sphingosine-1-phosphate
catabolism.
The sphingosine kinase 1-sphingosine-1-phosphate (SK1-S1P) pathway exerts
significant proliferative activities in cancer cells. Studies in human colon cancer cells
have shown that sphingosine-1-phosphate protects colon cancer cells from
chemotherapy-induced apoptosis. Silencing sphingosine kinase by RNA interference
suppressed cell viability and increased caspase activity and cellular ceramide
formation after oxaliplatin treatment (Nemoto et al., 2009). Forced expression of
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sphingosine-1-phosphate lyase, the enzyme that degrades sphingosine-1-phosphate,
increased apoptosis in DLD1 colon cancer cells both at baseline and in response to
treatment with the chemotherapeutic drug, daunorubicin. Several recent studies have
identified a novel and specific role for sphingosine kinase 1 in mediating COX-2
expression and PGE2 production in various cell models (Pettus et al., 2003; Pettus et
al., 2005; Kawamori et al., 2005). The arachidonic acid cascade is a major
inflammatory pathway involved in colon carcinogenesis. Kawamori et al. (2009)
reported that downregulation of sphingosine kinase 1 by RNA interference (RNAi)
significantly reduced COX-2 expression and PGE2 production induced by cytokines in
HT-29 human colon cancer cells. Enforced sphingosine kinase 1 expression also
induced COX-2 protein in normal intestinal epithelial cells. In addition, they found
that sphingosine kinase 1 protein andmessage levels were increased in azoxymethane-
induced colon tumours in male F344 rats.
Greenspon and colleagues (2009) found that sphingosine-1-phosphate
protected intestinal epithelial cells from apoptosis through the Akt signalling pathway.
It increased levels of phosphorylated Akt and increased Akt activity without changing
total Akt. The activation of Akt was associated with decreased levels of caspase-3
expression and activity. Moreover, when Akt was inactivated by treatment with a
PI3K inhibitor, the protective effect of sphingosine-1-phosphate on apoptosis was
abolished.
The opposing effects of ceramide and S1P in signalling pathways underscores
the importance of characterising ceramide synthase enzymes with respect to tissue
distribution, substrate specificity and inhibition by S1P. A recent study showed that
family members of mammalian ceramide synthase (CerS) enzymes have specific
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acylchain length preferences. (Laviad et al., 2008). For example CerS2  has a
remarkable specificity for long acylchain CoA (C20-C26) showing no activity for
C16:0-CoA and very low activity for C18:0.  Sphingolipidomic analyses of ceramides
in cells and tissues using mass spectrometry will be important in providing evidence
linking length of fatty acid chain with defined roles in cell physiology.
1.3.2.4. Ceramide-1-phosphate
Ceramide-1-phosphate is another proliferative and proinflammatory factor
produced in mammalian cells by the phosphorylation of ceramide by ceramide kinase,
an enzyme located on the trans golgi network in many cell types. Marcu and Chalfant
(2007) reported that nanomolar concentrations of C16-ceramide-1-phosphate rapidly
activated cPLA2, thereby increasing release of arachidonic acid. Mechanistic studies
demonstrated that the interaction of ceramide-1-phosphate and cPLA2a was very
specific, since closely related lipids and metabolites were unable to activate cPLA2 in
cells. It appears to act in concert with sphingosine-1-phosphate to stimulate the
formation of PGE2 and promote inflammation and carcinogenesis (Chalfant and
Spiegel, 2005). Other biological responses of ceramide-1-phosphate include a role in
membrane fusion, phagocytosis, mobilisation of calcium from the endoplasmic
reticulum and cell survival. Possible targets of ceramide-1-phosphate are protein
phosphatases PP1 and 2A which, as outlined above, play roles in induction of
apoptosis. Gomez-Munoz et al. (2005) demonstrated that ceramide-1-phosphate
promoted the survival of bone-marrow-derived macrophages by stimulating the
PI3K/Akt pathway, activating NF-κB and increasing anti-apoptotic Bcl-XL levels,
which may be indicative of effects of ceramide-1-phosphate on alternative splicing of
Bcl-XL mRNA as a result of PP1 inhibition.
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Taken together, there is a lot of evidence that sphingosine-1-phosphate and
ceramide-1-phosphate promote significant proliferative and anti-apoptotic activities in
cancer cells, leading also to malignant transformation. Enzymes that convert pro-
apoptotic sphingosine and ceramide to anti-apoptotic ceramide-1-phosphate and
sphingosine-1-phosphate, and vice-versa, play a significant role in regulating the
balance between cell death and cell survival in cancer and become a target for
pharmaceutical companies.
1.3.3. Glycosphingolipids
Ceramide is also a common precursor for glycosphingolipids. Synthesis of
glycosphingolipids starts when glycosyltransferase catalyzes attachment of glucose or
galactose to ceramide. Further attachment of galactose residue to glucosylceramide
forms lactosylceramide, which is then a mother lipid for all the gangliosides in the
cells. Addition of one, two or three sialic acids by membranous glycosyltransferases
to lactosylceramide leads to formation of precursors for more complex gangliosides,
GM3, GD3 and GT3, respectively (Bektas and Spiegel, 2003), which are formed in the
lumen of the Golgi apparatus. Milk fat globule membrane (MFGM) is an abundant
natural source of glycosylated sphingolipids, in particular lactosylceramide,
glucosylceramide and several gangliosides including GD3, GD1b1, GM2, GM3 and GM1
(Bektas and Spiegel, 2003). Similar to sphingomyelin, glycosylated sphingolipids are
mostly involved in membrane structure, signalling and formation of specific
detergent-insoluble domains, so-called “lipid rafts”, which are believed to play an
additional role in cellular signalling (Parton and Simons, 1995; Hinrichs et al., 2005).
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1.3.3.1. Glucosylceramide
Glucosylceramide is one of the controversial lipids as it has been shown that it
possesses anti-apoptotic properties in cancer cells. The level of glucosylceramidase
synthase which converts ceramide to glucosylceramide may determine multidrug
resistance in cancer cells. Higher glucosylceramide amounts and overexpression of
glucosylceramidase synthase enzyme were observed in multidrug-resistant breast
cancer cell line MCF-7-AdrR (Adriamycin-resistant) (Lavie et al., 1996). Liu et al.
(1999a and 1999b) confirmed that the drug sensitive breast cancer cell line transfected
with glucosylceramidase synthase gene, MCF-7/GCS was resistant to drug treatment
and also to TNF-α induced apoptosis. Van Vlerken et al. (2007) reported recently that
coadministering ceramide with paclitaxel, a commonly used chemotherapeutic agent,
restored apoptotic signalling and overcame multidrug resistance in ovarian cancer in
vitro. Targeting glucosylceramidase synthase enzyme functions in drug-resistant
cancer cells may be an approach for pharmaceutical companies and novel
investigations.
1.3.3.2. Lactosylceramide
Lactosylceramide is a member of the glycosphingolipid family. It consists of a
non-polar component ceramide, to which glucose and galactose are attached via
Galβ1-4Glcβ1-Cer linkages. It is generated predominantly by lactosylceramide
synthase, a Golgi localized enzyme that transfers galactose residues from UDP-
galactose to glucosylceramide. At least two lactosylceramide synthases occur in
mammalian tissues; β1,4-GalT-V is a constitutively expressed lactosylceramide
synthase present in almost all human embryonic and adult tissues (Chatterjee et al.,
2008) while β1,4-GalT-VI is expressed predominantly in human embryonic and adult
brain cells. Catabolism of gangliosides, such as GM3 and GD3 and complex
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glycosphingolipids, such as globotrosylceramide by sialidases and glycosidases,
respectively, can also generate significant amounts of lactosylceramide. Evidence of
its potential role in regulating cell function stems from observations that
lactosylceramide induced expression of cell adhesion molecules such as intercellular
cell adhesion molecule-1, vascular cell adhesion molecular-1 and platelet cell
adhesion molecule (Bhunia et al., 1998; Gong et al., 2004; reviewed in Chatterjee and
Pandey, 2008) and that it activated an “oxygen-sensitive” signalling pathway
involving superoxides, nitric oxides and PI3K/Akt activation (Rajesh et al., 2005),
thereby contributing to cell proliferation, adhesion, migration and angiogenesis.
Lactosylceramide is largely found in MFGM, next to sphingomyelin and
glucosylceramide. Thin layer chromatographic analysis of glycolipids extracted from
colon cancers and adjacent non-cancerous mucosa revealed that colon cancer
exhibited a marked accumulation of lactosylceramide (Kakugawa et al., 2002). The
latter also showed that addition of lactosylceramide to Colo-205, a human colon
cancer cell line reduced apoptotic cells during sodium butyrate treatment. The
increased expression of the constitutive enzyme, β1,4-GalT-V in endothelial cells
from human colon cancer as compared to endothelial cells from normal colon
suggests that lactosylceramide metabolism may provide novel targets for development
of anticancer therapeutics (Chatterjee and Pandey, 2008).
1.4. Hydrolysis of sphingomyelin
1.4.1. Digestion of dietary sphingomyelin
The main dietary sphingolipids are sphingomyelin and glycosphingolipids.
Their amounts in food vary considerably, from dairy products as major sources (1–2
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g/kg), followed by meat and fish, eggs and soybeans, while vegetables are poor
dietary sources (Vesper et al., 1999).
Hydrolysis of dietary sphingolipids takes place in the small intestine as well as
in the colon and it is catalyzed by alkaline sphingomyelinase (SMase) (Nilsson, 1968;
Schmelz et al., 1994; Nyberg et al., 1997; reviewed by Duan, 1998). Schmelz et al.
(1994) and Nyberg et al. (1997) found that sphingomyelin digestion is a slow process
and not all of the sphingolipids are hydrolyzed and absorbed. They demonstrated that
there is a correlation between the amount of sphingolipids that is fed and the amount
found in the intestine. It was shown by Nyberg et al. (1997) that the level of ceramide
in intestine increased with increasing amount of dietary sphingomyelin. Alkaline
sphingomyelinase is the first major enzyme responsible for digestion of dietary
sphingomyelin (Nyberg et al., 1997). It is present in the intestinal tract but is absent
from brain, pancreas, kidney, spleen, milk and urine (Nilsson, 1969; Duan et al.,
1996). A second source of alkaline sphingomyelinase is human bile (Duan et al.,
1996). Sphingomyelin digestion is under the control of cholecystokinin secreted from
endocrine cells in the intestine. Cholecystokinin stimulates release of alkaline
sphingomyelinase and bile salts, into the intestinal lumen. Both trihydroxyl and
dihydroxyl bile salts stimulate alkaline sphingomyelinase activity up to the critical
micellar concentrations and inhibit enzyme activity at concentrations above it (Duan
et al., 1996). Alkaline sphingomyelinase is also stimulated by the anticancer agent
ursulic acid and other pentacyclic triterpenoids widely present in fruits and vegetables
(Andersson et al., 2006).
An enzyme that cooperates with alkaline sphingomyelinase is neutral
ceramidase; its role is to hydrolyze ceramide to sphingosine in the intestinal lumen
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(Lundgren et al., 2001; Kono et al., 2006). Newly formed sphingosine is absorbed by
passive diffusion into the enterocytes where it is converted to ceramide. It was shown
by Duan et al. (2007) that the presence of bile salts is crucial for maintaining high
intraluminal concentrations of alkaline sphingomyelinase and neutral ceramidase. A
novel human alkaline ceramidase (haCER2) has been identified in gut which regulates
cell proliferation and survival by controlling levels of sphingosine and sphingosine-1-
phosphate (Xu et al., 2006).
Sphingomyelin digestion is a slow process, due to i) complexation of SM with
cholesterol (Liu et al., 2000 and 2002; Nyberg et al., 2000), ii) competition from
phosphatidylcholine for the substrate binding side of alkaline sphingomyelinase
(Duan and Nilsson, 1997) and iii) inhibitory effect of bile salts (taurocholate and
taurochenodeoxycholate) on alkaline sphingomyelinase (Olsson et al., 2004). This
situation occurs in the upper part of small intestine, where a high bile salts
environment is suitable for hydrolysis of fat and phospholipids. When most of the fat
has been absorbed, the reduced bile salts concentration in the lower part of the small
intestine favours sphingomyelin digestion. Undigested sphingomyelin and unabsorbed
ceramide move to the colon where the bile salt concentration is lower and stable
alkaline sphingomyelinase and neutral ceramidase are present to permit further
absorption (Duan, 2006).
1.4.2. Endogenous sphingomyelin
In addition to digestion of dietary sphingolipids, there is also a source of
ceramide from endogenous sphingomyelin hydrolysis. As reviewed by Kolter and
Sandhoff (1999), endogenous sphingolipids undergo both lysosomal and
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nonlysosomal degradation. The enzymes involved in nonlysosomal degradation of
endogenous sphingomyelin are neutral sphingomyelinase and neutral ceramidase. It
was first observed by Okazaki et al. (1989) that vitamin D3 induces sphingomyelin
hydrolysis in HL-60 cells by increasing neutral SMase activity. Since then, several
extracellular agents were shown to stimulate sphingomyelin hydrolysis in various cell
types. These agents include: i) tumour necrosis factor α (TNFα), fas ligand,
dexamethasone, nitric oxide, staurosporine which induce apoptosis; ii) vitamin D3,
TNFα, NGF, shear stress, retinoic acid, progesterone and serum deprivation which
induce differentiation; iii) daunorubicin, vincristine and oxidized LDL which induce
DNA damage (Huwiler et al., 2000; Kolter and Sandhoff, 1999 and the references
within).
In lysosomal degradation, fragments of membrane containing
glycosphingolipids and sphingomyelin are first endocytosed and they reach the
lysosome as intralysosomal membrane structures. Sphingomyelin is hydrolyzed by
acid sphingomyelinase and glycosphingolipids are hydrolyzed by exohydrolases,
which cleave sugar residues step-by-step starting from the nonreducing end of glyco-
structures to yield ceramide. Ceramide is then deacylated by an acid ceramidase to
form sphingosine (Koch et al., 1996; Li et al., 1998). The cleaved molecules (fatty
acids, sphingoid bases or the sugar residues) can then leave the lysosome and be
metabolized further, or else re-enter biosynthesis pathways. Lysosomal degradation is
normally a non-signalling pathway because ceramide is locked inside the lysosome
and not available as a signal transduction messenger, except when ceramide induces
apoptosis through activation of cathepsin D.
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1.5. Dietary sphingolipids and colon cancer
Sphingolipids are necessary for normal cell function and can be synthesized de
novo or obtained from the diet. Exogenous sphingolipids of dietary origin were found
to be required for the growth of Chinese hamster ovary (CHO) cells which were
deficient in serine palmitoyltransferase, the first enzyme in sphingolipid biosynthesis
(Hanada et al., 1992; Vesper et al., 1999). As bioactive sphingolipids have significant
roles in modulating colon tumour development and activation of apoptotic pathways
in cancer cells, the impact of dietary sphingolipids on different types of colon cancer
is of interest to academic and food industry research programmes.
1.5.1. Sphingomyelin digestion and colon cancer
1.5.1.1. Decreased alkaline sphingomyelinase activity in colon cancer
Intestinal mucosal alkaline sphingomyelinase is the enzyme responsible for
hydrolysis of sphingomyelin in the intestinal tract. Dudeja et al. (1986) first observed
an increased level of sphingomyelin in colonic rat mucosa after treating rats with the
chemical colonic carcinogen, 1,2-dimethylhydrazine. It has been also shown that the
level of sphingomyelin in human colon cancer cells is increased relative to normal
cancer cells, which can be a result of either decreased sphingomyelinase activity
and/or increased sphingomyelin synthesis (Merchant, 1995). Hertervig et al. (1997)
measured the activities of all three types of sphingomyelinase in human colorectal
carcinomas and compared them with the activities of these enzymes in the
surrounding tissues. They showed that alkaline sphingomyelinase activity was
predominantly decreased by 75% in colorectal carcinoma in comparison with acid and
neutral sphingomyelinase. Campbell et al. (1994) and Hertervig et al. (1998) showed
that in colorectal adenomas, an earlier stage of cancer development, that alkaline
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sphingomyelinase activity was reduced by 50%, whereas the acid and neutral
sphingomyelinase were unchanged. It has been also shown that, compared with
control patients, alkaline sphingomyelinase activity was decreased by 90% in
adenomatous polyps in patients with familial adenomatous polyposis (FAP) disease
(Hertervig et al., 1998). In vitro studies have shown that poorly differentiated human
colon cancer cells, such as Caco-2 and HT-29, possess a low activity of alkaline
sphingomyelinase (Wu et al., 2004a). However, unlike Caco-2, the low activity of
alkaline sphingomyelinase in HT-29 cells is due to deletion of exon 4 in alkaline
sphingomyelinase cDNA. After 21 days of culturing Caco-2 cells under
differentiating conditions, activities of alkaline sphingomyelinase and alkaline
phosphatase increased 12-fold and 2.4 fold respectively compared to activities found
in undifferentiated Caco-2 monolayer cells. No change in activity of these enzymes
was observed in HT-29 cells after culturing under the same conditions (Wu et al.,
2004a). These studies suggest that human alkaline sphingomyelinase, as an ecto-
enzyme located on the microvillar surface of epithelial cells shares some similarities
with other intestinal hydrolases, which are fully expressed during formation of the
brush border surface and differentiation of cells (Duan et al., 2003). Wu and co-
workers (2004b) suggested that there are at least two forms of alkaline
sphingomyelinase: one that is bound to the brush border by a COOH terminal domain
and the other that is in free form in the intestinal lumen which has its COOH-terminal
anchor cleaved. They showed that trypsin cleaved the alkaline sphingomyelinase at
the COOH terminal, releasing it from mucosa and that this action enhanced its activity
by approximately 70%. These findings indicated a physiological role for pancreatic
trypsin in sphingomyelin digestion. They hypothesize that the membrane-bound
alkaline sphingomyelinase may predominantly hydrolyze membrane-bound
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sphingomyelin and the free alkaline sphingomyelinase in the intestinal lumen is the
major enzyme targeting sphingomyelin in the intestinal content. Alkaline
sphingomyelinase may also have phospholipase C activity (Wu et al., 2006). They
found that alkaline sphingomyelinase cleaved the phosphocholine head group from
PAF, a pro-inflammatory phospholipid involved in pathogenesis of inflammatory
bowel diseases to generate 1-O-alkyl-2-acetyl-sn-glycerol. The hydrolysis and
inactivation of PAF reveals a novel function, by which alkaline sphingomyelinase
may counteract the development of intestinal inflammation and colon cancer.
1.5.1.2. Dietary sphingomyelin reduces colon cancer
Dillehay et al. (1994) showed that exogenous dietary supplementation with
purified bovine milk sphingomyelin reduced the number of aberrant colonic crypt foci
(an early marker of colonic carcinogenesis) by ~70% in the CF1 mouse model of
chemical carcinogenesis. In subsequent investigations, a significant shift in tumour
type from adenocarcinomas to the more benign adenomas was observed following
supplementation with milk sphingomyelin (Schmelz et al., 1996) and with milk
glycosphingolipids (glucosylceramide, lactosylceramide and gangliosides) (Schmelz
et al., 2000). Similar observations were made when CF1 mice and multiple intestinal
neoplasia (Min) mice, which develop intestinal tumour spontaneously, were fed with
soy glucosylceramide (Symolon et al., 2004). Tumour reduction was reported by
Lemonnier et al. (2003) when mice were fed sphingomyelin before and after tumour
initiation, indicating both chemopreventive and chemotherapeutic effects of
sphingolipids. Simon et al. (2009) observed that dietary sphingomyelin
downregulated β-catenin in carcinogen-treated CF1 mice. These changes suggest that
dietary sphingomyelin may reduce the risk of colon cancer and inhibit development to
malignant type.
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Studies have also highlighted a potential benefit of exogenous sphingomyelin
to propagate apoptotic signals in response to a variety of cytotoxic agents. Modrak et
al. (2002) provided evidence that sphingomyelin enhanced the efficacy of 5-
fluorouracil and irinotecan for the treatment of HT-29, HCT15 and GW-39 human
colonic tumour xenografts. Van Vlerken et al. (2007) showed that co-administration
of ceramide with paclitaxel, a commonly used chemotherapeutic agent restored
apoptotic signalling in a drug resistant human ovarian cancer cell line SKOV3.
Studies in pancreatic cancer have provided further evidence that targeting
sphingolipid metabolism is a means of enhancing the efficacy of chemotherapeutic
agents (Modrak et al., 2004 and 2009)
1.6. Summary and perspectives for future research
Cancer and cardiovascular disease are leading causes of morbidity and
mortality in Western societies. To address this problem, research institutes together
with pharmaceutical companies aim to discover drugs for cancer and other lethal
diseases. At the same time increasing consumer interest in the health improving role
of bioactive food components has enhanced demand for rapid advances in food
science and technology and development of new functional foods with health-
promoting or disease-preventing properties. Knowing potent biological activities of
sphingolipids, it is likely that they can be categorized as functional components of
food with regards to human health, especially for prevention of colon cancer as well
as being a cholesterol-lowering agent (Eckhardt et al., 2002; Noh and Koo, 2004) and
protectant against bacterial infections in the gut (Pfeuffer and Schrezenmeir, 2001).
However, currently there are no known nutritional requirements for their daily intake.
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Occurrence of sphingolipids and phospholipids in food is wide-spread, from
lower amounts in fruits and vegetables to rich sources, such as MFGM in dairy
products. The idea of functional food development inclines towards introducing dairy
products enriched in MFGM as a rich source of sphingolipids and phospholipids, as
well as proteins with beneficial properties. Additionally, MFGM is also a source of
antioxidants, such as vitamin E (Jensen and Nielsen, 1996) and riboflavin/vitamin B2
(Kanno, 1990). Investigation of the influence of enhancing cows’ fodder in
polyunsaturated fatty acids like omega-3 (DHA and EPA) on bovine milk
composition may be worthy, as it was shown that beside their wide range of beneficial
properties (Freeman et al., 2006; Mozaffarian and Rimm, 2006; Serini et al., 2009),
they also possess ability to activate the neutral sphingomyelinase-mediated pathway
of apoptosis in breast cancer cells (Siddiqui et al., 2005; Wu et al., 2005; Paranavitana
et al., 2006).
Expanding studies on enriching dairy products with probiotics may be of
interest because of their gut health and digestion properties. Additionally, Di Marzio
et al. (2001) showed that apoptotic effect of selected strains of lactic acid bacteria
(Streptococcus thermophilus) on Jurkat cells and colon cancer cells is also connected
to the sphingomyelin cycle. Soo et al. (2008) found that VSL#3 probiotic product
which consisted of eight different strains of bacteria (Bifidobacterium longum,
Bifidobacterium infantis, Bifidobacterium breve, Lactobacillus acidophilus,
Lactobacillus casei, Lactobacillus bulgaricus, Lactobacillus plantarum, and
Streptococcus salivarius subspecies thermophilus) upregulated mucosal alkaline
sphingomyelinase activity both in mouse models with colitis and humans with
ulcerative colitis, a form of inflammatory bowel disease. Duan (2007) confirmed that
LAB, such as Streptococcus thermophilus and Lactobacillus acidophilus possess the
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ability to hydrolyse sphingomyelin (Duan 2007). Duan et al. (1996) suggested that
alkaline sphingomyelinase is not derived from intestinal bacteria as they found high
alkaline sphingomyelinase activity in germ-free mice. However, Cheng et al. (2004)
fed mice with a diet including psyllium, which is a water-soluble fibre that acts as a
food source for colonic bacteria and observed 57% increase in alkaline
sphingomyelinase activity over the control. They suggested that this was a result of
the influence of psyllium on luminal bacteria growth (Cheng et al., 2004), however
the mechanism remains unclear. The importance of LAB as an alternative source of
alkaline sphingomyelinase in digestion of dietary sphingomyelin in colon cancer cells
and production of highly bioactive ceramide and sphingosine requires further
investigations. Nonetheless, in order to produce functional foods that could improve
consumer’s health and potentially prevent cancer and other diseases, as well as
maintain a healthy gut, there is a substantial necessity for further studies on the
influence of sphingolipids on human health and their mode of action at the cellular
level.
1.7. Thesis objectives
 To validate a rapid in vitro colorimetric assay for screening antiproliferative
activity of buttermilk samples
 To investigate the effects of a range of processing variables (cream separation
methods, washing, heating) and inoculation with microbial starter cultures on
antiproliferative activity of resultant buttermilks in the SW480 human colon
cancer cell line and FHC human normal colon epithelial cell line.
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 To examine the antiproliferative activity of feed, retentate and permeate samples
of buttermilk produced at pilot scale from unwashed and washed cream on human
colon cancer cell lines.
 To investigate the influence of drying (including spray, freeze and spin drying) on
antiproliferative activity of buttermilk on colon cancer cells.
 To investigate effects of buttermilk on biomarkers of apoptosis (ie morphology of
apoptotic cells, cleavage of caspases, translocation of phosphatidylserine,
mitochondrial outer membrane depolarization, translocation of apoptosis inducing
factor and endonuclease G to cells’ nuclei), and proliferation (i.e. β-catenin,
phosphorylated Akt and proteins involved in MAPK signalling pathway: ERK1/2,
p38 protein and JNK ).
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CHAPTER 2
Selection of colorimetric assay and processing method for studying
antiproliferative activity of buttermilk samples in vitro.
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Milk is well recognised as a source of lipid components with anti-
carcinogenic properties, such as rumenic acid and sphingolipids; however little
data is available on antiproliferative activity of dairy products, such as buttermilk.
The aim of this study was to set up a reliable and fast colorimetric method for
preliminary screening of potential antiproliferative activity of buttermilk samples,
which would be produced in large amount during process optimization in
subsequent steps of the project. We also attempted to separate buttermilk samples
into lipid classes and deliver them to the SW480 colon cancer cells in the form of
bile salt micelles. The acid phosphatase (AP) activity assay was selected for the
study of antiproliferative activity of buttermilk because it exhibited a better linear
response than MTS to cell number in SW480, Caco-2 and FHC cells. Our model
was validated using commercial lipids, spingosine, ceramide and
lactosylceramide, which inhibited growth of SW480 colon cancer cells by 50% at
concentrations 6, 14 and 9 µM, respectively after 3 days of treatment using acid
phosphatase assay. Unfortunately, after separation of buttermilk fat into lipid
classes, neutral lipid fractions did not form clear micellar solutions and the results
could not be compared with other fractions. Although fatty acid and polar lipid
fractions of buttermilks showed antiproliferative activity on SW480 colon cancer
cells (up to about 60% cell growth inhibition after 3 days of treatment), it was
decided that this method was not optimal for studying antiproliferative activity of
buttermilks on colon cancer cells because disruption of MFGM material during
fractionation may adversely affect the bioactivity of its components and would not
be representative of MFGM when presented in vivo as a whole beverage.
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2.1. Introduction
To date, numerous biologically active food components, such as
sphingolipids, flavonoids, isoflavonoids, vitamins, minerals, and omega-3 fatty
acids have been reported to exhibit anticancer effects based on in vitro or in vivo
data (Milner, 2006, Stan et al., 2008, Nobili et al., 2009). Of these, sphingolipids
are found almost exclusively in animal products with a level of approximately
several millimoles/kg in dairy products (Vesper et al., 1999). Intake of
sphingolipids in the normal diet is ~ 0.3-0.4 g/day (Vesper et al., 1999).
Sphingolipids are polar lipids found predominantly in the disrupted milk fat
globule membrane (MFGM) material of dairy products, especially buttermilk
(Rombaut et al., 2006). Buttermilk is a by-product of the butter-making process
and the composition and characteristics of MFGM depend on the production
technology and the quality of milk and cream used. Buttermilk consists of
approximately 91% water and contains about 9% total solids present in milk.
The nutritional and techno-functional properties of buttermilk have been
investigated in recent years. Compositional analysis of MFGM isolated from
buttermilk has revealed that it is a rich source of valued bioactive components
with potential to deliver health benefits as functional food ingredients. These
bioactive components include sphingolipids, phospholipids, fatty acid binding
protein, breast cancer type 1 and 2 susceptibility proteins, xantine oxidase, mucin
1, butyrophilin and lactadherin (Spitsberg et al., 1995, Li et al., 2009, Brody and
Biesecker, 1998, Vissac et al., 2002, Mana et al. 2004, Johns and Bernard, 1999,
Stefferl et al., 2000, Zeelenberg et al., 2008, Liu et al., 2005).
In order to optimise technology for producing buttermilk with anticancer
activity, it is essential to set up a reliable and fast method for preliminary
50
screening of large amounts of samples produced under different processing
conditions. In 1991 rapid colorimetric assay method for initial stage screening of
cytotoxic components was developed (Barltrop et al., 1991, Cory et al., 1991).
Using this method cell proliferation and viability can be quantified based on
reduction by live cells of 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) in
the presence of the electron coupling reagent phenazine ethosulfate, PES. This
tetrazolium salt forms a soluble purple formazan product under the action of a
mitochondrial dehydrogenase in active cells. Amongst other miniaturized in vitro
colorimetric assays, such as staining with a protein-binding dye, sulforhodamine
B; lysosome-accomulated dye, neutral red or protein-binding dye, crystal violet
(Skehan et al., 1990, Monks et al., 1991, Borenfreund and Puerner, 1985, Kueng
et al., 1989) there is also acid phosphatase (AP) assay developed by Martin and
Clynes (1991) and based on the ability of cytosolic and lysosomal AP enzyme of
cells to hydrolyze p-nitrophenylphosphate yielding a p-nitrophenyl chromophore
(O’Connor et al., 1998), which has shown higher sensitivity than MTT in
determining cell numbers (Martin and Clynes, 1993, O’Connor et al., 1998).
Formation of bile salt micelles is essential for optimal absorption of
dietary fat and fat-soluble vitamins in vivo. At a critical micellar concentration
(CMC), bile salts formed in the liver and secreted by the gall bladder form
micelles with fatty acids, which then are transported to the intestinal brush border
membrane. This allows complex lipids (e.g. lecithin) and lipid soluble vitamins
(A, D, E and K) to overcome the diffusion barrier and be absorbed by cells of the
small intestine. In order to optimise technology for producing buttermilk fractions
with anticancer activity, it was necessary to fractionate the lipid components of
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buttermilk and to incorporate them into micelles to mimic physiological
absorption in cell culture.
The overall aim of the work presented in this chapter was to validate a
rapid in vitro colorimetric assay for screening antiproliferative activity of
buttermilk samples produced under different processing conditions. The specific
objective of this study was to determine the suitability of the MTS and AP assays
to study growth inhibition of SW480 and Caco-2 cell lines after treatment with
commercially available pure MFGM lipids (phosphatidylcholine,
lactosylceramide, sphingomyelin and its hydrolysis products, sphingosine and
ceramide). We also fractionated buttermilk samples produced under different
processing conditions into three lipid classes: fatty acids, polar lipids and neutral
lipids and compared the effects of micellar lipid fractions on growth of SW480
human colon cancer cells.
An investigation of the health benefits of buttermilk’s MFGM may greatly
impact the dairy industry and may trigger conversion of buttermilk from a waste
product of butter-making process into one with added value. However, significant
scientific agreement on evidence provided by all preclinical and clinical studies is
required before a chemopreventive claim can be assigned to buttermilk’s MFGM.
Strength of evidence will be based on the quality of all the laboratory data
involving in vitro and in vivo animal and human studies. Because of the difficulty
in obtaining primary human gastrointestinal tissues and cells, human cancer cell
lines of intestinal origin that exhibit relatively stable behaviour, morphology and
growth were our first choice for beginning a study of the chemopreventive
potential of buttermilk.
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2.2. Materials and Methods
2.2.1. Materials
Chemicals and cell culture media and supplements were purchased from
Sigma-Aldrich Ltd. (Ireland) unless otherwise stated. C8-lactosylceramide and
1,2-dioleoyl-sn-glycero-3-phosphocholine  (DOPC)  were supplied by Avanti
Polar Lipids, Inc. (Alabaster, Alabama, USA).
2.2.2. Preparation of buttermilk samples for antiproliferative studies
2.2.2.1. Cream preparation
Buttermilk samples were generated by a project team member. Raw whole
milk was collected from the Moorepark Dairy Production Centre (MDPC) farm
(Fermoy, Co. Cork, Ireland) and immediately subjected to pasteurization at 72°C
for 15s in a thermostatically controlled waterbath and cooled to approximately
20°C in an ice bath. Raw milk was then separated into cream and skim milk using
variety of methods. One batch of cream was produced from raw milk separated at
45°C using an Armfield disc bowl centrifuge (Armfield, Ringwood, UK) at max
rpm (buttermilk 2). Raw milk was also allowed to separate naturally by
gravitational force at 4°C (buttermilk 3) and 20°C (buttermilk 4) over a period of
24h. One batch of raw cream was subjected to heat treatment at 95°C for 3s prior
separation (buttermilk 5). All creams were then standardised as required using
their corresponding skim milk to approximately 40% fat.
53
2.2.2.2. Buttermilk preparation
The experimentally-prepared creams were held at 4°C overnight prior to
high-speed mixing (setting 5) to simulate churning in a Kenwood Chef food mixer
(Model KM220, Harvant, Hants, UK) until the cream emulsion inverted and
buttermilk was generated. Mixing then continued at a slower rate (setting 1) until
the butter grains had aggregated. Buttermilk was obtained after filtering through a
cheesecloth to remove butter grains and collected and stored at – 30°C for further
analytical and antiproliferative analyses. As reference, a buttermilk sample was
also produced from commercial cream purchased in a local shop (buttermilk 1).
2.2.3. Compositional analyses of buttermilk samples
All compositional analyses of buttermilk samples were prepared by a
project team member. Protein content was determined using the macro-Kjeldahl
procedure for nitrogen determination and a conversion factor of 6.38
(International Dairy Federation, 1993). All measurements were made in duplicate.
Total solids (TS) were determined using a CEM Smart System 5 (CEM
Incorporated, Matthews, North Carolina, USA) set at maximum power. All
measurements were made in duplicate. Fat content was determined
gravimetrically using the Röse Gottlieb extraction method which uses ammonia to
break down any lipoprotein bonds in milk allowing all the fat to be dissolved by
ether (International Dairy Federation, 1987 a, b) and Gerber fat analysis for cream
which is based on separation of milk fat from proteins by adding sulfuric acid. All
measurements were made in duplicate.
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2.2.4. Cell culture
SW480, HT-29 and Caco-2 human colon cancer cell lines, HepG2 human
hepatocellular cancer cell line and FHC normal human foetal colon epithelial cell
line were obtained from European Collection of Cell Cultures, ECACC. Culture
media and supplements were purchased from Sigma-Aldrich Ireland, Ltd. The
HepG2 and Caco-2 cells were maintained in modified Eagle’s medium (MEM).
The SW480 and HT-29 cells were grown in Leibovitz-15 and McCoy’s 5A
medium, respectively. All media were supplemented with L-glutamine (4 mM),
fetal bovine serum (FBS) (10%, v/v) and penicillin/streptomycin (1 U/ml). The
FHC cells were grown in DMEM/Ham’s Nutrient Mixture F-12 supplemented
with L-glutamine (2.5 mM), sodium bicarbonate (1.2 g/L), HEPES (25 mM),
sodium puryvate (0.5 mM), FBS (10%, v/v), cholera toxin (10 ng/ml), insulin
(0.005 mg/ml), transferrin (0.005 mg/ml), hydrocortisone (100 ng/ml) and
penicillin/streptomycin (1 U/ml). Cells were grown at 37°C, with 5% CO2 access,
except when grown in Leibovitz-15 medium which does not require CO2 (flask’s
caps were fully closed).
2.2.5. Optimization of cell growth of different cell lines
To optimize seeding density SW480 human colon cancer cells were
seeded in 96-well plates at densities ranging 1-10x103 cells/well. All the other cell
lines (HT-29, Caco-2, HepG2 and FHC) were seeded in the same way but in the
range 0.5-5x103 cells/well. To allow the cells to attach, they were cultured for 24
h at 37°C without 5% CO2 (SW480 cells) or with 5% CO2 access (HT-29, Caco-2,
HepG2 and FHC cells). After 3 days of incubation at 37°C, cell survival was
measured by an indirect colorimetric endpoint assay for acid phosphatase activity
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(O’Connor et al., 1998). The basis of the assay is the ability of the acid
phosphatase enzyme present in cell lysosomes to hydrolyze p-nitrophenyl
phosphate yielding formation of p-nitrophenyl chromophore and development of a
yellow colour. For this purpose, after 3-day incubation, the medium was removed
and wells were rinsed with 100 µl PBS. Next, 100 µl of freshly prepared 10 mM
p-nitrophenyl phosphate in 0.1 mol/L sodium acetate buffer (pH 5.5) containing
0.1% Triton X-100, was added to each well and incubated at 37°C for 2 h. The
reaction was terminated by the addition of 50 µl 1M NaOH. The OD
measurements at 405 nm were then recorded on Multi-Detection Microplate
Reader SynergyTM HT (supplied by BioTek® Instruments, Inc).
Cell growth at different seeding densities was also determined using MTS
assay for SW480 and Caco-2 cell lines. Briefly, after 3-day incubation MTS
reagent (Promega Corporation, Madison, WI, USA) was added to the wells. After
2 h of incubation at 37°C OD at 490 nm was recorded on Multi-Detection
Microplate Reader SynergyTM HT (supplied by BioTek® Instruments, Inc).
2.2.6. Antiproliferative activity of commercial lipids: sphingosine, ceramide,
lactosylceramide, sphingomyelin and phosphatidylcholine (DOPC)
Commercial lipids, C2-ceramide (N-acetyl-D-sphingosine), D-sphingosine
and C8-lactosylceramide were dissolved in 100% ethanol to a final stock
concentration of 5 mg/ml. Sphingomyelin and phosphatidylcholine (1,2-dioleoyl-
sn-glycero-3-phosphocholine, DOPC) were dissolved in 100% ethanol to a final
concentration of 100 mg/ml. SW480 cells were cultured at a density of 3.5x103
cells/well in 96-well plates at 37°C without CO2 access for 24 h allowing cells to
attach. Next, cells were incubated for further 3 days in Leibovitz-15 medium
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supplemented with commercial lipids at varying concentrations between 0-20 μM
for ceramide and sphingosine; 0-35.7 μM for lactosylceramide; 0-1 mM for
sphingomyelin and 0-0.9 mM for phosphatidylcholine (DOPC). As controls for
lipid treatments, cells were also incubated with pure ethanol at the same ethanol
concentrations which were used for commercial lipids (0-0.5%, v/v). Cells were
treated with sodium butyrate (5 mM), a growth inhibitory fatty acid (McBain et
al., 1997) which served as biological control for each experiment. After 3 days of
incubation at 37°C, cell survival was measured by an indirect colorimetric
endpoint assay for acid phosphatase activity and/or MTS assay, as described.
2.2.7. Lipid extraction and fractionation of buttermilk lipid classes
To extract lipid classes from buttermilk samples, a modified version of the
extraction method of Folch et al., (1957) and Bligh and Dyer (1959) was used.
Briefly, 3.75 ml of chloroform:methanol (2:1, v:v) was added to 500 μl of each
buttermilk sample and vortexed for 3 min. Next, 1.25 ml of chloroform was
added, vortexed and centrifuged at 2000 rpm for 8 min. The lower organic phase
was collected and all steps above were repeated to obtain better phase separation.
The lower organic phase was then dried under nitrogen. Fractionation of
buttermilk lipid classes was performed according to the method of Kaluzny et al.,
(1985). Sep-Pak Vac 3cc (500 mg) NH2 cartridges (Bond Elut columns) were
placed in the Vac Elut apparatus and washed twice with 2 ml aliquots of hexane.
Collection tubes for eluates were placed in the Vac Elut and buttermilk lipids
dissolved in chloroform were applied to the column without the vacuum to let the
lipid mixture stay on the column and chloroform was collected in collection tubes.
Next, the columns were eluted with 4 ml of different solvents to separate different
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lipid classes: chloroform:2-propanol (2:1, v/v) for separation of neutral lipids, 2%
acetic acid in diethyl ether for separation of fatty acids, methanol for separation of
phospholipids. Lipid film was then mixed in sodium taurocholate solution as
described below.
Immediately after lipid separation, 100 μl of each lipid fraction was
collected into Eppendorf tubes and frozen in -20ºC.
2.2.8. Preparation of micellar solutions
Micellar solutions of bile salt sodium taurocholate were prepared prior to
cell treatment. Fatty acid (FA), polar lipid (PL) and neutral lipid (NL) fractions
were dissolved in chloroform:methanol 2:1 (v/v) and mixed with
phosphatidylcholine (DOPC) and sodium taurocholate in molar ratio of
DOPC:NaTC of 1:1. The concentration of sodium taurocholate added to form
micelles was 0.36 mM for fatty acid and polar lipid fractions and 1.2 mM for the
neutral lipid fraction. The organic solvent was removed under N2 and the resulting
lipid film on the bottom of the tube was dispersed in ethanol under gentle heat and
mixed with serum-free Leibovitz-15 medium, followed by bath sonication with
ultrasound at 37°C until optically clear.
2.2.9. Antiproliferative activity of buttermilk fractions
To assess the antiproliferative activity of buttermilk samples, SW480 cells
were cultured at a density of 3x103 cells/well (for 5 and 7 days of treatment) and
5x103 cells/well (for 3 days of treatment) in 96-well plates. Cells were cultured for
24 h to allow the cells to attach. Next, fatty acid, polar and neutral lipid micellar
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solutions from 5 different buttermilk samples were diluted in serum-free feeding
media and were added to the wells containing the cells. Appropriate
concentrations of sodium taurocholate and phosphatidylcholine (DOPC) were
added to control wells. All the buttermilk samples were sterilized prior to
treatment by incubation at 72°C for 15s. The wells with the SW480 cells were
covered with parafilm to prevent CO2 access to the cells. Four replicates of each
buttermilk concentration were performed. After 3, 5 or 7 days of incubation at
37°C, cell survival was measured by an indirect colorimetric endpoint assay for
acid phosphatase activity, as described above.
2.2.10. Statistical analysis
Three independent experiments were performed in quadruplicate and the
Student’s t-test was used to determine significant differences between treatments
and controls. Statistically significant differences were represented as follows: * =
P ≤ 0.05; ** = P ≤ 0.01; *** = P ≤ 0.001.
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2.3. Results
2.3.1. Optimization of 96-well plate cytotoxicity assays (MTS vs. acid
phosphatase) for evaluating effects of buttermilk on cell growth
To select a sensitive and efficient method for cytotoxicity testing we
examined the relationship between seeding density and growth of SW480 cells
using two indirect growth assays (MTS and AP) (Fig. 2.1 a, b). Both assays
showed high repeatability within three different experiments. However, better
linearity of cell growth against cell seeding density was observed using AP assay;
hence this assay was used to determine optimal seeding density for other cell lines
planned for use in further studies: HT-29 colon cancer, HepG2 hepatocellular
cancer and FHC normal colon epithelial cells (Fig. 2.2 a, b, c). All three cell lines
showed good linear increase in growth from initial seeding density. For further
studies on the antiproliferative effect of buttermilk after 3 days of treatment, cells
were seeded at following densities: HT-29, HepG2 and FHC at 3.5x103 cells/well;
SW480 at 5x103 cells/well. Caco-2 cells were seeded in the range of 0.5-5x103
cells/well and cell growth was determined using MTS and acid phosphatase
assays (Fig. 2.3 a, b).
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Fig. 2.1. Comparison of two assays for measuring cell growth: MTS (a) and acid
phosphatase AP (b) as a function of cell seeding density. The SW480 cells were
grown in Leibovitz-15 medium. Data refer to mean ± SD of three independent
experiments.
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Fig. 2.2. HT-29 (a), HepG2 (b) and FHC (c) cell growth, obtained using AP assay
after 4 days from seeding. The HT-29, HepG2 and FHC cells were grown in
McCoy’s 5A, MEM and DMEM/Ham’s Nutrient Mixture F-12 media,
respectively. Data refer to mean ± SD of three independent experiments.
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Fig. 2.3. Caco-2 cell growth, obtained using MTS (a) and AP (b) assays after 4
days from seeding. The Caco-2 cells were grown in MEM medium. Data refer to
mean ± SD of three independent experiments.
2.3.2. Comparative analysis of effects of sphingosine and ceramide on SW480
cell growth as determined by MTS and AP assays
Fig. 2.4 demonstrates that sphingosine inhibited growth of SW480 cells to
a greater extent than C2-ceramide (N-acetyl-D-sphingosine). The IC50 for
sphingosine was 2.3-fold lower (6 µM) than IC50 for ceramide (14 µM) using the
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AP assay (Fig. 2.4 a). The corresponding IC50 values for sphingosine (11.5 µM)
was 1.9-fold higher using MTS and the IC50 value for ceramide was the same (14
µM) using MTS (Fig. 2.4 b).
a)
b)
Fig. 2.4. Growth inhibition in SW480 human colon cancer cell line incubated with
C2-ceramide (■) and sphingosine (◊) (0-20 μM) for 3 days assessed using AP (a)
and MTS (b) assays. The SW480 cells were grown in Leibovitz-15 medium.
Growth inhibition was expressed as a percentage relative to control which was
taken to be 0%. Data refer to mean ± SD of three independent experiments.
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Growth inhibition was considered significantly different than control when: * = P
≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
To exclude possible antiproliferative effect of lipid solvent, cells were
treated with ethanol in the range used in lipid treatment (Fig. 2.5). Ethanol in the
range 0-0.5% (v/v) did not exhibit antiproliferative activity on SW480 colon
cancer cells. Minor cell growth progression was observed, however it was not
constant between each experiments, resulting in relatively large error bars.
Fig. 2.5. Effect of ethanol (v/v) on SW480 colon cancer cell growth assessed
using AP assay. Growth inhibition was expressed as a percentage relative to
control which was taken to be 0%. Data refer to mean ± SD of three independent
experiments. Growth inhibition compared to control without treatment was
considered significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
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2.3.3. Effect of commercial lipids: sphingomyelin, lactosylceramide and
phosphatidylcholine (DOPC) on growth of SW480 colon cancer cells
Commercial lipids: sphingomyelin, lactosylceramide and
phosphatidylcholine (DOPC) were screened for antiproliferative activity using
SW480 colon cancer cells. Treatment of cells with sphingomyelin in the range 0-1
mM inhibited cell growth by up to 40% (Fig. 2.6). Treatment with
lactosylceramide in ethanol inhibited cell growth by up to 100% (Fig. 2.7). IC50
values were approximately 9 µM and 10 µM after 3 and 7 days, respectively,
indicating a possible cytostatic effect after 3 days. Lactosylceramide, when
presented to cells in micellar form inhibited cell growth to a lower extent - IC50
values were 20 and 25 µM after 3 days and 7 days, respectively. Treatment of
cells with phosphatidylcholine (DOPC) in the range 0-0.9 mM stimulated growth
by up to 25% while less growth was observed following 3 days of treatment for 7
days (Fig. 2.8).
Fig. 2.6. Growth inhibition in SW480 human colon cancer cell line incubated with
sphingomyelin assessed using acid phosphatase (AP) assay after 3 days of
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treatment. The SW480 cells were maintained in Leibovitz-15 medium. Growth
inhibition was expressed as a percentage relative to control which was taken to be
0%. Data refer to mean ± SD of three independent experiments. Growth inhibition
compared to control without treatment was considered significant when: * = P ≤
0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
Fig. 2.7. Growth inhibition in SW480 human colon cancer cell line incubated
with: LacCer dissolved in EtOH for 3 (◊) and 7 ( ) days; LacCer in form of
micelles formed with sodium taurocholate incubated for 3 (▲) and 7 ( ) days.
Results were assessed using acid phosphatase (AP) assay. The SW480 cells were
maintained in Leibovitz-15 medium. Growth inhibition was expressed as a
percentage relative to control which was taken to be 0%. Data refer to mean ± SD
of three independent experiments. Growth inhibition compared to control without
treatment was considered significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤
0.001.
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Fig. 2.8. Growth stimulation in SW480 human colon cancer cell line incubated
with phosphatidylcholine (DOPC) for 3 (◊) and 7 (■) days assessed using acid
phosphatase (AP) assay. The SW480 cells were maintained in Leibovitz-15
medium. Growth stimulation was expressed as a percentage relative to control
which was taken to be 0%. Data refer to mean ± SD of three independent
experiments. Growth inhibition compared to control without treatment was
considered significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
The inhibitory effects of sphingosine, ceramide, sphingomyelin and
lactosylceramide relative to sodium butyrate (5 mM) are shown in Fig. 2.9.
Butyrate inhibited SW480 cell growth by 85 % after 3 days of exposure. It is
apparent that hydrolytic products of sphingomyelin at concentrations as low as 20
µM were more potent than sphingomyelin (1 mM) and were as potent as sodium
butyrate (Fig. 2.9). Sphingomyelin, by contrast was less potent than sodium
butyrate. Lactosylceramide (17.8 µM) was a more potent inhibitor of cell growth
than ceramide alone (Fig. 2.9).
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Fig. 2.9. Comparison of antiproliferative activity of different commercial lipids
with 5 mM sodium butyrate assessed using AP assay after 3 days of treatment in
SW480 cells. The SW480 cells were maintained in Leibovitz-15 medium.
Growth inhibition was expressed as a percentage relative to control which was
taken to be 0%. Data refer to mean ± SD of three independent experiments.
2.3.4. Compositional analyses of buttermilk samples
Table 2.1 shows compositional analysis of buttermilk samples. The
highest amount of total phospholipids was found in buttermilk sample produced
from centrifugally separated commercial cream (0.31%), following sample
produced from gravitationally separated cream at 4°C (0.13%). However, the
latter showed significantly (P ≤ 0.001) higher contest of total solids (32.98%) and
fat (29.2%) than other samples, which comprise total solids and fat in the ranges:
2-6.7% and 1.7-6.4%, respectively).
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Table 2.1. Compositional analysis of buttermilk samples prepared from:
commercial cream centrifugally separated (1), cream from raw milk  centrifugally
separated (2), cream from raw milk separated naturally by gravitational force at
4°C (3) and 20°C (4), cream from raw milk heat-treated at 95°C for 3s prior
centrifugal separation (5). Data obtained by a project team member. All values are
expressed as mean %.
Phospholipid as % of:
Sample Totalsolids (%)
Protein
(%)
Fat
(%) Totalweight Fat
Total
solids
1
2
3
4
5
3.02
6.71
32.98
2.03
4.24
0.28
0.30
0.43
0.21
0.32
1.7
6.4
29.2
1.7
1.7
0.31
0.05
0.13
0.05
0.07
1.84
0.74
0.46
2.98
3.81
1.03
0.71
0.40
2.49
1.57
2.3.5. Fatty acids
Fatty acid (FA) fractions from each buttermilk sample were prepared as
described previously. Micellar solution with sodium taurocholate was incubated
with SW480 colon cancer cells for 3, 5 and 7 days. Due to insufficient volume of
buttermilk samples received, fatty acid fractions collected were not quantified;
hence final results were expressed as volume of buttermilk (µl) subjected to lipid
extraction and separation. After 3 days of incubation at lower concentrations (100
and 150 µl buttermilk) FA micellar solutions showed cancer promoting effect,
however at 500 µl of buttermilk taken for extraction, FA micellar solutions from
all buttermilk samples, except sample 4 (buttermilk produced from cream
separated by gravitational force at 20°C) significantly (P ≤ 0.001) inhibited
growth of SW480 colon cancer cells (Fig. 2.10 a, b, c, d, e).
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d)
e)
Fig. 2.10. Growth inhibition of SW480 colon cancer cells incubated with micellar
solution of fatty acid fractions from buttermilks produced from: commercial
cream centrifugally separated (a), raw milk cream centrifugally separated (b), raw
milk cream separated by gravitational force at 4°C (c) and 20°C (d), raw milk
cream heat-treated at 95°C for 3s prior centrifugal separation (e) assessed using
AP assay after 3 (◊), 5 ( ) and 7 (▲) days of treatment. The SW480 cells were
maintained in Leibovitz-15 medium. Growth inhibition was expressed as a
percentage relative to control which was taken to be 0%. Growth inhibition
compared to control without treatment was considered significant when: * = P ≤
0.05, ** = P ≤ 0.01, *** = P ≤ 0.001. Significance was calculated only for
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minimum (100 µl) and maximum (500 µl) treatment, as well as for treatment
points exhibiting cancer cell growth stimulation.
2.3.6. Polar lipid fraction
Polar lipid (PL) fractions from each buttermilk sample were collected.
Micellar solution with sodium taurocholate was incubated with SW480 colon
cancer cells. Due to insufficient volume of buttermilk samples received, polar
lipid fractions collected were not quantified; hence final results were expressed as
volume of buttermilk (µl) subjected to lipid extraction and separation. It could be
observed that after 3 days of incubation, at 500 µl of buttermilk taken for
extraction, PL micellar solution from buttermilks produced from: commercial
cream (1), centrifugal separated cream (2) and gravitational separated cream at
4°C (3) showed similar antiproliferative activity but higher than PL solution from
buttermilks produced from: gravitational separated cream at 20°C (4) and heat-
treated cream (5) (Fig. 2.11 a, b, c, d, e). After 7 days of incubation, at 500 µl of
buttermilk taken for extraction, PL micellar solution from buttermilk 1 showed the
highest antiproliferative activity, inhibiting SW480 colon cancer cell growth by
71.6%, followed by buttermilks 3 and 5, which inhibited cell growth by 58.2%
and 55.5%, respectively. The lowest antiproliferative activity after 7 days of
incubation was observed for PL solution from buttermilk 4, which inhibited
cancer cells growth by 28.8% (Fig. 2.11 a, b, c, d, e).
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d)
e)
Fig. 2.11. Growth inhibition of SW480 colon cancer cells incubated with micellar
solution of polar lipid fractions from buttermilks produced from: commercial
cream centrifugally separated (a), cream from raw milk centrifugally separated
(b), cream from raw milk separated naturally by gravitational force at 4°C (c) and
20°C (d), cream from raw milk heat-treated at 95°C for 3s prior centrifugal
separation (e) assessed using AP assay after 3 (◊), 5( ) and 7 (▲) days of
treatment. The SW480 cells were maintained in Leibovitz-15 medium. Growth
inhibition was expressed as a percentage relative to control which was taken to be
0%. Growth inhibition compared to control without treatment was considered
significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001. Significance was
calculated only for minimum (100 µl) and maximum (500 µl) treatment.
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2.3.7. Neutral lipid fraction
Neutral lipid (NL) fractions from each buttermilk sample were collected,
as described above. Micellar solution with sodium taurocholate was incubated
with SW480 colon cancer cells. Due to insufficient volume of buttermilk samples
received, neutral lipid fractions collected were not quantified; hence final results
were expressed as volume of buttermilk (µl) subjected to lipid extraction and
separation. Micellar solutions of neutral lipids were not optically clear after
sonication, even at 50ºC. However, cells were treated with unclear solutions to
test possible influence of the unclear NL micellar solutions on SW480 colon
cancer cells. At lower concentrations (up to 150 µl of buttermilk taken for
extraction), after 3 days of incubation only NL micellar solutions from buttermilks
produced from centrifugal separated cream (2) and heat-treated cream (5) showed
antiproliferative activity against SW480 colon cancer cells (Fig. 2.12 a, b, c, d, e).
Furthermore, NL solutions from buttermilks produced from commercial cream
(1), gravitational separated creams at 4°C (3) and at 20°C (4) significantly (P ≤
0.01 after 3-day incubation and P ≤ 0.001 after 5 and 7-day incubation) promoted
cancer cell growth when compared to control with sodium taurocholate only.
However, after 3 days of incubation, at 500 µl of buttermilk taken for extraction,
NL solutions from all buttermilks inhibited growth of SW480 colon cancer cells,
with buttermilks 2 and 5 being the most potent. At 500 µl taken for extraction, NL
solutions from all buttermilks maintained antiproliferative activity (Fig. 2.12 a, b,
c, d, e).
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d)
e)
Fig. 2.12. Growth inhibition of SW480 colon cancer cells incubated with micellar
solution of neutral lipid fractions from buttermilks produced from: commercial
cream centrifugally separated (a), cream from raw milk centrifugally separated
(b), cream from raw milk separated naturally by gravitational force at 4°C (c) and
20°C (d), cream from raw milk heat-treated at 95°C for 3s prior centrifugal
separation (e) assessed using AP assay after 3 (◊), 5 ( ) and 7 (▲) days of
treatment. The SW480 cells were maintained in Leibovitz-15 medium. Growth
inhibition was expressed as a percentage relative to control which was taken to be
0%. Growth inhibition compared to control without treatment was considered
significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001. Significance was
calculated only for minimum (100 µl) and maximum (500 µl) treatment.
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For the comparative purposes, fatty acid, polar lipid and neutral lipid
fractions of all buttermilks after 3 days of incubation are shown on Figure 2.13
(a, b, c, respectively). Figure 2.14 shows effect of sodium taurocholate on
SW480 colon cancer cells. At the concentration of 0.36 mM, which was used for
the formation of fatty acid and polar lipid micelles sodium taurocholate did not
significantly (P > 0.05) inhibit growth of SW480 colon cancer cell (about 5% of
growth inhibition). At concentration 1.2 mM NaTC, which was used to form
micelles with neutral lipids sodium taurocholate showed high antiproliferative
activity (about 35%) against SW480 colon cancer cells (P ≤ 0.001).
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Fig. 2.13. Comparison of antiproliferative activity of fatty acid (a), polar lipid (b)
and neutral lipid (c) fractions of buttermilks produced from: commercial cream
centrifugally separated (◊), cream from raw milk centrifugally separated ( ),
cream from raw milk separated naturally by gravitational force at 4°C (▲) and
20°C (■), cream from raw milk heat-treated at 95°C for 3s prior centrifugal
separation ( ). Results were assessed after 3 days of incubation in SW480 cells
using AP assay. The SW480 cells were maintained in Leibovitz-15 medium.
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Growth inhibition was expressed as a percentage relative to control which was
taken to be 0%.
Fig. 2.14. Growth inhibition of SW480 colon cancer cells incubated with sodium
taurocholate (NaTC) solution. Results were assessed after 3 (◊), 5 ( ) and 7 (▲)
days of incubation using AP assay. The SW480 cells were maintained in
Leibovitz-15 medium. Growth inhibition was expressed as a percentage relative to
control which was taken to be 0%. Growth inhibition compared to control without
treatment was considered significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤
0.001.
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2.4. Discussion
The overall aim of this project was to optimize technology for production of
buttermilk that is enriched in biologically active components of MFGM. Initially, it
was necessary to establish a robust, efficient and economically attractive method for
evaluating cytotoxicity of buttermilk samples prepared using different processing
methods and for selecting a buttermilk product for further studies. Selection of an
appropriate cell based in vitro assay for screening buttermilks during the production
process is important as it will be used in the post-production phase to monitor the
desired effectivity and safety of the product. In choosing between MTS and acid
phosphatase (AP) for in vitro cytotoxicity testing two decisive factors were
considered. The first critical issue was the sensitivity and accuracy of the cytotoxicity
assay. Both the MTS and AP assays were comparable with respect to variation but
SW480 cell growth in the range up to 103 cells was better detected using AP assay
than MTS assay, as judged by the linearity of the standard curve. This confirms a
previous report that acid phosphatase activity assay demonstrated a higher sensitivity
than MTS in determining cell number (Martin and Clynes, 1993, O’Connor et al.,
1998). Furthermore, complex dietary sphingolipids, such as sphingomyelin and
glycosphingolipids have been reported to inhibit the development of colon cancer in
vivo (Dillehay et al., 1994, Schmelz et al., 1996, Schmelz et al., 2000, Symolon et al.,
2004). This protective role may be the result of the conversion of complex
sphingolipids to bioactive metabolites including sphingosine and ceramide which
were reported to inhibit proliferation and stimulate apoptosis also in colon cancer cell
culture models, such as HT-29 and HCT-116 (Ahn and Schroeder, 2002, Ahn and
Schroeder, 2010), as well as SW480 and T84 cells (Schmelz et al., 2001). In our
study, we used commercial sphingosine and ceramide to evaluate the suitability and
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the difference between MTS and AP assay. In both cases, we found that sphingosine
and ceramide showed antiproliferative activity against SW480 colon cancer cells
indicating both assays as potentially adequate in our further studies. Sphingolipids
which are present in MFGM, such as sphingomyelin and lactosylceramide were also
screened for antiproliferative activity. We found that sphingomyelin and
lactosylceramide inhibited growth of SW480 colon cancer cells, which confirmed
previous findings; hence validated our model for antiproliferative studies. The second
factor taken into consideration in choosing a cytotoxicity method for further studies
was the economical aspect, by which we included a costing of the reagents for
performing assays in large quantities. Due to the large number of buttermilk samples
planned for screening in this project, it was decided to use the more sensitive and
economically more efficient AP assay in place of the MTS assay.
Development of functional foods designed to combat diseases, such as
coronary heart disease, diabetes, hypertension, and cancer is hugely dependent on
effective delivery systems to encapsulate, protect and release bioactive lipophilic
components, such as sphingolipids, omega-3 fatty acids, conjugated linoleic acid,
tributyrin, vitamins, antioxidants, carotenoids, and phytosterols. Dietary lipids must
be hydrolysed by pancreatic lipase to fatty acids and monoacylglycerol or by
sphingomyelinase to sphingosine and ceramide before they can cross the apical
membrane of enterocytes. Although passive diffusion of lipids, such as free fatty acids
can take place across the apical brush-border membrane, it is understood that
physiological absorption of polar lipolytic products takes place from a micellar phase
made up of bile salts (taurocholate) and lecithin (phosphatidylcholine). This chapter
reports on the relative effects of exposing colon cancer cells to pure sphingolipid
preparations and to lipid fractions of various processed buttermilks. The former were
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presented to cells in the form of ethanolic solutions; the latter were presented in
micellar form.
Delivery of lipid mixtures in the form of micellar solutions formed with bile
salts (e.g. taurocholate) is increasingly being used in in vitro studies (Jackson et al.,
2009, Ho and Storch, 2001, Trotter et al., 1996). Monoglycerides and fatty acids can
be solubilized to form a colloidal dispersion within bile salt-lecithin mixed micelles
(Shiau, 1987). Bile salt micelles solubilize the hydrophobic lipids before they are
transported across the unstirred water layer to the intestinal brush border membrane.
Ranheim et al., (1994) showed that human intestinal cell line Caco-2 can assimilate
fatty acids four times faster from a micellar solution than from albumin-bound fatty
acids in vitro and can incorporate them into triacylglycerols that are subsequently
secreted. In recognition that most lipid fractions have a low water solubility and must
be incorporated into some kind of delivery system to make them readily taken up by
cells in culture, mixed micelles made from taurocholate and phosphatidylcholine
(DOPC) were used to deliver fatty acids, polar lipids and neutral lipid fractions of
buttermilk to SW480 cells in culture. The concentration of sodium taurocholate (0.36
mM) used for the formation of fatty acid and polar lipid micelles did not significantly
(P > 0.05) affect the antiproliferative activity of treatments (about 5% cytotoxicity).
However, 1.2 mM NaTC, which was used to form micelles with neutral lipids showed
high antiproliferative activity (about 35%) against SW480 colon cancer cells. This
and the fact that the neutral lipids fractions were not clear when treating cells
(indicating that micelles were not formed) suggest that this method of delivering
neutral lipids to cells was not successful. Hence, the antiproliferative activity of the
neutral lipid fraction from buttermilk was not compared with fatty acid and polar lipid
fractions.
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In our studies, the polar lipid fraction of buttermilks showed relatively greater
anticancer activity in comparison with the free fatty acid fraction (P not significantly
different for buttermilk sample 4; P ≤ 0.05 for buttermilk 1; P ≤ 0.001 for buttermilks
2, 3 and 5). The polar lipid fraction from each buttermilk (except buttermilk 4, which
was produced from cream separated at 20ºC using gravitational force) reached about
50-60% cell growth inhibition when 500 μl buttermilk was taken for extraction and
micellar solution was incubated with cells for 3, 5 and 7 days. The antiproliferative
activity may be associated with sphingolipids in MFGM membrane, which were
shown to possess anticancer activity (Simon et al., 2009, Schmelz, 2004, Lemonnier
et al., 2003) or with phosphoglyceride-containing polyunsaturated fatty acids or
conjugated linoleic acid present in bovine milk. Fong et al. (2007) have studied
composition of fatty acids incorporated into bovine MFGM phospholipids using
capillary GC. According to Fong et al. (2007), the major fatty acids associated with
MFGM phospholipids were palmitic, stearic, oleic and linoleic acid. They also
observed that SM contained significantly higher proportions of fatty acids with carbon
chain length greater than 20. Numerous in vitro, in vivo and epidemiology studies
show that polyunsaturated fatty acids and cis9, trans11-conjugated linoleic acid
(CLA) but not saturated, monounsaturated and dienoic fatty acids, have an inhibitory
effect on cell proliferation/viability (Nano et al., 2003, Igarashi and Miyazawa, 2000,
O’Shea et al., 2000). It is likely that the presence of unesterified CLA and/or omega-3
fatty acids accounts for the inhibitory effect on cell proliferation of the fractions
reported in this study.
In our study, processing of buttermilk did influence the antiproliferative
activity of buttermilk fractions in SW480 cells. Irrespective of the type of lipid in each
fraction, buttermilks produced from centrifugally separated creams were more potent
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than buttermilks produced from gravity-separated creams maintained at 4ºC or 20ºC.
Cream that was heated to 95ºC for 3 s prior to centrifugal separation also yielded a
greater potency than unheated gravity-separated cream.
Although mixed micelles are commonly used in food and pharmaceutical
research, we did not find them suitable for delivering different lipid classes of
buttermilk in our in vitro studies. It was particularly difficult to evaluate the growth
modulatory properties of neutral lipids because the final micellar solution was not
optically clear, even at high concentrations of sodium taurocholate (up to 1.2 mM)
and when sonication at 50ºC was used. A possible solution to address this difficulty
may have been to subject the neutral lipid fraction to in vitro digestion by pancreatic
lipase and entrap the resulting lipolytic product in liposomes comprising
phosphatidylcholine so as to form a stable emulsion for delivery to cells.
Microfluidization is increasingly being used to form liposomes for encapsulation of
hydrophobic and hydrophilic compounds. This technique has the advantage over
traditional techniques in that liposomes are formed by high pressure homogenisation
without the use of sonication, detergents, solvents, or alcohols. Microfluidised
liposomes prepared from MFGM phospholipid fraction were shown to possess
significantly higher entrapment efficiency for hydrophobic β-carotene than liposomes
formed from soybean phospholipids (Thompson et al., 2009), a property that was
attributed to differences in the composition of phospholipid material used.
Given that whole buttermilk contains disrupted MFGM and that the objective
of the study was to examine the antiproliferative potential of buttermilk samples
containing MFGM material, it was considered that testing whole buttermilks would
provide more information than just testing lipid fractions. MFGM is a complex
formation of proteins, glycoproteins, lipids (including fatty acids, as well as polar and
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neutral lipids) and enzymes (e.g. oxidoreductases and transferases). Some of the
MFGM proteins were found to possess beneficial properties on human health, such as
fatty acid binding protein (FABP) (Spitsberg et al., 1995, Li et al., 2009), breast
cancer type 1 and 2 susceptibility protein (BRCA1, BRCA2) (Brody and Biesecker,
1998, Vissac et al., 2002), butyrophilin (Mana et al. 2004, Johns and Bernard, 1999,
Stefferl et al., 2000), and lactadherin (PAS6/7, MFG-E8) (Zeelenberg et al., 2008, Liu
et al., 2005). Fractionation of this material may adversely affect the bioactivity of its
components and would not be representative of MFGM when presented in vivo as a
whole beverage. Therefore, we decided that further studies on the effect of processed
buttermilk samples on growth of colon cancer cells would be conducted using whole
buttermilk samples in preference to mixed micelles of its lipid components.
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2.5. Conclusions
The data show that acid phosphatase assay is a reliable colorimetric method
for screening antiproliferative activity of buttermilk fractions in vitro. However,
separation of buttermilks into lipid classes and delivery of them into the cells in the
form of bile salt micellar solutions does not yield reliable results. In particular, there
was difficulty in formation of micellar solution with neutral lipid fractions, even at
high concentrations of sodium taurocholate (up to 1.2 mM), which itself was toxic to
colon cancer cells. Furthermore, given that whole buttermilk contains disrupted
MFGM and that the objective of the study was to examine the antiproliferative
potential of buttermilk samples containing MFGM material, it was considered that
testing whole buttermilks would provide more information than just testing lipid
fractions.
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CHAPTER 3
Effect of sweet and fermented buttermilk samples on growth of
SW480 human colon cancer cells and FHC normal colon epithelial
cells.
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The milk fat globule membrane (MFGM) that surrounds fat globules in milk is
a natural source of sphingolipids, phoshpholipids and proteins with defined anticancer
properties. Dairy processing operations can affect the structure and composition of
MFGM, potentially influencing its anticancer activity. The aim of this study was to
determine if anticancer activity can be attributed to unfermented and fermented
buttermilks which contain fragments of MFGM and examine if different milk
processing operations (mode of separation, washing, heating) may influence the
antiproliferative activity of resultant buttermilks. After 3 days of incubation of SW480
cells with buttermilk produced from centrifugally separated cream (0.38 mg total
solids/ml) there was significant (P ≤ 0.001) inhibition of growth of SW480 human
colon cancer cells by 97.5%, but no toxic effect on FHC human normal colon cells
was found, as determined by the acid phosphatase cytotoxicity assay. Corresponding
buttermilk produced from washed cream (0.062 mg total solids/ml) inhibited SW480
cell growth by 96.2%. The anticancer activity of buttermilks was retained after heat
treatment but was lost after spray drying. Fermented buttermilks inhibited SW480 cell
growth to a lesser extent; the highest cytotoxicity was obtained for buttermilk
fermented with Streptococcus thermophilus HDPC4694, which inhibited SW480 cell
growth by 46.6% at concentration of 0.94 mg total solids/ml.
90
3.1. Introduction
A functional food/beverage is a conventional food/beverage that is consumed
as part of a usual diet, and is demonstrated to have physiological benefits and/or
reduce the risk of chronic disease beyond basic nutritional functions, i.e. they contain
bioactive compound. The potential of buttermilk to serve as a food ingredient and as a
functional beverage is high due to the beneficial properties of milk fat globule
membrane (MFGM) constituents: phospholipids, sphingolipids and membrane
proteins. The approximate ratio of proteins, lipids, and carbohydrates within the
membrane is 4:3:1 (Spence et al., 2009). The major PL fractions consist of
phosphatidylcholine (PC), phosphatidylethanolamine (PE), sphingomyelin (SM),
phosphatidylinositol (PI) and phosphatidylserine (PS) (Barenholz and Thompson,
1999). Much research work has focused on sphingolipids present in MFGM, which
are known to play roles in differentiation, proliferation, immune recognition, as well
as transmembrane signalling and cell-to-cell interactions (Okazaki et al., 1989, Kim et
al., 1991, Huwiler et al., 2000, Deguchi, 2004, Colombaioni and Garcia-Gil, 2004,
Duan and Nilsson, 2009). Because of antiproliferative activity of sphingomyelin
break-down products, such as ceramide and sphingosine (Ogretmen and Hannun,
2004), buttermilk has the potential to become a functional beverage assisting in
chemopreventive therapies (Schmelz et al., 1996, Spitsberg, 2005, Snow et al., 2010).
Modern dairy processing operations, such as homogenization, heating,
aeration, agitation or drying as well as milk handling and transportation affect MFGM
structure and composition (Fox & McSweeney, 1998). Churning of cream during
buttermaking results in disruption of MFGM from lipid droplets and the release of
fragments into the aqueous phase (buttermilk), a byproduct of butter production.
Hence, buttermilk is naturally rich in disrupted MFGM material and its polar lipid
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content is relatively high compared with most other dairy products. According to
Rombaut et al. (2006) when butter is made, up to 42.4% of the membrane material is
recovered in the aqueous fraction.
Dairy operations produce buttermilk for commercial use by inoculating milk
with starter and probiotic cultures. For example Lactococcus lactis is used to stimulate
lactic acid production by fermentation of lactose, the primary sugar found in milk.
However, unlike buttermilk produced in the traditional fashion, most of the fat in
cultured buttermilk is skimmed, leaving only traces of MFGM. Advances in dairy
technology, such as membrane filtration have the potential to produce MFGM
enriched fractions from buttermilk, thereby converting a low value by-product into a
new high value functional beverage.
To address whether a specific functionality could be attributed to a by-product
originating from the dairy industry, we prepared a variety of buttermilks and
examined the effects of cream separation methods, washing, heating and inoculation
with different probiotic cultures on the antiproliferative activity of resultant
buttermilks in the SW480 human colon cancer cell line and the FHC human normal
colon epithelial cell line. Unfermented buttermilk selectively inhibited growth of
SW480 cells. In general, samples heated to 95ºC maintained the growth inhibitory
effect towards cancer cells; washing of cream before churning increased anticancer
activity of buttermilk. Spray-dried buttermilk powder had negligible activity on
growth of cells. Fermented buttermilks were in general less inhibitory comparing to
unfermented buttermilks. To our knowledge this is the first in vitro study to
demonstrate bioactivity of dairy liquid products enriched in MFGM.
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3.2. Materials and methods
3.2.1. Preparation of buttermilk samples for antiproliferative studies
3.2.1.1. Cream preparation
Buttermilk samples were generated by a member of the project team. Raw
whole milk was collected from the Moorepark Dairy Production Centre (MDPC)
farm (Fermoy, Co. Cork, Ireland) and immediately subjected to pasteurization at
72°C for 15s in a thermostatically controlled waterbath and cooled to approximately
20°C in an ice bath. Raw milk was then separated into cream and skim milk using
variety of methods. One batch of cream was produced from raw milk separated at
45°C using an Armfield disc bowl centrifuge (Armfield, Ringwood, UK) at max rpm.
Raw milk was also allowed to separate naturally by gravitational force at 4°C over a
period of 24h. One batch of raw cream was subjected to heat treatment at 95°C for 3s
prior centrifugal separation. All creams were then standardized as required using their
corresponding skim milk to approximately 40% fat. In order to determine the
influence of cream composition on that of the buttermilks subsequently produced, a
cream-washing option was included at this stage. An aliquot (500 ml) of each cream
sample was washed with simulated milk ultrafiltrate (SMUF, Jenness and Koops,
1962). The cream was suspended in 5 volumes of SMUF and held at 37 °C for 1 h.
This mixture was then separated (Armfield disc bowl centrifuge) and cream collected.
Washing in SMUF was repeated twice more. Buttermilk samples were prepared from
each of the unwashed and washed creams.
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3.2.1.2. Buttermilk preparation
The experimentally-prepared creams were churned until the cream emulsion
inverted and buttermilk was generated by a project team member, as described in
Chapter 2, subsection 2.2.2.1. As a reference a buttermilk sample was also produced
from commercial cream purchased in a local shop.
Fermented buttermilks, skim milk and buttermilk powder after spray drying
(inlet 180°C, outlet 85°C) were also assayed for anticancer activity. Skim milk was
purchased from a local supermarket.
3.2.1.3. Fermentation studies
Buttermilk samples were fermented at 37°C for 12h using individual lactic
strains e.g. Lactococcus lactis DPC 4268, Lactobacillus helveticus DPC TH3,
Streptococcus thermophilus DPC 4694 and Lactococcus lactis diacetylactis DPC 911,
which are commonly used in dairy industry as starter cultures. The buttermilks were
thermised (65°C, 30 min) prior to inoculation. Bacterial inactivation on completion of
incubation was accomplished by heating to 72°C for 15 min before freezing of
samples.
3.2.2. Compositional analysis of buttermilk samples
All compositional analysis of buttermilk samples were performed by a project
team member, as described in Chapter 2, subsection 2.2.3.
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3.2.2.1. Characterisation of MFGM phospho- and sphingolipid components
Extraction and analysis of phospho- and sphingolipids in natural and washed
cream buttermilk samples was carried out using HPLC according to the method of
Rombaut et al. (2005). Briefly, 5 g of sample was diluted with deionised water to 20
ml and mixed thoroughly. Phospho- and sphingolipids were then extracted by
addition of 80 ml 2:1 (v/v) chloroform:methanol, followed by mixing. The mixture
was allowed to stand and the lower chloroform layer was collected. This procedure
was repeated twice using 40 ml of 20:1 (v/v) chloroform:methanol which was added
to the upper phase. In the final step 40 ml of 86:14:1 (v/v/v)
chloroform:methanol:water containing 0.9 % NaCl (pH 4.5) was used. Each of the
lower phases were pooled and evaporated using a rotary vacuum evaporator at 50°C.
The lipid extracts were redissolved in 10 ml 2:1 (v/v) chloroform:methanol and stored
at –30°C until HPLC analysis.
Lipid extracts were analyzed using a Waters HPLC system (Milford, MA,
USA) comprising of a 2695 separations module, column heater and Empower Pro
software, which was coupled with an ESA Corona charged aerosol detector (ESA
Ltd., Chelmsford, MA, USA). The nebulising gas was N2, which was supplied at a
pressure of 35 psi (2.4 bar). A 150 x 3.2 mm Prevail silica column with 3 µm particle
diameter (Alltech, Lokeren, Belgium) was used in addition to a pre and post in line
filters with the same packing. The elution programme was a linear gradient with
87.5:12:0.5 (v/v/v) chloroform:methanol:1M formic acid (pH 3, triethylamine) at t =
0 min to 28:60:12 (v/v/v) at t = 16 min. the mobile phase was brought back to the
initial conditions at t = 17 min and the column was allowed to equilibrate for the next
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4 min (t = 21 min). The flow rate was 0.5 ml/min and injection volume was 20 µl.
The samples and column were equilibrated and held at 40°C throughout. Standards
used for calibration were phosphatidylethanolamine (PE), phosphatidylcholine (PC),
phosphatidylserine (PS), phosphatidylinositol (PI), sphingomyelin (SM),
lactosylceramide (LC) and glucosylceramide (GC).
3.2.3. Cell culture
SW480 human colon cancer cell line and FHC human normal colon cell line
were obtained from European Collection of Cell Cultures, ECACC. Culture media
and supplements were purchased from Sigma-Aldrich Ireland, Ltd. The SW480 cells
were maintained in Leibovitz-15 medium supplemented with L-glutamine (4 mM),
foetal bovine serum (FBS) (10%, v/v) and penicillin/streptomycin (1 U/ml). The FHC
cells were grown in DMEM/Ham’s Nutrient Mixture F-12 supplemented with L-
glutamine (2.5 mM), sodium bicarbonate (1.2 g/l), HEPES (25 mM), sodium
pyruvate (0.5 mM), FBS (10%, v/v), cholera toxin (10 ng/ml), insulin (0.005 mg/ml),
transferrin (0.005 mg/ml), hydrocortisone (100 ng/ml) and penicillin/streptomycin (1
U/ml). Both cell lines were grown at 37°C, with 5% CO2 for the FHC and in non-CO2
conditions for the SW480.
3.2.4. Acid phosphatase activity assay
To assess the antiproliferative activity of buttermilk samples, SW480 and the
FHC cells were seeded in 96-well plates at densities of 5x103/well and 3.5x103/well,
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respectively. Cells were cultured for 24 h to allow the cells to attach and then sweet
or fermented buttermilks were diluted in feeding media and were added to the wells
with the cells. Cells were also incubated in the presence buttermilk samples which
were high-heat treated (95°C, 30 min) prior incubation with cells, skim milk and
reconstituted buttermilk powder after spray drying. Controls contained only media.
Sodium butyrate (5 mM), a potent apoptotic fatty acid (McBain et al., 1997) served
as a positive control. Different buttermilk samples were taken for the experiments in
the range of concentrations between 0-0.94 mg total solids/ml. All the buttermilk
samples were pasteurized prior to treatment by incubation at 72°C for 15 s. The wells
with the SW480 cells were covered with parafilm to prevent CO2 access to the cells.
Four replicates of each buttermilk concentration were performed. After 3 days of
incubation at 37°C, cell survival was measured by an indirect colorimetric end point
assay for acid phosphatase activity (O’Connor et al., 1998), as described in Chapter
2, subsection 2.2.5.
3.2.5. Statistical analysis
3.2.5.1. Compositional analyses of buttermilks
Results were analyzed statistically using Graph Pad Prism 3.03 for Windows
software package (GraphPad Software, San Diego, California, USA). The ANOVA
procedures were performed and mean comparisons were carried out using Tukey’s
test. Results were considered significantly different at P ≤ 0.05.
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3.2.5.2. Cytotoxicity assays
Three independent experiments were performed in quadruplicate and the
Student’s t-test was used to determine significant difference between treatments and
the controls. Results were considered significantly different when: * = P ≤ 0.05, ** =
P ≤ 0.01, *** = P ≤ 0.001.
3.3. Results
3.3.1. Compositional analysis of buttermilks
Tables 3.1-3.2 show compositional analysis of buttermilk samples produced
from unwashed and washed creams. It was found that buttermilks showed significant
(P ≤ 0.05) differences between their respective total solids, fat, protein and
phospholipid contents (Table 3.1). Washing of cream leads to decrease in total solids
of the resultant buttermilks; hence buttermilks produced from unwashed cream
possess significantly (P ≤ 0.05) higher total solids contents, ranging from 8.87% to
10.61%, when compared to buttermilks produced from washed cream which range
from 2.43 to 3.45% (Table 3.1). Washing of cream before churning also leads to
decrease in serum protein; hence to a higher proportion of MFGM protein material.
We also found a decrease in PE, PI, PS, PC and LC in buttermilk produced from
washed gravitational separated cream comparing to its corresponding unwashed
sample (Table 3.2). However, PE, PI and LC contents increased in buttermilk
produced from washed centrifugally separated cream comparing to unwashed sample.
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Table 3.1. Compositional analysis of unwashed and washed buttermilk samples; data obtained by a project team member. All values
are expressed as mean %. b Values for phospholipid expressed as a % of fat and total solids. c, d Significant (P ≤ 0.05) difference
between buttermilks produced from unwashed and washed cream. Abbreviations: CC, buttermilk produced from commercial cream;
CSC, buttermilk produced from centrifugally separated cream; G4SC, buttermilk produced from gravitational separated cream at 4°C.
Percentage of phospholipids in:
Sample Total solids(%) Protein (%)
MFGM proteins
(%) Lipids (%) Sample (%) Total fat (%) Total solids(%)
Unwashed
CC 9.36±0.05c 3.06±0.23c 48.11 0.80±0.00c 0.05±0.00c 8.05±0.04 b 0.56±0.00 b
CSC 10.61±0.06c 3.82±0.00c 46.92 1.85±0.05c 0.08±0.00c 4.53±0.00 b 0.79±0.00 b
G4SC 8.87±0.04c 3.90±0.02c 50.74 1.00±0.00c 0.04±0.00c 3.94±0.01 b 0.44±0.00 b
Washed
CC 3.45±0.02d 0.41±0.02d 61.67 1.70±0.10d 0.03±0.00d 1.84±0.00 b 1.03±0.00 b
CSC 2.43±0.01d 0.29±0.00d 64.75 0.45±0.05d 0.04±0.00d 8.22±0.07 b 1.52±0.00 b
G4SC 2.98±0.01d 0.49±0.01d 60.55 2.20±0.10d 0.03±0.00d 1.52±0.00 b 1.12±0.00 b
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Table 3.2. Phospho- and sphingolipid compositions of unwashed and washed buttermilk samples; data obtained by a project team
member. All values are expressed as mean %. Abbreviations: CC, buttermilk produced from commercial cream; CSC, buttermilk
produced from centrifugally separated cream; G4SC, buttermilk produced from gravitationally separated cream at 4°C; PE,
phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; GC, glucosylceramide; LC,
lactosylceramide; SM, sphingomyelin.
Buttermilk sample PE (%) PI (%) PS (%) PC (%) GC (%) LC (%) SM (%)
Unwashed
CC 30.44±0.01 2.21±0.04 8.64±0.11 35.47±0.11 ND 4.42±0.18 18.18±0.06
CSC 34.34±0.04 4.01±0.02 8.49±0.01 33.36±0.03 ND 3.61±0.01 16.19±0.03
G4SC 32.46±0.06 5.90±0.01 12.46±0.07 35.16±0.03 ND 3.27±0.10 10.76±0.08
Washed
CC 27.05±0.04 8.81±0.06 10.84±0.04 32.79±0.05 ND 1.15±0.02 19.36±0.00
CSC 35.68±0.08 13.62±0.11 5.19±0.08 25.61±0.10 ND 9.51±0.16 10.40±0.20
G4SC 26.80±0.00 2.86±0.01 9.34±0.00 28.99±0.00 ND 3.19±0.04 27.37±0.05
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3.3.2. Cytotoxicity
3.3.2.1. Optimization of incubation time and concentration of buttermilk for
cytotoxicity assay using SW480 human colon cancer cells
Growth inhibition was expressed as a percentage relative to control which was
set at 0%. Data represent the mean ± standard error of the mean of three independent
experiments performed in quadruplicate. Buttermilk produced from unwashed
centrifugally separated cream was incubated with SW480 colon cancer cells at
different concentrations and different time points. The antiproliferative activity of
buttermilk (in the concentration range: 0.19-0.94 mg total solids/ml) was assessed
after 1, 2 and 3 days of incubation and it was proportional to incubation time and
concentration of buttermilk solids used in the experiment (Fig. 3.1). At concentration
of 0.38 mg total solids/ml buttermilk reduced cell growth by 22.2%, 61.4% and 97.1%
after 1, 2 and 3 days of incubation, respectively. Furthermore, after 1 day of
incubation with buttermilk solids in the range 0.19 to 0.94 mg/ml, growth inhibition
did not exceed 25%; after 2 days growth inhibition was 78.1% at a concentration of
0.94 mg total solids/ml.
3.3.2.2. Comparison of antiproliferative activity of buttermilk samples produced
from unwashed and washed creams
Reduced levels of protein in serum during cream washing contribute to an
increase relative proportion of MFGM in total solids in the resulting buttermilk
samples (Morin et al., 2007 a). Hence, buttermilk samples generated from washed and
unwashed creams were screened for antiproliferative activity. Washed buttermilks
inhibited growth of SW480 colon cancer cells with a greater potency than
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Fig. 3.1. Growth inhibition in SW480 colon cancer cells incubated with buttermilk
produced from unwashed centrifugally separated cream for 1 (), 2 ( ), 3 () days
assessed using AP assay. The SW480 cells were grown in Leibovitz-15 medium. Data
refer to mean ± SD of three independent experiments. Growth inhibition was
considered significantly different than control without treatment when: * = P ≤ 0.05;
** = P ≤ 0.01; *** = P ≤ 0.001.
their corresponding unwashed samples (Fig. 3.2). Buttermilks produced from
unwashed: commercial cream, centrifugally separated cream and gravitational
separated cream inhibited cell growth by 97.3%, 98.2% and 29.5% at concentrations:
0.4, 0.47 and 0.87 mg total solids/ml, respectively. Their corresponding washed
samples were more potent, inhibiting cell growth by 98.5%, 96.2% and 97.8% at
concentrations: 0.27, 0.062 and 0.074 mg total solids/ml, respectively. It was also
found that pasteurisation of cream before churning at 72°C for 15s did not influence
antiproliferative activity of buttermilk on SW480 colon cancer cells.
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Fig. 3.2. Growth inhibition in SW480 colon cancer cells incubated with buttermilk
produced from: unwashed commercial cream ( with dashed line), unwashed
centrifugally separated cream (), unwashed gravitationally separated cream (▲),
washed commercial cream ( with continuous line), washed centrifugally separated
cream () and washed gravitationally separated cream ( with dashed line) for 3
days assessed using AP assay. The SW480 cells were grown in Leibovitz-15 medium.
Data refer to mean ± SD of three independent experiments. The same volume of
different buttermilk samples was taken for the experiments and the concentrations of
buttermilks were calculated as mg of total solids in 1 ml of buttermilk taken.
3.3.2.3. Comparison of influence of buttermilk on growth of SW480 colon cancer
cells and FHC normal colon epithelial cells
To investigate selectivity of buttermilk’s cytotoxic activity on colon cancer
cells, buttermilk was also incubated with FHC normal colon epithelial cells. It was
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found that the growth inhibitory effect of buttermilk produced from centrifugally
separated cream was selective to SW480, as growth inhibition on FHC was only 3.4 ±
3.1% (Fig. 3.3). It was also apparent that sodium butyrate inhibited growth to a
greater extent in SW480 cells (96.9 ± 1.1%) compared to FHC cells (53.3 ± 0.5%)
(Fig. 3.3).
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Fig. 3.3. Comparison of growth inhibition in SW480 colon cancer cells ( ) and FHC
normal colon epithelial cells () incubated with sodium butyrate (5 mM) and
buttermilk produced from unwashed centrifugally separated cream (0.38 mg total
solids/ml) for 3 days assessed using AP assay. Data refer to mean ± SD of three
independent experiments. Growth inhibition compared to control without treatment
was considered significant when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
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3.3.2.4. Evaluation of influence of high heat treatment and spray drying on
antiproliferative activity of buttermilk
It was found that incubation of buttermilk at 95°C for 30 min prior to
treatment with SW480 colon cancer cells did not alter the antiproliferative activity of
buttermilk (Fig. 3.4). However, it was found that buttermilk which was spray-dried
and then reconstituted to initial volume in water lost all antiproliferative activity. No
activity was also observed when incubating SW480 cells with skim milk (Fig. 3.4).
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Fig. 3.4. Comparison of growth inhibition in SW480 colon cancer cell line incubated
with unheated buttermilk produced from unwashed centrifugally separated cream (
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high temperature (95°C, 30 min) treated buttermilk produced from unwashed
centrifugally separated cream ( ), reconstituted buttermilk after spray drying () and
skim milk () for 3 days assessed using AP assay. The Sw480 and FHC cells were
grown in Leibovitz-15 and DMEM/Ham’s Nutrient Mixture F-12 media, respectively.
Data refer to mean ± SD of three independent experiments. Growth inhibition
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compared to control without treatment was considered significant when: * = P ≤ 0.05,
** = P ≤ 0.01, *** = P ≤ 0.001.
3.3.2.5. Antiproliferative activity of fermented buttermilk samples
Buttermilks were also fermented with lactic acid bacteria strains in order to
obtain a product beneficial for digestion and balance of intestinal bacteria. For this
purpose the following strains were used for fermentations of buttermilks: Lactococcus
lactis DPC 4268, Lactobacillus helveticus DPC TH3, Streptococcus thermophilus
DPC 4694 and Lactococcus lactis diacetylactis DPC 911. It was found that
antiproliferative activity of fermented buttermilks was significantly lower (P ≤ 0.001)
compared to unfermented buttermilk produced from centrifugally separated cream
(Fig. 3.5). Fermented buttermilks inhibited SW480 colon cancer cell growth by
16.8%, 24.8%, 38.2% and 46.6% at buttermilk concentrations: 0.84, 0.78, 0.73 and
0.94 mg total solids/ml, for buttermilks fermented with Lactococcus lactis DPC 4268,
Lactobacillus helveticus DPC TH3, Lactococcus lactis diacetylactis DPC 911 and
Streptococcus thermophilus DPC 4694, respectively. To eliminate a negative
influence of low pH of fermented buttermilks on viability of cancer cells, pH of
fermented buttermilk was adjusted to 6.5. At this pH, the precipitated casein was
reconstituted in the buttermilk solution. Colon cancer cells were treated with the
above fermented buttermilk (pH 6.5) as previously described. It was found that pH
adjustment to 6.5 did not alter toxicity of fermented buttermilks on SW480 colon
cancer cells (Fig. 3.6).
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Fig. 3.5. Comparison of growth inhibition in SW480 colon cancer cells incubated with
unfermented buttermilk produced from unwashed centrifugally separated cream ()
with buttermilks fermented with strains: Lactococcus lactis DPC 4268 (),
Lactobacillus helveticus DPC TH3 (), Streptococcus thermophilus DPC 4694 (▲)
and Lactococcus lactis diacetylactis DPC 911 () assessed using AP assay. The same
volume of different buttermilk samples was taken for the experiments and the
concentrations of buttermilks were calculated as mg of total solids in 1 ml of
buttermilk taken. The SW480 cells were maintained in Leibovitz-15 medium. Data
refer to mean ± SD of three independent experiments.
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Fig. 3.6. Comparison of growth inhibition in SW480 colon cancer cells incubated with
fermented buttermilk at pH 3.7 () and fermented buttermilk with pH adjusted to 6.5
() assessed using AP assay. The SW480 cells were maintained in Leibovitz-15
medium. Data refer to mean ± SD of three independent experiments. Statistical
difference between treatments was not significant (P > 0.05).
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3.4. Discussion
In this study, we have described the use of a human colon cancer cell line,
SW480 to study the effect of processed buttermilks on growth of cancer cells. Using
an indirect cytotoxicity assay, it was possible to show that cell growth was inhibited to
varying extents depending on the method of cream separation and heat treatments
used. Interestingly, fermented buttermilks were relatively less potent in inhibiting cell
growth than buttermilks produced from unfermented creams. Demonstration of an
antiproliferative activity that was selective to colon cancer cells by buttermilks is
novel and is in accordance with recent papers showing that colon cancer cell lines
represent a useful model system to investigate the effects of dairy products at the
cellular level.
Previously reported studies have demonstrated that several steps in the
processing of buttermilk affect the composition and microstructure of buttermilk and
MFGM isolates (Morin et al., 2007 a). Processing of buttermilk is therefore of
particular importance considering the inhibition of tumour growth observed by
MFGM lipids in an animal model of colon carcinogenesis (Schmelz et al., 2001). We
have initiated a study into the positive health benefits of buttermilks produced by
modern and traditional cream separation techniques. Washing of cream produced
buttermilks that were depleted in casein and whey (Morin et al., 2007 b) while
centrifugal separation of cream was more effective than gravitational separation in
producing buttermilks having higher contents of MFGM proteins and phospholipids
(Table 3.1). However, no work to date has evaluated the relative effects of modern
cream separation techniques, washing and heating on the antiproliferative effects of
buttermilks. To this end, we compared the effects of buttermilk produced from
commercial cream, gravitationally and centrifugally separated creams with and
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without cream washing on acid phosphatase activity, an enzymatic marker of SW480
cell growth.
Buttermilk produced from unwashed gravitationally separated cream had a
significantly lower (P ≤ 0.05) antiproliferative activity than buttermilks produced
from commercial cream and from centrifugally separated cream (Table 3.1; Fig. 3.2).
The latter however contained higher phospholipids content and lower MFGM protein
content compared with buttermilk produced from gravitationally separated cream,
suggesting that antiproliferative activity may be more associated with polar lipid
components of the buttermilks than with protein components.
The highest antiproliferative activity was observed for buttermilks produced
from washed centrifugally separated cream and washed gravitationally separated
cream. Washing of the cream before churning decreased total solids, casein and whey
proteins. Similar observations of the effect of washing were reported by Morin et al.
(2007 b). Analysis of the lipid content (Table 3.2) showed that washing decreased the
level of SM in centrifugally separated cream but increased SM in buttermilks
produced from commercial cream and gravitationally separated cream. It is apparent
therefore that the greater cytotoxicity observed for buttermilk produced from washed
centrifugally separated cream compared to other buttermilk samples could not be
attributed solely due to SM content. Many studies now suggest that glycosylated
sphingolipids are an important defence against tumour growth (Bektas & Spiegel,
2003) and that MFGM is an abundant natural source of glycosylated sphingolipids, in
particular lactosylceramide, glucosylceramide and several gangliosides including GD3,
GD1b1, GM2, GM3 and GM1 (Vesper et al., 1999). Interestingly, LC was observed to
increase by a factor of 2.6 in buttermilk produced from washed centrifugally separated
cream and may contribute to the potent cytotoxicity of this sample. It is apparent from
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a previous study (Schmelz et al., 2001) that a complex mixture of glycosylated
sphingolipids, which included 20% LC and 67% SM was more potent than ceramide
alone in suppressing tumour formation in colon. Another lipid factor that may have
contributed to the greater antiproliferative activity of washed buttermilk samples was
a relative decrease in PC that was observed in all washed samples. PC is an important
membrane source of cellular arachidonic acid metabolites that play a key role in
cancer cell survival and proliferation.
Other phospholipids present in buttermilk samples were PE, PS and PI. PE
was the predominant phospholipid and was present in highest amounts in buttermilk
produced from washed centrifugally separated cream (Table 3.2). Exposure of colon
cancer cells to exogenous buttermilk sources enriched in PS and PE may trigger early
steps in the apoptotic cascade and may account for cytotoxicity of buttermilk samples
in this study. A recent study showed that exogenous exposure of HepG2 cells to PE, a
neutral phospholipid normally present in the inner leaflet of the plasma membrane in
mammalian cells induced apoptosis via the Bcl-2/Bax pathway (Yao et al., 2009).
The normally pro-survival PI was the relatively least abundant of the
phosphoglycerolipids in buttermilk samples tested but it did increase in buttermilks
produced from washed commercial cream and centrifugally separated cream,
suggesting that epidermal growth factor receptor-phosphatidylinositol 3-kinase
signaling may have been antagonised by PE and PS or by MFGM protein
components, known to possess anticancer activity such as breast cancer type 1 and
type 2 susceptibility proteins (Brody & Biesecker, 1998) and fatty acid binding
protein (Bansal et al., 1989).
Heat-treated buttermilk produced from unwashed centrifugally separated
cream showed the same antiproliferative activity as unheated buttermilk. This
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suggests that β-lactoglobulin interactions with MFGM as a result of heat treatment
had negligible effects on the cellular signalling circuitry that regulates cell growth and
death. This is in accordance with an earlier study of the comparative cytotoxic activity
of dairy derived ingredients in human cancer cells which demonstrated that β-
lactoglobulin had only mild cytotoxic activity (Chan-Remillard & Ozimek, 2008).
However, we did observe loss of anticancer activity in the case of reconstituted spray-
dried buttermilk powder. Morin et al. (2007 a) reported significant loss in
phospholipids content in buttermilk after spray drying, mostly from the inner leaflet of
the membrane: PE, PS and PI. However, they observed that the relative distribution of
PC and SM increased. They suggested that heat combined with rapid water removal
and increased ionic strength created by spray drying could lead to formation of
complexes within MFGM proteins and phospholipids; hence modifying their
solubility in the extraction solvent. In our studies, we have observed total loss of
antiproliferative activity of spray-dried buttermilk and we propose that it might be
caused by changes within MFGM as suggested first by Morin et al. (2007 a). Changes
in the structure within and between the membrane components after spray drying and
its influence on cytotoxicity require further investigation.
A decrease in anticancer activity was also observed when SW480 cells were
incubated with fermented buttermilks, which were pasteurized prior to testing (72ºC,
30s). Of the four fermented buttermilks that were tested, anticancer activity of
DPC4694 and DPC911 was greater than that of DPC4268 and DPCTH3.
Compositional analysis revealed no significant difference between sweet and
fermented buttermilks in MFGM protein content (unpublished data). However, there
was a decrease in total phospholipid content in fermentations DPC4694 and DPC911
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compared with DPC4268 and DPCTH3 suggesting that phospholipid content is an
influencing factor in growth.
To our knowledge, it has not been examined if there are any changes in the
structure of MFGM components that might account for the lower anticancer activity
of fermented and unfermented buttermilks enriched in MFGM. A comparative
examination of the arrangement of protein and lipid complexes within the MFGM of
buttermilks including an investigation of the extent to which non MFGM proteins
adsorb to MFGM components in fermented buttermilks and the influence of bacterial
enzymes (lipases, phospholipases, proteinases or glycosidic hydrolases) on MFGM
components may provide an understanding of why fermented buttermilks show lower
anticancer activity than unfermented samples. The choice of bacterial strain in
DPC4694 (Streptococcus thermophilus) and DPC911 (Lactococcus lactis
diacetyllactis) in fermentations may be a factor in the relative production of bioactives
that reduced growth of SW480 cells. Baricault et al. (1995) reported that milk
fermented with L. helveticus and Bifidobacterium had a role not only in inhibiting
colon cancer cell growth but also in promoting cell differentiation. Casein peptides
generated by dairy starter cultures and yogurts fermented with Streptococcus
thermophilus and Lactobacillus bulgaricus are other examples of dairy products that
have been shown to exert antiproliferative properties in human colon cancer Caco-2
cells (Macdonald et al., 1994, Ganjam et al., 1997). Dairy propionibacteria are known
to induce apoptosis in colon cancer cells via production of short-chain fatty acids that
activate the mitochondrial death pathway (Jan et al., 2002). Apoptotic activity in HT-
29 and Caco-2 cells was attributed to non-heated propionibacteria strains as heated or
lyophilised strains had no antiproliferative effect. It is of interest that in our studies,
the fermented buttermilks used for cytotoxicity assays were heat-treated before
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incubating with cells, hence the probiotics were rendered inactive prior to
investigating the effects of fermented dairy products at the cellular level. Together,
these studies suggest that the antiproliferative activity of fermented dairy products is
dependent on the presence of live bacteria and may involve activity of bacterial
enzymes. It is of interest that some colon cancer cells, like HT-29, lack alkaline
sphingomyelinase, the enzyme responsible for intestinal SM digestion. A deletion of
exon 4 in alkaline sphingomyelinase cDNA caused loss of enzyme function in HT-29
cells (Wu et al., 2004). Hence, the formation of bioactive hydrolytic components,
ceramide and sphingosine was significantly reduced. Duan (2007) has shown that
lactic acid bacteria used in production of yogurt, in particular Streptococcus
thermophilus and Lactobacillus acidophilus have high levels of alkaline
sphingomyelinase and thus the ability to hydrolyse sphingomyelin. It remains to be
determined if bacterial strains used in this study also have sphingomyelinase activity
which may affect cell growth via affecting levels of bioactive ceramide in SW480
colon cancer cells.
Although the growth of SW480 cells was impaired by sodium butyrate, a short
chain fatty acid that induces apoptosis and terminal differentiation in a variety of
human colon cancer cell lines, there was a greater level of protection in FHC cells
following exposure to butyrate. Comalada et al. (2006) reported that the growth-
inhibitory effects of butyrate in colonic epithelia depended on cellular phenotype; the
greater the level of cell confluence and differentiation the more protection from
butyrate.
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3.5. Conclusions
The data show that using acid phosphatase activity assay unfermented
buttermilk samples within the concentration range 0.19-0.94 mg total solids/ml
significantly (P ≤ 0.001) inhibited growth of SW480 colon cancer cells up to 99% and
had no toxic effect on FHC normal colon cells. The cytotoxic activity of buttermilk
was found to be similar to that of sodium butyrate, a key apoptotic fatty acid in colon
cancer cells. Centrifugal separation of cream and washing of cream before churning
increased anticancer activity of buttermilk. It was also found that pasteurisation of
cream (72°C, 15s) before churning and high heat treatment of buttermilk (95°C, 30
min) did not change antiproliferative properties of buttermilk. However, the
anticancer activity of buttermilk was lost after spray drying suggesting that the phase
state of buttermilk may influence the functional activity of its components. Fermented
buttermilks demonstrated lower antiproliferative activity compared with unfermented
samples. As yet, the reasons for the decrease in anticancer activity in fermented
buttermilks remain unclear and need to be further investigated.
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CHAPTER 4
Effect of buttermilk samples produced at pilot scale on growth of
SW480, HT-29 and Caco-2 human colon cancer cell lines and HepG2
human hepatocellular cancer cell line.
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Buttermilk is a rich source of milk fat globule membrane (MFGM), which is
naturally formed during lactation by phospholipids, sphingolipids and proteins from
mammary cellular membrane. A wide range of health benefits has been attributed to
MFGM components, including anti-viral, anti-inflammatory, anti-bacterial and
chemopreventive properties mediated through effects on cell growth, transmembrane
signalling and cell-to-cell interactions. The aim of this study was to determine if the
buttermilks produced in pilot scale and subjected to fractionation using microfiltration
exhibit antiproliferative activity in vitro. It was found that at the concentration of 0.3
mg total solids/ml feed, retentate and permeate inhibited growth of SW480 and HT-29
colon cancer cells and HepG2 hepatocellular cancer cells by approximately 92-99%,
but had no effect on differentiated Caco-2 cells representing normal intestinal
enterocytes. Furthermore, buttermilk inhibited growth of cancer cells to a greater
extent in cells cultured in medium containing galactose than in media with glucose
suggesting that buttermilk components may be selectively toxic to mitochondria.
117
4.1. Introduction
For centuries churning of butter has been widespread in different
populations of the world, however different sources for butter manufacturing had
been used, such as whole milk, cream or yoghurt. In United States butter is also
made from whey cream (Spence et al., 2009; Tunick, 2009). The most popular
ethnic method in conventional butter production was to allow whole milk to
naturally (gravitationally) separate into cream and skimmed milk. In the mean
time, cream was fermented by wild strains of lactic acid bacteria (LAB) acquired
from the environment. Butter was then manually churned. Nowadays, to fasten
butter-making process and to improve recovery of milk elements, cream is washed
repeatedly three to six times with water before churning. During churning, as a
result of mechanical treatment, the membrane that surrounds the milk fat droplets,
i.e. the milk fat globule membrane (MFGM) is shed and released into buttermilk,
whereas the lipid droplets aggregate into butter (Fox and McSweeney, 1998).
Technological processes that improve the recovery of health beneficial
sphingolipid- rich MFGM in buttermilk are critical for successful development of
possible functional beverage. Some researchers have attempted to use different
methods for fractionating polar lipid content in buttermilk. Rombaut et al., (2006)
used microfiltration to separate MFGM from butter serum upon addition of
sodium citrate for casein micelle disassociation. Morin et al. (2007 a) showed that
washing of cream before churning removes casein and whey proteins from
buttermilk, yielding a higher proportion of MFGM components in the final
product. Moreover, microfiltration combined with supercritical fluid extraction
(SFE) (Astaire et al., 2003, Spence et al., 2009) can selectively remove
triglycerides while concentrating polar lipids of the MFGM in buttermilk.
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Cancer cells differ from normal cells in that they avidly convert glucose to
lactate, even when oxygen is adequate for oxidative phosphorylation. Known as
the Warburg effect (Warburg, 1930), this altered pattern of metabolism allows
cancer cells to sustain higher proliferative rates and resist cell death signals,
particularly those mediated by increased oxidative damage. Glycolytic rates that
are about 200 times higher (regardless of aerobic or anaerobic conditions) than in
normal cells have been documented (reviewed by Jezek et al., 2010, Heiden et al.,
2009). The high glycolytic phenotype of most cancer cells is triggered by
activation of oncogenes, such as MYC, Ras, Akt and PI3K genes or loss of tumour
suppressor genes, such as p53 which induce transcriptional and post-
transcriptional effects in glycolytic enzymes. The large increase in glucose
requirement of glycolytically poised cancer cells is met by an increased
expression of glucose transporter genes, which encode proteins that facilitate
diffusion of glucose and galactose into epithelial cells. GLUT1 glucose
transporter, normally restricted to red blood cells and blood-tissue barriers is
expressed in many epithelial malignancies. Haber et al. (1998) provided evidence
that increased GLUT1 expression in tumours from colorectal cancer patients has
prognostic significance. Oxidative phosphorylation operates at low capacity in
cancer cells leading to a higher than normal level of ROS generation which
promotes genetic instability of tumour cells and favours growth.
Furthermore, interest in cancer cell metabolism has re-emerged recently
following reports that metabolism may be engineered to scale up production of
novel therapeutics (Wlaschin and Hu, 2007). Additionally, it was found that
growing cancer cells in DMEM containing galactose instead of glucose is a better
cell model for drug safety testing as it forced them to shift from a reliance on
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aerobic glycolysis to oxidative phosphorylation for energy production (Marroquin
et al., 2007). For instance, glucose-grown HepG2 cells were resistant to a wide
range of classical mitochondrial toxicants and a selection of drugs having
documented mitochondrial toxic activity, whereas galactose-grown cells exhibited
an increased rate of oxygen consumption and were more susceptible to
mitochondrial toxins. In addition to respiration, biosynthesis of pyrimidines,
lipids, hemes and fatty acid oxidation are essential and fundamental metabolic
pathways carried out in the mitochondria that ensure cancer cell survival. Many of
these pathways provide druggable targets for cancer therapy (reviewed in Tennant
et al., 2010).
The objective of the present study was to examine the antiproliferative
activity of feed, retentate and permeate samples of buttermilk produced at pilot
scale from unwashed and washed cream. For this purpose, SW480 and HT-29
colon cancer cell lines were examined in addition to Caco-2 colon cancer cell line,
which also served as normal colon epithelial cells when grown in polarizing
conditions. Antiproliferative activity of buttermilk samples were also studied
using HepG2 hepatocellular carcinoma cells, which is a major organ for lipid
metabolism. A comparative analysis of the effect of buttermilk samples on growth
of cells relying on oxidative phospohorylation or on aerobic glycolysis was
conducted to determine if buttermilks specifically targeted mitochondria.
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4.2. Materials and methods
4.2.1. Buttermilk production
Buttermilk samples were generated by a member of the project team from
raw whole milk collected from the Moorepark Dairy Production Centre (MDPC)
farm, Fermoy, Co. Cork, Ireland. Briefly, in the first pilot plant trial cream was
separated from skim milk in separator at 45-50°C. Cream was pasteurized at 72°C
for 15sec, and cooled down to 10°C. During churning, buttermilk was separated
from butter. Buttermilk (feed) was also microfiltered through an 0.8 μm ceramic
membrane at 50°C giving retentate (fraction of buttermilk that did not cross the
membrane) and permeate (fraction of buttermilk that crossed the membrane). In
the second pilot plant trial, cream was washed before churning. Briefly, cream
sample was suspended in 5 volumes of Simulated Milk Ultra-Filtrate (SMUF),
held at 37°C for 1h and separated using an Armfield disc bowl centrifuge
(Armfield, Ringwood, USA) at max rpm. Washing in SMUF was repeated twice
more. Feed, retentate and permeate samples were collected and stored at -30 for
further analytical and antiproliferative analyses. Compositional analysis of
buttermilk samples was performed by a project team member as described in
Chapter 2, subsection 2.2.3. Analysis of MFGM phospho- and sphingolipid
components was also performed by a project team member as described in
Chapter 3, subsection 3.2.2.1.
4.2.2. Cell culture
SW480, HT-29 and Caco-2 human colon cancer cell lines and HepG2
human hepatocellular cancer cell line were obtained from European Collection of
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Cell Cultures, ECACC. Culture media and supplements were purchased from
Sigma-Aldrich Ireland, Ltd. The HepG2 and Caco-2 cells were maintained in
modified Eagle’s medium (MEM). The SW480 and HT-29 cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) and McCoy’s 5A medium,
respectively. The HepG2, SW480 and HT-29 cells were also grown in Leibovitz-
15 medium. All media were supplemented with L-glutamine (4 mM), fetal bovine
serum (FBS) (10%, v/v) and penicillin/streptomycin (1 U/ml). Cells were grown
at 37°C, with 5% CO2 access, except when grown in Leibovitz-15 medium which
does not require CO2.
4.2.3. Acid phosphatase activity assay
To assess antiproliferative activity of buttermilk samples, the cells were
grown in parallel in two different media to eliminate possibility of the influence of
media components on the antiproliferative activity of buttermilk samples. SW480
cells were seeded in 96-well plates at density of 5x103/well both in Leibovitz-15
and in DMEM medium. HT-29 and HepG2 cells were seeded at density 7x103
cells/well in Leibovitz-15 medium and at density 3.5x103cells/well in McCoy’s
5A and MEM media, respectively. To allow the cells to attach, they were cultured
for 24 h at 37°C without 5% CO2 (Leibovitz-15 medium) or with 5% CO2 access
(all the other media). Next, buttermilk samples from both pilot plant trials (feed,
retentate and permeate) were diluted in feeding media and were added to the wells
with the cells in the range of concentrations between 0-1 mg total solids/ml. Only
media was added to the control wells. All the buttermilk samples were sterilized
prior to treatment by incubation at 72°C for 15s. The wells with the cells grown in
Leibovitz-15 media were covered with parafilm to prevent CO2 access to the cells.
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Four replicates of each buttermilk concentration were performed. After 3 days of
incubation at 37°C, cell survival was measured by an indirect colorimetric
endpoint assay for acid phosphatase activity (O’Connor et al., 1998), as described
in Chapter 2, subsection 2.2.5. To perform comparative studies and eliminate
influence of media components on buttermilk’s cytotoxicity the same growing
media was used for all cell lines, Leibovitz-15 supplemented with 4 mM L-
glutamine, 10% fetal bovine serum (FBS) and 1 U/ml penicillin/streptomycin
(37ºC, without CO2 access). Cancer cell growth inhibition was expressed as a
percentage relative to control which was taken to be 0%. Data represent the mean
± standard error of the mean of three independent experiments performed in
quadruplicate.
4.2.4. Preparation of Caco-2 cells monolayer
Caco-2 cells were grown and maintained in supplemented MEM in T-75
flasks at 37°C with 5% CO2. At about 75% confluency, cells were trypsinized and
seeded at density 3.5x103 cells/well in presoaked Millicell hanging cell culture
inserts with pore size 3 μm (Millipore Corporation, MA, USA), which were
placed in a 12-well plate and incubated at 37°C with 5% CO2. Medium was
replaced carefully every other day. The transendothelial electrical resistance
(TEER) values were taken to measure monolayer integrity formation. After 21
days of incubation wells showing the same TEER values were taken for
experiment. Differentiated Caco-2 monolayers as well as undifferentiated Caco-2
cells were treated with 1 mg total solids/ml of buttermilk and 5 mM sodium
butyrate, which served as positive control. After 3 days of incubation at 37°C with
5% CO2 cells were washed twice with PBS carefully. Cell viability was
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determined using the MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenol)-2-(4-sulfophenyl)-2H-tetrazolium) reagent (Promega
Corporation, Madison, WI, USA). After 2 h of incubation at 37°C, OD was read
at 490nm on Multi-Detection Microplate Reader SynergyTM HT (supplied by
BioTek® Instruments, Inc).
4.2.5. Preparation of DMEM media for metabolism study
Dulbecco’s Modified Eagle’s Medium base was purchased from Sigma
Aldrich, Ireland. It was supplemented with 4 mM L-glutamine, 10% fetal bovine
serum (FBS) and 1 U/ml penicillin/streptomycin. Media then was divided into
three separate batches containing: 4.5 g/l glucose and 3.7 g/l sodium bicarbonate;
only 0.9 g/l galactose and 0.9 g/l galactose with 3.7 g/l sodium bicarbonate.
Phenol red was added to all media to final concentration of 0.015 g/l, pH was
adjusted to 7 and media was sterile filtered.
4.2.6. Statistical analysis
Three independent experiments were performed in quadruplicate for each
treatment and the Student’s t-test (Microsoft Office Excel) was used to determine
significant difference between treatments or comparing to the control. Statistical
analysis of antiproliferative activity of retentate produced from unwashed cream
on SW480 colon cancer cells grown in DMEM media supplemented with
different sugar sources (Fig. 4.9) was analyzed by the analysis of variance
(ANOVA) coupled with Tukey’s post-hoc analysis (PASW statistics 17.0).
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4.3. Results
4.3.1. Compositional analysis of buttermilks
Tables 4.1-4.4 show compositional analysis of buttermilk samples
produced from unwashed and washed creams, provided by project team member .
Comparative analysis of phospholipid distribution of feed from washed cream
showed a greater concentration of PE and PS that averaged 26.34 % and 14.47%
respectively compared with 18.42% and 5.26%, respectively in feed from
unwashed cream. Washing had little effect on sphingomyelin content of feed.
However, feed from washed cream was depleted of PC and PI by 33% and 50%,
respectively. Retentate from washed cream was depleted of SM, PC, PS, PI and
GC by 60%, 75%, 30%, 80% and 50% and was enriched in both LC (44.26%
relative to 1.55%) and PE (21% relative to 12.93%) compared to retentate from
unwashed cream. Unfortunately, analytical composition of permeate fraction was
not supplied, hence it is impossible to perform analysis on possible components
associated with lower antiproliferative activity of permeate compared to feed and
retentate fractions.
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Table 4.1. Compositional analyses of feed, retentate and permeate produced from unwashed cream, obtained by a project team member. All
values are expressed as mean %.
Percentage of phospholipids in:Sample Total solids(%)
Protein
(%)
MFGM proteins
(%)
Lipids
(%) Sample Total fat Total solids
Lactose
(%)
Feed 9.07 3.18 0.93 1.15 0.14 12.65 1.60 4.03
Retentate 10.35 3.47 2.49 2.78 0.20 7.16 1.93 3.33
Permeate 8.00 3.04 1.13 0.64 0.11 17.01 1.05 3.66
Table 4.2. Phospho- and sphingolipid composition of feed, retentate and permeate produced from unwashed cream, obtained by a project team
member. All values are expressed as mean %. Abbreviations: CC, buttermilk produced from commercial cream; CSC, buttermilk produced from
centrifugally separated cream; G4SC, buttermilk produced from gravitationally separated cream at 4°C; PE, phosphatidylethanolamine; PI,
phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; GC, glucosylceramide; LC, lactosylceramide; SM, sphingomyelin.
Sample GC (%) LC (%) PE (%) PI (%) PS (%) PC (%) SM (%)
Feed 0 0 18.42 17.41 5.26 33.21 25.7
Retentate 1.01 1.55 12.93 17.19 6.22 31.57 29.52
Permeate 0.58 1.20 15.92 19.15 5.77 35.8 21.58
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Table 4.3. Compositional analysis of feed, retentate, permeate produced from washed cream, obtained by a project team member. All values are
expressed as mean %.
Percentage of phospholipids in:Sample Total solids(%)
Protein
(%)
MFGM proteins
(%) Lipids (%) Sample Total fat Total solids Lactose (%)
Feed 8.19 0.43 0.43 5.55 0.098 1.76 1.19 2.18
Retentate 12.38 0.19 0.19 11.25 0.088 0.78 0.71 0.89
Table 4.4. Phospho- and sphingolipid composition of feed, retentate and permeate produced from washed cream, obtained by a project team
member. All values are expressed as mean %. Abbreviations: CC, buttermilk produced from commercial cream; CSC, buttermilk produced from
centrifugally separated cream; G4SC, buttermilk produced from gravitationally separated cream at 4°C; PE, phosphatidylethanolamine; PI,
phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; GC, glucosylceramide; LC, lactosylceramide; SM, sphingomyelin.
Sample GC (%) LC (%) PE (%) PI (%) PS (%) PC (%) SM (%)
Feed 0 0 26.34 9.03 14.47 23.68 26.48
Retentate 0.59 44.26 21.00 3.83 9.87 8.57 11.87
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4.3.2. Cytotoxicity
4.3.2.1. Antiproliferative activity of feed, retentate and permeate samples
produced from unwashed cream
Three fractions of buttermilk filtrates feed, retentate and permeate
produced from unwashed cream were incubated with SW480 and HT-29 colon
cancer cells and HepG2 hepatocellular cancer cells in Leibovitz-15 medium at
different concentrations ranging from 0-0.3 mg total solids/ml. Buttermilk
samples at concentrations ranging from 0-1 mg total solids/ml were also incubated
with SW480 and HT-29 colon cancer cells and HepG2 hepatocellular cancer cells
grown in DMEM, McCoy’s 5A and MEM medium, respectively. The cytotoxicity
was assessed after 3 days of incubation. There was a dose-dependent effect of the
feed, retentate and permeate samples on antiproliferative activity of SW480, HT-
29 and HepG2 cancer cells.
At a concentration of 0.3 mg total solids/ml, all buttermilk fractions
produced from unwashed cream reached about 95-99% cell growth inhibition in
all three cancer cell lines grown in Leibovitz-15 medium (Fig. 4.1). However, at
lower concentrations it was observed that feed fraction was less potent in
inhibiting SW480, HT-29 and HepG2 cell growth compared to retentate and
permeate fractions. In Leibovitz-15 medium SW480, HT-29 and HepG2 cell
growth was inhibited by feed by 15.5, 26.2 and 33.2%, respectively; by retentate
by 44.3, 69.7 and 64.5%, respectively and by permeate by 55.6, 88.2 and 91.4%,
respectively at concentration of 0.03 mg total solids/ml (Fig. 4.1). At a
concentration of 0.06 mg total solids/ml, cell growth inhibition by retentate and
permeate was significantly higher (P ≤ 0.01 and P ≤ 0.001, respectively) than by
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feed in all three cell lines. SW480, HT-29 and HepG2 cell growth was inhibited
by feed by 34.1, 55 and 56.7%, respectively; by retentate by 73.2, 90.6 and
93.6%, respectively and by permeate by 82.8, 94.6 and 97.1%, respectively. These
results correlate with our previously reported, obtained from buttermilk produced
in laboratory scale. Production of feed fraction of buttermilk produced from
unwashed cream yielded a level of antiproliferative activity comparable to
buttermilk produced from pasteurized cream (72ºC, 15 sec) in laboratory scale
(Fig. 4.3).
When growing and treating cells in their assigned media, buttermilk feed,
retentate and permeate fractions inhibited cell growth in all three cell lines with
significantly lower potency than when the same cell lines were grown in
Leibovitz-15 medium (Fig. 4.2). Maximum buttermilk concentration used for cell
treatment when grown in their assigned media was 1 mg total solids/ml and even
then, there was a high cell survival observed. At concentration 1 mg total
solids/ml feed fraction inhibited SW480, HT-29 and HepG2 cell growth by 31.6,
38.6 and 71.2%, respectively; retentate fraction by 57.4, 54.6 and 83.1%,
respectively and permeate by 48.1, 52.1 and 91.6%, respectively. SW480 and HT-
29 colon cancer cells responded similarily to feed, retentate and permeate
fractions. However, all three buttermilk fractions were relatively more potent in
inhibiting growth of HepG2 liver cancer cells.
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Fig. 4.1. Antiproliferative activity of feed (□), retentate (
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fractions produced from unwashed cream on gro th of a) SW480, b) HT-29 and
c) HepG2 cancer cells assessed using AP assay. Cells were grown and treated in
galactose-containing Leibovitz-15 medium. Data refer to mean ± SD of three
independent experiments. a,b,c values without a common subscript are significantly
different (P ≤ 0.05) at given concentration.
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Fig. 4.2. Antiproliferative activity of feed (□), retentate (
0
20
40
60
80
100
0.03 0.06 0.12 0.3
mg total solids/ml
% g
row
th i
nhi
biti
on
) and permeate (
0
20
40
60
80
100
0.03 0.06 0.12 0.3
mg total solids/ml
% 
gro
wt
h i
nh
ibi
tio
n )
fractions produced from unwashed cream on growth of a) SW480, b) HT-29 and
c) HepG2 cancer cells maintained and treated in their corresponding media,
contaning glucose; assessed using AP assay. Data refer to mean ± SD of three
independent experiments. a,b,c values without a common subscript are significantly
different (P ≤ 0.05) at given concentration.
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Fig. 4.3. Comparison of growth inhibition of SW480 colon cancer cells incubated
with feed produced from unwashed cream in pilot plant (
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) to buttermilk
produced in laboratory scale (□) at given concentrations; assessed using AP assay.
The SW480 cells were grown in Leibovitz-15 medium. Data refer to mean ± SD
of three independent experiments. a,b values without a common subscript are
significantly different (P ≤ 0.05) at given concentration.
4.3.2.2. Antiproliferative activity of feed, retentate and permeate samples
produced from washed cream
Different tendency could be observed in cell growth treated with feed,
retentate and permeate buttermilk samples produced from washed cream (Fig.
4.4). Buttermilk fractions were incubated with SW480, HT-29 and HepG2 cells
grown in Leibovitz-15 medium as described in Material and Methods. All three
fractions inhibited SW480 cell growth at lower potency than HT-29 and HepG2
cell lines. At concentrations 0.06-0.12 mg total solids/ml permeate was
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significantly less potent in inhibiting HT-29 and HepG2 cells growth than feed (P
≤ 0.01 and P ≤ 0.05, respectively) and retentate (P ≤ 0.05 for both cell lines).
Moreover, permeate produced from washed cream was significantly (P ≤ 0.001)
less potent in inhibiting cancer cell growth than permeate fraction produced from
unwashed cream at concentrations 0.03-0.12 mg total solids/ml. However, in
HepG2 hepatocellular cancer cells retentate at concentrations 0.03-0.06 mg total
solids/ml showed significantly higher ability in inhibiting cell growth comparing
to feed (P ≤ 0.01) and permeate (P ≤ 0.05). At concentration 0.03 mg total
solids/ml none of the buttermilk fractions produced from washed cream reached
IC50 in inhibiting cell growth. SW480, HT-29 and HepG2 cell growth was
inhibited by feed by 9.8, 37.7 and 13.4%, respectively; by retentate by 19.9, 43.6
and 39.1%, respectively and by permeate by 16.7, 35.2 and 15.3%, respectively at
concentration of 0.03 mg total solids/ml. At concentration of 0.06 mg total
solids/ml cell growth of SW480, HT-29 and HepG2 cells was inhibited by feed by
38.3, 77 and 42%, respectively; by retentate by 48.3, 72.5 and 76.1%, respectively
and by permeate by 31.5, 59.6 and 33.8%, respectively.
Feed, retentate and permeate fractions produced from washed cream
inhibited growth of SW480, HT-29 and HepG2 cell lines grown in their assigned
media with lower potency than when growing cells in Leibovitz-15 medium (Fig.
4.5). At concentration 1 mg total solids/ml feed fraction inhibited SW480, HT-29
and HepG2 cell growth by 30.5, 30.4 and 56.7%, respectively; retentate fraction
by 37.8, 31.7 and 56.1%, respectively and permeate by 20.5, 28.1 and 54.6%,
respectively. The highest cell growth inhibition was observed for HepG2 liver
cancer cells and it was similar for all three buttermilk fractions.
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Fig. 4.4. Antiproliferative activity of feed (□), retentate (
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fractions produced from washed cream on growt  of a) SW480, b) HT-29 and c)
HepG2 cancer cells; assessed using AP assay. Cells were grown and treated in
galactose-containing Leibovitz-15 medium. Data refer to mean ± SD of three
independent experiments. a,b,c values without a common subscript are
significantly different (P ≤ 0.05) at given concentration.
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Fig. 4.5. Antiproliferative activity of feed (□), retentate (
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fractions produced from washed cream on growt  of a) SW480, b) HT-29 and c)
HepG2 cancer cells maintained and treated in their corresponding media
containing glucose; assessed using AP assay. Data refer to mean ± SD of three
independent experiments. a,b,c values without a common subscript are significantly
different (P ≤ 0.05) at given concentration.
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4.3.2.3. Evaluation of buttermilk treatment on growth of differentiated and
non differentiated Caco-2 cells
Due to economical reasons in the evaluation of antiproliferative activity of
buttermilk on proliferating and non-proliferating Caco-2 cells only one
representative buttermilk was used, retentate produced from unwashed cream. At
high concentration of 1 mg total solids/ml it inhibited proliferating Caco-2 cell
growth by 56.2% and differentiating Caco-2 cells by only 6.6% (Fig. 4.6).
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Fig. 4.6. Influence of buttermilk (retentate produced from unwashed cream) on
growth of proliferating (■) and non-proliferating polarized ( ) Caco-2 cells. Data
was assessed using MTS assay. Data refer to mean ± SD of three independent
experiments.
4.3.3. Analysis of influence of media components (glucose vs galactose) on
buttermilk’s antiproliferative activity
To examine the response of SW480 and HT-29 colon cancer and HepG2
hepatocellular cancer cells to buttermilk’s components when treated in aerobic
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and anaerobic conditions, cells were grown in media, which differed in energy
sources: glucose versus galactose. It was apparent that when cells were grown in
high-glucose media, they were more resistant to buttermilk and their survival was
higher (Fig. 4.7 a-f). In the next step 0.9 g/l galactose was added to DMEM media
already containing 4.5 g/l glucose but this did not alter buttermilk’s cytotoxicity in
initial high-glucose DMEM media. However, after adding 4.5 g/l glucose to
Leibovitz-15 medium, antiproliferative activity of buttermilk was reduced but not
as much as in cells grown with high-glucose media (Fig. 4.8). To eliminate
influence of other media components, DMEM powder media (glucose-deprived)
was supplemented according to Materials and Methods and results are shown on
Fig. 4.9. Buttermilk in DMEM supplemented with galactose but without sodium
bicarbonate inhibited growth of SW480 cell line with the same potency as
buttermilk in Leibovitz-15 medium indicating that differences in essential amino-
acids, vitamins and other media components have no effect of buttermilk’s
cytotoxicity on colon and hepatocellular cancer cells used in experiment. After
adding sodium bicarbonate to DMEM medium supplemented with galactose, the
antiproliferative effect of buttermilk decreased, resulting in 63.6% growth
inhibition at concentration 0.3 mg total solids/ml indicating that addition of
sodium salt decreases buttermilk’s antiproliferative activity (P ≤ 0.001).
Moreover, cells grown in DMEM media with 4.5 g/l glucose showed much higher
(P ≤ 0.001) resistance to buttermilk treatment with 79.1% survival.
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Fig. 4.7. Antiproliferative activity of feed (◊), retentate (■) and permeate ( )
produced from unwashed cream (a, c, e) and washed cream (b, d, f) on SW480 (a,
b), HT-29 (c, d) and HepG2 (e, f) cancer cells. Cells were grown either in
Leibovitz-15 (dashed lines), a galactose-containing medium or in DMEM,
McCoy’s 5A and MEM glucose-containing media, respectively (continuous
lines). Data was assessed using AP assay. Data refer to mean ± SD of three
independent experiments.
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Fig. 4.8. Antiproliferative activity of retentate produced from unwashed cream on
SW480 colon cancer cells, assessed using AP assay. Cells were grown in
Leibovitz-15 (◊), in Leibovitz-15 medium with addition of 4.5 g/l glucose (■), in
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DMEM medium ( ) and in DMEM medium with addition of 0.9 g/l galactose
( ).Data refer to mean ± SD of three independent experiments.
Fig. 4.9. Antiproliferative activity of retentate produced from unwashed cream on
SW480 colon cancer cells grown in sugar-free DMEM media supplemented with
different sugar sources compared to SW480 cells grown in Leibovitz-15 medium.
Data was assessed using AP assay. Data refer to mean ± SD of three independent
experiments. Abbreviations: L-15, Leibovitz-15 medium; DMEM, Dulbecco’s
Minimum Essential medium; SB, sodium bicarbonate. a,b,c values without a
common subscript are significantly different (P ≤ 0.001), as analyzed using
ANOVA.
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4.4. Discussion
We have previously shown that buttermilk produced from whole milk in
the laboratory scale significantly (P ≤ 0.001) inhibited SW480 colon cancer cell
growth and had no toxic influence on growth of FHC normal foetal epithelial cells
(Chapter 3). In this study, we examined if buttermilk produced in pilot plant scale
also exhibited antiproliferative activity against human colon cancer cells. To
address this question three colon cancer cell lines were used: SW480, HT-29,
Caco-2 and also the hepatocellular carcinoma cell line HepG2.
Feed, retentate and permeate fractions of buttermilk produced from
unwashed cream inhibited growth in a dose dependent manner in all cell lines
(Fig. 4.1). Of the three fractions that were analyzed it was apparent that the feed
fraction was less potent in inhibiting cancer cell growth than retentate and
permeate. At the concentration 0.5 mg total solids/ml the level of growth
inhibition (96%) by feed produced from unwashed cream in pilot plant
corresponded with our previously reported findings (98%) obtained from
buttermilk sample produced in laboratory scale from unwashed centrifugally
separated cream. This indicates that scaling up production maintained buttermilk’s
biological activity.
Compositional analysis of buttermilks showed that retentate and permeate
fractions produced from unwashed cream had higher MFGM protein content than
feed fraction, suggesting that their antiproliferative activity might be associated
with MFGM proteins. MFGM proteins that inhibit growth of cancer cells include
breast cancer type 1 and type 2 susceptibility proteins (Brody and Biesecker,
1998, Vissac et al., 2002) and fatty acid binding protein (Bansal et al., 1989). The
former are ubiquitously expressed tumour suppressor proteins whose activities are
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not restricted to breast cancers (Tannenbaum et al., 2007). Marot et al. (2006)
reported a pronounced in vitro antiproliferative effect on H1299 lung and HT-29
colon cells when treated with a recombinant adenovirus expressing the wtBRCA1
gene. Growth of HT-29 tumours in nude mice was also significantly reduced
when BRCA1 was overexpressed. FABP are a family of proteins that have been
reported to alter growth and differentiation of various cell types, including
embryonic stem cells, hepatocytes, prostate cancer cells, oral squamous carcinoma
cells and melanoma breast cancer cells. Liver fatty acid binding protein and
intestinal fatty acid binding protein are two such forms found in colon epithelial
cells. A comparative proteome analysis and histochemical analysis identified
consistent loss of liver fatty acid binding proteins in colorectal cancer compared
with normal colon (Lawrie et al., 2004, Carroll et al., 1990 and Davidson et al.,
1993).
Other potential growth inhibitory components present in buttermilk
fractions include sphingomyelin, lactosylceramide and glucosylceramide.
Sphingomyelin was shown to have chemopreventive and chemotherapeutic
properties (Schmelz et al., 1996, Lemonnier et al., 2003). Glucosylceramide and
lactosylceramide, major glycosphingolipids in milk, also inhibited early stages of
colon cancer to a similar extent as sphingomyelin, as manifested by decrease in
appearance of aberrant crypt foci (ACF) (Schmelz et al., 2000, 2001).
In our studies, washing of cream prior to fractionation significantly
reduced the sensitivity of SW480, HT-29 and HepG2 cells to feed, permeate and
retentate when presented to cells at 0.03 mg total solids/ml. At higher
concentrations cells responded to washed fractions in a manner similar to
unwashed samples. Washing of cream before churning is expected to reduce the
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casein content of buttermilk so as to increase the phospholipids to protein ratio.
Lamothe et al. (2008) reported that washing bovine cream and caprine cream
before churning to make buttermilk and butter had no effect on phospholipid
profiles of the creams but improved the phospholipids/protein ratio in respective
buttermilks and butter sera. Comparative analysis of feed and retentate fractions
obtained in our study revealed a 4 to 5 fold higher lipids content in washed
fractions compared to unwashed fractions (Tables 4.1 and 4.3). This suggests that
buttermilk fractions from washed cream may offer potential for the production of
phospholipids concentrates that have antiproliferative activity against cancer cells.
Elucidation of which phospholipid component(s) may be responsible is not
possible as each fraction differed in phospholipid distribution and yet all fractions
were equally inhibitory at concentration 0.3 mg total solids/ml. For instance, feed
from washed cream was enriched in PE and PS; retentate from washed cream was
enriched in LC and PS.
Feed, retentate and permeate produced from washed cream also showed a
dose-dependent inhibition in SW480, HT-29 and HepG2 cells with maximum
inhibition observed at 0.3 mg total solids/ml. No significant difference was
apparent between the fractions in colon cancer cell lines; however at
concentrations less than 0.12 mg total solids/ml, the potency of retentate to inhibit
growth of HepG2 cells was greater than feed and permeate (Fig. 4.4 c). It is
apparent from Tables 4.3 and 4.4 that retentate and feed differed substantially in
composition analysis. Retentate from washed cream had relatively lower levels of
not only MFGM protein and SM but also growth proliferative phospholipids, in
particular PC and PI. By contrast, it had higher levels of glycosphingolipids. The
biological significance of such differences in composition cannot be explained as
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growth in colon cancer cells was similar following treatment with each fraction. It
is apparent that decreases in the level of PC and PI more than compensated for the
decrease in MFGM protein and SM and may account for the relatively greater
growth inhibition of the retentate in HepG2 cells. The presence of elevated levels
of glucosylceramide and lactosylceramide in retentate compared with feed had
apparently negligible effect on colon cancer cells.
To study if buttermilk targets mitochondria of cancer cells, we have grown
cells in media containing glucose and/or galactose. Leibovitz-15 medium, as used
in our study, is a bicarbonate-free medium which is buffered by its complement of
salts, basic amino acids (arginine, cysteine and histidine) and galactose. The use
of galactose instead of glucose as a carbohydrate source is expected to reduce the
amount of lactic acid produced by cells and hence reduces the need for buffering.
It is apparent from Fig. 4.2, 4.5 and 4.7 that SW480, HT-29 and HepG2 cells were
resistant to buttermilk fractions when grown in DMEM, MEM and McCoy’s 5A
medium, respectively, due to high glycolytic capacity. When grown in L-15
media, cells maintained ATP levels by increasing respiration rates. Our studies
showing that buttermilk inhibited growth of SW480, HT-29 and HepG2 cells to a
greater extent in cells cultured in L-15 medium than in media containing glucose
(Fig. 4.2, 4.5 and 4.7) suggest that buttermilk components may be selectively
toxic to mitochondria.
However, addition of 25 mM glucose to L-15 medium enhanced the
survival of SW480 cells treated with the retentate buttermilk fraction (Fig. 4.8).
This suggests that growing SW480 cells in L-15 medium containing
supraphysiological glucose allowed them to up-regulate GLUT1 carriers to
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achieve an increased intracellular glucose level that enabled cells to switch
phenotype and derive energy from glycolysis rather than from mitochondrial
oxidative phosphorylation. Furthermore, addition of physiological level of
galactose to DMEM had no apparent effect on phenotype as the level of growth in
the presence of buttermilk over the concentration range 0 to 0.8 mg total solids/ml
was similar to that observed in DMEM. It was apparent from Fig. 4.9 that
removing glucose from bicarbonate-free DMEM and substituting galactose as the
sole source of carbohydrate enhanced the susceptibility of SW480 cells to
buttermilk to a level similar to what was achieved in bicarbonate free Leibovitz-
15 medium. Adding bicarbonate to DMEM media containing galactose enhanced
the survival of cells exposed to buttermilk. A role for exogenous bicarbonate in
regulating mitochondrial ATP production was reported by Acin-Perez et al.
(2009). HCO32- may ensure cell survival by initiating a mitochondrial signalling
cascade that activates protein kinase A. The latter phosphorylates mitochondrial
proteins regulating ATP production, ensuring cell survival. Even in the presence
of bicarbonate, buttermilk targeted oxidative phosphorylation-poised SW480 cells
to a greater extent than glycolytically-poised cells indicating that cells growing in
galactose are a better cell model for understanding underlying mechanisms by
which buttermilks impair cell viability.
In this study we have also shown that buttermilk was not only cytotoxic
for cancer and hepatocellular carcinoma cells but also it did not possess cytotoxic
activity towards normal intestinal cells, which were represented by Caco-2 cells
grown in polarized conditions. Caco-2 cells were previously used as human
intestinal cell line to study absorbtion of fatty acids and other dietary components
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from the lumen into polarized enterocytes that line the small intestine (Ranheim et
al., 1994, Cogburn et al., 1991). When grown in culture, Caco-2 cells
spontaneously develop many functions characteristic of mature villus cells of the
small intestinal epithelium, including tight junction formation, lipoprotein
secretion across the basolateral membrane, and the expression of L- and I-fatty
acid binding protein (Darimont et al., 1998). However, Caco-2 cells were found to
have few different features from native enterocytes, including the synthesis of
apoB-100 rather than apoB-48 (Traber et al., 1987). It was also found that Caco-2
cells still possess some characteristics similar to foetal cells or crypt cells of the
colon (Pinto et al., 1983). Despite their limitations, Caco-2 cells allow the study
of a polarized enterocyte monolayer, provide separate access to apical and
basolateral surfaces and are a commonly used model system for studies of
intestinal lipid absorption and metabolism (Field et al., 2002, Rong et al., 2002,
Ho et al., 2002, Chateau et al., 2005, Murota and Storch, 2005) as well as
studying the ways food modulate intestinal functions and promote gut health via
molecular interactions (Shimizu, 2010).
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4.5. Conclusions
The data show that using acid phosphatase activity assay buttermilk samples
produced from unwashed and washed creams and followed by microfiltration
significantly (P ≤ 0.001) inhibited growth of SW480 and HT-29 colon cancer cells
and HepG2 hepatocellular cancer cells at the concentration 0.3 mg total solids/ml.
However, buttermilk did not show toxic effect on differentiated Caco-2 cells
representing normal intestinal enterocytes. It is not yet established which buttermilk
components play crucial roles in its antiproliferative activity; however they possibly
control functions of mitochondria in cancer cells. Evaluating compositional analysis
of buttermilk we could not point definite bioactive ingredient(s) responsible for
buttermilks’ anticancer activity, as yet. With the object of production of functional
beverage, further investigations are required to understand accurate mechanism of
action of buttermilk’s bioactive component(s).
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CHAPTER 5
Effect of spray, freeze and spin drying of buttermilk on its
antiproliferative activity against SW480 human colon cancer cells.
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Buttermilk, a by-product from butter production, is naturally enriched in
MFGM components with anticancer properties (Dewettinck et al., 2008, Vesper et al.,
1999), which gives opportunity for dairy industry to develop potential functional
beverage. However, large scale processing operations may lead to changes in the
bioactivity of some buttermilk’s components. In industry food ingredients are dried to
the form of powder for storage, preservation and transport. In this study we
investigated influence of different drying methods, such as spray, freeze and spin
drying on antiproliferative activity of buttermilk on SW480 colon cancer cells, using
acid phosphatase activity assay. We found that spray drying, but not freeze and spin
drying, significantly reduced anticancer activity of buttermilk fractions, suggesting
that harsh conditions of drying (hot air stream) might negatively affect active
components in buttermilk. Therefore, the form of drying and its parameters should be
considered in buttermilk production in large commercial scale.
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5.1. Introduction
Drying is a method of preservation, by which products are changed to a form
which is light and capable of being stored at room temperature. It is widely used in the
dairy industry in the manufacture of skimmed milk powder (Bank, 1993). Dried milk
products play a significant part in storage since their biological value can be retained
for long periods of time under relatively simple storage conditions. To avoid
deterioration during storage careful drying is necessary (Labuza and Tannenbaum,
1972). Spray drying is a commonly used method in the dairy industry for drying raw
milk into milk powders because of rapid moisture removal. By spraying into a stream
of hot air, liquid products can be dried within a few seconds. Spray drying involves
atomizing concentrated milk into a hot air stream (180-200°C). By controlling the size
of the droplets, the air temperature, and the airflow, it is possible to evaporate almost
all the moisture while exposing the solids to relatively low temperatures (Bank, 1993).
Another method of drying is freeze drying, which refers to drying of a product
in the frozen state (Mellor and Bell, 2003). Ice evaporates without passing through the
liquid state in a process known as sublimation (Pikal et al., 1983). Products to be
dried almost always contain substances in solution, which lower the freezing point of
the pure solvent. The most important advantage of freeze drying is the greatest
possible degree of preservation of the structure, the colour, the vitamin and amino
acid content, flavour and odour of the freeze dried product (Fennema, 1976). The
sublimation of the ice in the frozen material leads to a product with a highly porous
structure which is generally easily reconstituted in water and which has good instant
properties. Due to higher capital and running costs than other drying methods, freeze
drying is recommended for valuable products such as coffee, tea, egg and milk
products.
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In spin (centrifugal) drying samples are spun in a centrifuge and the g-force
applied prevents the solvent from evaporating or ejecting material in an uncontrolled
way. As atmospheric pressure decreases, the boiling point of solvent reduces. When
pressure is low enough, solvent boils and is removed by vacuum applied. Evaporation
under lower pressure is the main process involved in spin drying (Bouman and
Waalewijn, 1994).
The aim of this project is to produce buttermilk with high concentration of
MFGM components which have been shown to possess anticancer properties
(Dewettinck et al., 2008, Vesper et al., 1999). However, methods for concentrating
valuable components in buttermilk may become ineffective if other processing
operations adversely affect bioactivity. In large scale production, spray drying is one
of the most convenient methods for producing milk powders and for stabilizing milk
constituents. However, spray drying leads to undesirable changes and/or losses of
variety of nutrients, such as proteins, fats, vitamins, flavours and others due to high
temperature and pressure used (Indyk et al., 1996).
To address our previous findings of spray drying dramatically influencing
buttermilk’s antiproliferative activity (chapter 3), we also examined influence on
possible changes in activity of powdered buttermilks following other methods for
drying, such as freeze drying and spin drying. In general, we found that freeze and
spin drying, as opposed to spray drying, maintained antiproliferative activity of
buttermilk.
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5.2. Materials and methods
5.2.1. Buttermilk production
Pilot plant buttermilk samples were generated by a member of the project
team, as described in Chapter 4, subsection 4.2.1. Buttermilk samples (feed,
retentate and permeate) were collected, concentrated by water evaporation and
spray dried (inlet 180°C, outlet 85°C). Liquid samples, as well as evaporated and
spray dried samples were collected and stored at -30 for further analytical and
antiproliferative analyses. Compositional analysis of buttermilk samples was
performed by a project team member as described in Chapter 2, subsection 2.2.3.
Analysis of MFGM phospho- and sphingolipid components was also performed
by a project team member as described in Chapter 3, subsection 3.2.2.1.
Buttermilk samples (feed, retentate and permeate) were also subjected to
freeze and spin drying. Freeze drying was performed using the AdVantage Freeze
Dryer (VirTis, NY, USA). Spin drying was performed using miVac Quattro
Concentrator with a miVac SpeedTrap refrigerated condenser from Genevac
Technology.
5.2.2. Cell culture
SW480 human colon cancer cell line was obtained from European
Collection of Cell Cultures, ECACC. Culture media and supplements were
purchased from Sigma-Aldrich Ireland, Ltd. The SW480 cells were grown in
Leibovitz-15 medium. All media were supplemented with L-glutamine (4 mM),
fetal bovine serum (FBS) (10%, v/v) and penicillin/streptomycin (1 U/ml). Cells
were grown at 37°C, without 5% CO2 access.
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5.2.3. Acid phosphatase activity assay
To assess antiproliferative activity of buttermilk samples, the cells were
grown in parallel in two different media to eliminate possibility of the influence of
media components on the antiproliferative activity of buttermilk samples. SW480
cells were seeded in 96-well plates at density of 5x103/well. To allow the cells to
attach, they were cultured for 24 h at 37°C without 5% CO2. Next, concentrated
and powdered buttermilk samples from both pilot plant trials (feed, retentate and
permeate) were reconstituted to former concentration, diluted in feeding media
and added to the wells with the cells in the range of concentrations between 0-1
mg total solids/ml. Only media was added to the control wells. All the buttermilk
samples were sterilized prior to treatment by incubation at 72°C for 15s. The wells
with the SW480 cells were covered with parafilm to prevent CO2 access to the
cells. Four replicates of each buttermilk concentration were performed. After 3
days of incubation at 37°C, cell survival was measured by an indirect colorimetric
endpoint assay for acid phosphatase activity (O’Connor et al., 1998), as described
in Chapter 2, subsection 2.2.5.
5.2.4. Statistical analysis
Three independent experiments were performed in quadruplicate for each
treatment and the Student’s t-test (Microsoft Office Excel) was used to determine
significant difference between treatments or comparing to the control.
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5.3. Results
5.3.1. Compositional analysis of buttermilks
Tables 5.1-5.4 show analytical analysis of buttermilk samples.
Comparative analysis of phospholipid distribution of concentrated feed, retentate
and permeate produced from unwashed cream showed about 3-fold greater
concentration of PI comparing to concentrated feed, retentate and permeate from
washed cream. Washing had little effect on sphingomyelin content of
concentrated feed and retentate; however concentrated permeate from washed
cream was enriched in sphingomyelin comparing to permeate produced from
unwashed cream (38% relative to 22%). It was also observed that concentrated
retentate and permeate from washed cream were about 2-fold enriched in PS and
about 2-fold depleted in PC. Moreover, compositional analysis of spray-dried
powders from both washed and unwashed creams showed altered profile of
phospholipids. Levels of PI, PC, GC and LC were reduced by ~60-100% while PE
and PS were increased. Unfortunately, only retentate from unwashed cream was
spray-dried; hence it could not be compared with retentate from washed cream.
155
Table 5.1. Compositional analysis of liquid, concentrated and spray-dried feed, retentate and permeate produced from unwashed cream; data
obtained by a project team member. All values are expressed as mean %.
Percentage of phospholipids in:Sample Total solids(%) Protein (%)
MFGM proteins
(%) Lipids (%) Sample Total fat Total solids
Lactose
(%)
Feed 9.07 3.18 0.93 1.15 0.14 12.65 1.60 4.03
Retentate 10.35 3.47 2.49 2.78 0.20 7.16 1.93 3.33
Permeate 8.00 3.04 1.13 0.64 0.11 17.01 1.05 3.66
Feed CONC 46.64 16.75 12.74 4.33 0.64 14.80 1.37 21.86
Retentate CONC 38.13 12.49 8.44 10.43 1.06 10.13 2.77 12.75
Permeate CONC 51.04 17.75 5.09 3.51 0.71 20.18 1.39 25.88
Retentate SPRAY DRIED 96.80 31.54 23.58 23.91 1.45 6.09 1.50 35.60
Permeate SPRAY DRIED 96.73 34.45 8.23 5.72 0.99 17.27 1.02 49.06
Table 5.2. Phospho- and sphingolipid composition of feed, retentate and permeate produced from unwashed cream; data obtained by a project team member. All values are expressed as %. Abbreviations: CC,
buttermilk produced from commercial cream; CSC, buttermilk produced from centrifugally separated cream; G4SC, buttermilk produced from gravitationally separated cream at 4°C; PE, phosphatidylethanolamine; PI,
phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; GC, glucosylceramide; LC, lactosylceramide; SM, sphingomyelin.
Sample GC (%) LC (%) PE (%) PI (%) PS (%) PC (%) SM (%)
Feed 0 0 18.42 17.41 5.26 33.21 25.70
Retentate 1.01 1.55 12.93 17.19 6.22 31.57 29.52
Permeate 0.58 1.20 15.92 19.15 5.77 35.80 21.58
Feed CONC 0.11 0.35 20.81 15.96 12.52 24.50 25.75
Retentate CONC 0.57 0.17 14.83 15.80 6.31 31.11 31.22
Permeate CONC 1.74 0.41 17.00 13.34 5.44 40.01 22.07
Retentate SPRAY DRIED 0 0.05 14.39 12.26 6.28 37.94 29.08
Permeate SPRAY DRIED 0 0.16 24.40 10.93 8.33 33.75 22.44
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Table 5.3. Compositional analysis of liquid, concentrated and spray-dried feed, retentate, permeate produced from washed cream; data obtained
by a project team member. All values are expressed as mean %.
Percentage of phospholipids in:Sample Total solids(%) Protein (%)
MFGM proteins
(%) Lipids (%) Sample Total fat Total solids
Lactose
(%)
Feed 8.19 0.43 0.43 5.55 0.10 1.76 1.19 2.18
Retentate 12.38 0.19 0.19 11.25 0.09 0.78 0.71 0.89
Feed CONC 60.80 2.21 2.21 41.58 0.23 0.57 0.39 16.84
Retentate CONC 28.87 0.76 0.76 26.39 0.23 0.87 0.80 1.59
Permeate CONC 9.27 3.21 3.21 3.56 0.49 13.85 5.32 2.01
Permeate SPRAY DRIED 96.73 33.01 32.22 34.26 2.89 8.42 2.98 23.84
Table 5.4. Phospho- and sphingolipid composition of feed, retentate and permeate produced from washed cream; data obtained by a project team member. All values are expressed as mean %. Abbreviations: CC,
buttermilk produced from commercial cream; CSC, buttermilk produced from centrifugally separated cream; G4SC, buttermilk produced from gravitationally separated cream at 4°C; PE, phosphatidylethanolamine; PI,
phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine; GC, glucosylceramide; LC, lactosylceramide; SM, sphingomyelin.
Sample GC (%) LC (%) PE (%) PI (%) PS (%) PC (%) SM (%)
Feed 0 0 26.34 9.03 14.47 23.68 26.48
Retentate 0.59 44.26 21.00 3.83 9.87 8.57 11.87
Feed CONC 0 6.98 23.96 5.38 14.20 19.57 29.91
Retentate CONC 2.47 16.01 18.06 6.25 13.47 15.64 28.10
Permeate CONC 0.65 4.85 19.59 4.19 13.85 19.22 37.66
Permeate SPRAY DRIED 0 13.13 16.52 6.32 12.26 16.84 34.94
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5.3.2. Cytotoxicity
5.3.2.1. Antiproliferative activity of concentrated buttermilk fractions produced
from unwashed and washed cream
From the industrial point of view it was important to examine if
antiproliferative activity of buttermilk was unaffected following spray drying - the
most common drying method used in industry. All buttermilk fractions were
concentrated prior to drying and samples were collected for cytotoxicity studies. The
antiproliferative activity was assessed after 3 days of incubation. At the concentration
of 0.5 mg total solids/ml concentrated feed, retentate and permeate produced from
unwashed cream inhibited SW480 colon cancer cell growth by 93.8, 93.3 and 88.7%,
respectively. However, at lower concentrations the difference in colon cancer cell
growth inhibition was greater. At the concentration of 0.18 mg total solids/ml
concentrated feed, retentate and permeate produced from unwashed cream inhibited
SW480 colon cancer cell growth by 68.0, 71.9 and 64.4%, respectively (Fig. 5.1).
There could be observed a significant difference in SW480 colon cancer
growth inhibition in the case of concentrated feed and retentate produced from
washed cream. At the concentration of 0.5 mg total solids/ml concentrated feed and
retentate inhibited SW480 colon cancer cell growth by 6.7 and 14.6%, respectively
indicating loss of antiproliferative activity. Nevertheless, permeate produced from
washed cream was more potent in inhibiting colon cancer cell growth after
concentration than before concentration. At concentrations of 0.09, 0.18 and 0.5 mg
total solids/ml concentrated permeate inhibited SW480 colon cancer cell growth by
83.5, 97.6 and 99.1%, respectively and liquid permeate inhibited cancer cell growth
by 45.4, 72.5 and 94.3%, respectively (Fig. 5.2).
158
Fig. 5.1. Antiproliferative activity of concentrated feed (
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) on growth of SW480 colon cancer
cells. Cells were maintained and treated in Leibovitz-15 medium. The level of
significance was established between liquid sample and its corresponding concentrate.
Data was assessed using AP assay. Data refer to mean ± SD of three independent
experiments. a,b,c values without a common subscript are significantly different (P ≤
0.05) at given concentration.
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Fig. 5.2. Antiproliferative activity of concentrated feed (
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Cells were maintained and treated in Leibovitz-15 medium. The level of significance
was established between liquid sample and its corresponding concentrate. Data was
assessed using AP assay. Data refer to mean ± SD of three independent experiments.
a,b,c values without a common subscript are significantly different (P ≤ 0.05) at given
concentration.
0
20
40
60
80
100
0.09 0.18 0.5
mg total solids/ml
% 
gro
wt
h i
nh
ibi
tio
n
a
b b b
a
a
b a
a
a
b
b a
b
b
a ba
160
5.3.2.2. Antiproliferative activity of buttermilk samples after spray, freeze and
spin drying
Buttermilk samples produced from washed and unwashed cream were also
subjected to freeze, spray and spin drying. The resultant powders were reconstituted
back in distilled water and incubated with cell lines to assess their antiproliferative
activity. It was observed that after spray drying buttermilk fractions lost the anticancer
activity. Among the three spray-dried buttermilk samples used for experiment
(unwashed retentate and permeate and washed permeate) the highest activity was
observed for washed permeate, which inhibited SW480 colon cancer cell growth by
37.7% at concentration 0.3 mg total solids/ml (Fig. 5.3). However, after freeze drying
and spin drying, the activity remained almost the same. At concentration 0.12 mg total
solids/ml unwashed feed, retentate and permeate after freeze drying inhibited SW480
colon cancer cell growth by 61.2, 84.1 and 95%, respectively (Fig. 5.4 a). At the same
concentration washed feed, retentate and permeate after freeze drying inhibited
SW480 cell growth by 64.4, 77.8 and 55.3%, respectively (Fig. 5.4 b). At
concentration 0.12 mg total solids/ml unwashed feed, retentate and permeate after
spin drying inhibited SW480 colon cancer cell growth by 14.7, 86.1 and 98.2%,
respectively (Fig. 5.5 a). At the same concentration washed feed, retentate and
permeate after spin drying inhibited SW480 cell growth by 76.1, 82.6 and 74.1%,
respectively (Fig. 5.5 b).
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Fig. 5.3. Antiproliferative activity of buttermilk samples:  retentate produced from
unwashed cream (◊), permeate produced from unwashed cream (■) and permeate
produced from washed cream ( ) following spray drying on SW480 colon cancer
cells. Cells were maintained and treated in Leibovitz-15 medium. Data was assessed
using AP assay. Data refer to mean ± SD of three independent experiments. At
concentration 0.3 mg total solids/ml of buttermilk showed significantly (P ≤ 0.001)
lower SW480 cell growth inhibition after spray drying comparing to their former
liquid samples.
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Fig. 5.4. Antiproliferative activity of buttermilk samples produced from a) unwashed
and b) washed cream: feed (◊), retentate (■) and permeate ( ) following freeze drying
on SW480 colon cancer cells. Cells were maintained and treated in Leibovitz-15
medium. Data was assessed using AP assay. Data refer to mean ± SD of three
independent experiments.
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Fig. 5.5. Antiproliferative activity of buttermilk samples produced from a) unwashed
and b) washed cream: feed (◊), retentate (■) and permeate ( ) following spin drying
on SW480 colon cancer cells. Cells were maintained and treated in Leibovitz-15
medium. Data was assessed using AP assay. Data refer to mean ± SD of three
independent experiments.
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5.4. Discussion
As described in Chapter 1, the MFGM comprises mainly membrane-specific
glycoproteins and polar lipids including phospho- and sphingolipids. Many of these
components are biologically active and have potentially important modulatory effects
on cancer cell biology. Development of new functional beverage/food containing
MFGM material demands that methods used in production minimize loss of MFGM,
so that the end material ingredient is representative of the natural MFGM in terms of
composition, technical properties and bioactivity. Objective of the work described in
this chapter was to evaluate the growth modulatory effects of buttermilk fractions
obtained in pilot scale and subjected to water evaporation and drying.
As described in Chapter 4, the enhanced antiproliferative activity of retentate
and/or permeate fractions over feed demonstrated the advantage of fractionation of
buttermilk. However, for production of a long term stable ingredient with
antiproliferative activity it was necessary to investigate the effects of concentration
(water evaporation) and drying on a colon cancer cell line. SW480 was chosen, as it
was a responsive cell line to each of the buttermilk fractions. Evaporation of water
from fractions of both washed and unwashed creams concentrated MFGM proteins,
lipids and lactose. Evaporation of water from feed fraction from unwashed cream had
negligible effects on sphingomyelin and phospholipids, except for phosphatidylserine
which was increased by a factor of 2.2 (Table 5.2). Concentration of feed did not
adversely effect the antiproliferative activity of feed sample in SW480 cells. Unlike
unwashed sample, concentrated feed from washed cream had an opposite effect; cell
growth was promoted in the range 0.09 to 0.5 mg total solids/ml, suggesting that
concentration may have removed bioactive lipid or protein component responsible for
growth inhibition from the washed feed. A possible candidate for promoting growth
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of washed feed fraction may be lactosylceramide, which was present at 7%. Although
Schmelz et al. (2001) revealed an inhibory effect of lactosylceramide on a key marker
of cell migration (β-catenin), another study by Kakugawa et al. (2002) showed that
lactosylceramide had an anti-apoptotic effect on a colon cancer cell line and that
accumulation of lactosylceramide was prevalent in colon cancer tissue relative to
adjacent normal tissue. Concentrated retentate and permeate fractions from unwashed
cream inhibited growth in a dose dependent manner, similar to fractions prior to
evaporation. Concentrated permeate, but not retentate, had a potent antiproliferative
effect. Analysis of composition of concentrated permeate suggest the antiproliferative
activity may be attributed to the effects of a relative enrichment of sphingomyelin.
Changes in antiproliferative activity suggest that water evaporation led to physical
changes within MFGM protein/lipid active complexes. No similar studies could be
found on this subject; hence it needs further investigations.
Snow et al. (2010) used in their studies spray-dried buttermilk, which showed
chemopreventive properties in Fischer-344 rats treated with carcinogen. Earlier on
Schmelz et al. (1996) also showed that sphingomyelin purified from spray-dried
buttermilk showed antiproliferative activity in CF1 mice. Moreover, spray drying is
commonly used as method for encapsulation of bioactive molecules as oils and
flavours (Jafari et al., 2008) and bioactive living cells (probiotics) in dairy products,
however with lower survival rates than other microencapsulation methods (de Vos et
al. 2010). Some recent data show that parameters used for spray drying might
influence storage and functionality of spray dried powders. Gaiani et al. (2010) claim
that functional properties of powders during storage can be related to temperature of
spray drying, as it influences dairy powder surface composition. They found that
surface active components, as proteins and phospholipids were over-expressed at the
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surface when drying at low temperatures (Gaiani et al., 2010, symposium abstract). In
our study, spray-dried concentrated retentate and permeate fractions yielded
buttermilk powders containing 96% total solids and fat content between 5 and 34%.
Retentate and permeate samples after spray drying showed much lower (P ≤ 0.001)
antiproliferative activity than their corresponding liquid samples. Spray-dried
permeate produced from washed cream and retentate produced from unwashed cream
inhibited growth of SW480 cells by 57% and 30.7%, respectively, while spray-dried
permeate produced from unwashed cream showed no antiproliferative activity in
SW480 colon cancer cells (1.9%), suggesting temperature and/or pressure-induced
impairment of bioactive components responsible for antiproliferative activity
inhibition. Compositional analysis of spray-dried powders from both washed and
unwashed creams showed altered profile of phospholipids. Levels of PI, PC, GC and
LC were reduced by ~60-100% while PE and PS were increased. Loss of nutrients,
such as proteins, fats, vitamins, flavours as a result of the high temperature and
pressure of spray drying has been previously documented (Indyk et al., 1996).
Temperature is the single most important factor affecting the drying of buttermilk and
its MFGM. Morin et al., (2007 b) showed that spray drying affected the composition
of buttermilk and its MFGM, in particular, it significantly lowered phospholipid
content when compared with initial buttermilks. A reduction in phospholipid content
was also observed in MFGM isolates following spray drying. Accordingly, non-
thermal treatments including freeze drying may be more effective in overcoming the
loss of nutrients during spray drying process (Kim et al. 2010). Furthermore, heat
occurred during spray drying can be crucial to initiate and/or increase the lipase
activity in milk (Hwang et al., 2007).
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However, freeze drying of feed, retentate and permeate fractions maintained
their antiproliferative activity (Fig. 5.4). It is apparent that freeze-dried retentate and
permeate fractions from unwashed cream were more potent than freeze-dried feed
fraction, as had been observed prior to freeze drying (Fig. 4.1, Chapter 4). Similarly,
freeze-dried retentate fraction from washed cream was more potent than freeze-dried
feed and permeate, as had been observed prior to freeze drying (Fig. 4.4, Chapter 4).
Like freeze drying, spin drying of feed, retentate and permeate fractions
maintained their antiproliferative activity (Fig. 5.5). It was apparent that spin-dried
retentate and permeate fractions from unwashed cream were more potent than spin-
dried feed fraction, as had been observed prior to spin drying (Fig. 4.1, Chapter 4).
Similarly, spin-dried retentate fraction from washed cream was also more potent than
spin-dried feed and permeate, as had been observed prior to spin drying (Fig. 4.4,
Chapter 4).
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5.5. Conclusions
It was found that spray drying, but not freeze and spin drying. significantly (P
≤ 0.001) reduced antiproliferative activity of buttermilk samples produced in pilot
scale from unwashed and washed creams followed by microfiltration.
Antiproliferative activity that was maintained by buttermilk samples after freeze and
spin drying suggest that harsh conditions used during spray drying (pressure and/or
temperature) may permanently deactivate buttermilk’s bioactive component(s).
However, because spray drying is commonly used in dairy industry as the cheapest
and the most efficient method of drying powders, further studies are necessary to
establish possible spray drying conditions that would maintain bioactivity of
buttermilk.
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CHAPTER 6
Analysis of antiproliferative mode of action of buttermilk on SW480
colon cancer cells.
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Knowing that buttermilk is a rich source of sphingolipids with antiproliferative
activity, we examined possible biochemical pathways known to be triggered by pure
sphingolipids in colon cancer. The aim of this study was to analyze key signalling
molecules in cell growth and cell death pathways, such as hallmarks of apoptosis
(phosphatidylserine translocation, mitochondrial outer membrane depolarization,
cleavage of caspase-3, caspase-9 and poly(ADP-ribose) polymerase (PARP), as well
as translocation of apoptosis-inducing factor, AIF and endonuclease G to cells’
nuclei), tumour biomarkers (Akt, β-catenin), as well as key proteins of the mitogen-
activated protein kinase (MAPK) pathways, which lead to a wide range of cellular
responses, including growth, differentiation, inflammation and apoptosis. Using a
variety of fluorescence methods (fluorescence-activated cell sorting, fluorescence
microscopy, confocal microscopy), cytological staining and immunoblotting we
observed that buttermilk induced apoptosis in SW480 colon cancer cells
(morphological changes, membrane alteration and mitochondria depolarization);
however we could not detect other hallmarks of apoptosis, such as cleavage of
caspases or PARP, which indicated that cell death may be caspase-independent or
induced by autophagy. Immunofluorescent labelling of AIF and endonuclease G
showed their translocation from mitochondria to cells’ nuclei, signifying caspase-
independent apoptosis as a possible pathway involved in colon cancer cells death.
Buttermilk also downregulated levels of colon cancer biomarkers: β-catenin and
phosphorylated Akt, as well as MAPK pathways proteins: ERK1/2 and c-myc.
However, it did not alter levels of other MAPK pathway signalling components, such
as phosphorylated p38 and phosphorylated JNK.
171
6.1. Introduction
Phospholipids and sphingolipids of milk fat globule membrane (MFGM) are
known to possess cancer risk reduction properties in vivo and in vitro (Segui et al.,
2006, Ogretmen, 2006, Schmelz, 2004). Recent reports attribute their
chemopreventive activity to products of sphingomyelin hydrolysis, in particular
ceramide, sphingosine, and glycosphingolipids, which affect multiple cellular targets
that control cell growth, differentiation and apoptosis (Huwiler et al., 2000, Merill et
al., 1997). Knowing the potential health benefits of MFGM lipids and proteins and the
influence of a well-balanced diet on colon cancer prevention dairy industries address
their research in developing new functional dairy products enriched in beneficial
MFGM components, i.e. buttermilk.
Chapters 3-5 demonstrated anticancer activity of buttermilk samples across
model colorectal cancer cell lines. Moreover, washing of cream before churning into
butter and microfiltration of buttermilk through 0.8 µm ceramic membrane at 50°C
allowed us to obtain a final product, retentate, enriched in MFGM components
(Chapter 4). The aim of this study was to examine the mode of action of resultant
product (retentate produced from washed cream) on SW480 colon cancer cells.
Two basic types of cell death exist: apoptosis, referred to as programmed cell
death and necrosis (Kerr et al., 1972, Saikumar et al., 1999, Adams, 2003). Cytotoxic
compounds that exert anti-tumour effects by induction of programmed cell death
afford greater potential for prevention of colon cancer than those which cause
damaging inflammation, characteristic of necrosis. Identification of biomarkers from
within the apoptotic machinery of colon cancer cells that are responsive to buttermilk
would be the first critical aspect in predicting buttermilk’s suitability as a functional
dairy beverage. However, to make a claim at a scientific level further steps are
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required in design and development of functional food/beverage. They include
demonstration of efficacy,  determination of the intake level necessary to achieve the
desired effect; demonstration of safety of the component at efficacious levels and
development of a suitable food vehicle for the component.  Independent peer review
of scientific evidence for efficacy and health claim accuracy is also warranted.
In this study, we set out to identify biochemical and morphological changes
that serve as hallmarks of the cell death process. Biochemical changes during the
early stages of apoptosis include activation of caspase enzymes and disruption of
active mitochondria, leading to changes in mitochondrial membrane potential (Kluck
et al., 1997). Biochemical changes during the middle to late stage of the cell death
process include the externalisation of phosphatidylserine on cell membrane (Fadok et
al., 1992). Several different approaches were used in this study to examine the effect
of buttermilk on cell death. Haematoxylin and eosin staining was used to distinguish
live cells from early and late apoptotic cells. Flow cytometry and fluorescence
microscopy were used to demonstrate externalisation of phosphatidylserine, FACS
was used to quantify apoptosis and cell cycle distribution using propidium iodine, a
water-soluble DNA intercalator dye. Mitochondrial dysfunction was assessed by
measuring loss of retention of TMRE, a highly fluorescent cationic lipophilic dye
whose retention by mitochondria is dependent on mitochondrial transmembrane
potential.
Molecular markers of apoptosis, such as cleaved caspase-3, caspase-9, cleaved
PARP, AIF and Endo G were measured using a variety of immunochemical methods,
such as immunoblotting and immunofluorescence. Proteins involved in cell survival
(Akt, β-catenin, ERK1/2, c-myc, p-p38, p-JNK) were studied using In-Cell Westerns,
also referred to as In-Cell ELISA.
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6.2. Materials and Methods
6.2.1. Materials
Antibodies: AIF, c-Myc (D84C12) XPTM, cleaved caspase-3 (Asp175),
cleaved PARP, cleaved caspase-9 (Asp330) and anti-rabbit secondary antibody were
purchased from Cell Signaling Technology, Inc. (Danvers, Massachusetss, USA). β-
catenin and FITC-conjugated anti-rabbit were purchased from Sigma-Aldrich, Ireland.
ENDOG (FL-297) (endonuclease G), p-JNK (G-7), p-p38 (Thr180/Tyr182), ERK2
(D-2), p-ERK1/2 (Thr177/Thr160) were purchased from Santa Cruz Biotechnology,
Inc. (Santa Cruz, California, USA). All other reagents were purchased from Sigma-
Aldrich (Ireland) or as stated in text.
Buttermilk sample was provided by a project team member and prepared from
raw whole milk collected from the Moorepark Dairy Production Centre (MDPC)
farm, Fermoy, Co. Cork, Ireland. Briefly, cream was separated from skim milk in
separator at 45-50°C. Cream was pasteurized at 72°C for 15sec, and cooled down to
10°C. Next, during churning buttermilk was separated from butter. Buttermilk sample
was microfiltered through 0.8 μm ceramic membranes at 50°C giving retentate and
permeate samples. Retentate sample was used to determine mode of action in the
whole study presented.
6.2.2. Cell culture
SW480 human colon cancer cell line was obtained from European Collection
of Cell Cultures, ECACC. Culture media and supplements were purchased from
Sigma-Aldrich, Ireland. The SW480 cells were grown in Leibovitz-15 medium
supplemented with L-glutamine (4 mM), fetal bovine serum (FBS) (10% , v/v) and
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penicillin/streptomycin (1 U/ml). Cells were grown at 37°C, without 5% CO2 access
(flask’s caps were fully closed and culture plates were sealed with parafilm).
6.2.3. Haematoxylin and eosin staining of cultured cells
Haematoxylin and eosin stains were used to display cytoplsmic and nuclear
features of cells treated with buttermilk. SW480 cells were seeded in T-25 flasks at
density 1x106 cells/flask. After 24h they were treated with buttermilk at concentration
0.4 mg total solids/ml and incubated at 37°C for another 24h. Suspension and attached
cells were harvested separately, centrifuged at 1000 rpm for 5 min, supernatant was
discarded and cell pellets were resuspended in PBS. A drop of cell solution was then
added to a cytospin slide (Andreas Hettich GmbH & Co., Germany) and spun at 500
rpm for 3 min using Hettich centrifuge with Hettich cyto-system (Andreas Hettich
GmbH & Co., Germany). To fix the cells slides were put into 3.7% paraformaldehyde
(Sigma-Aldrich, Ireland) for 10 minutes at room temperature and rinsed with PBS.
Next, slides were put into 100% methanol for 5 minutes followed by 40 seconds in
0.5% eosin (Sigma-Aldrich, Ireland). Next, the slides were washed in running tap
water and put into haematoxylin (Sigma-Aldrich, Ireland) for 5 seconds. The slides
were washed in tap water and allowed to dry at room temperature. About 5 μl of DPX
Mountant (Sigma-Aldrich, Ireland) for histology was put onto each slide and covered
with cover slips. Microscopy was done using fluorescent microscope Olympus BX51
(Olympus America Inc, Center Valley, Pennsylvania, USA) at a magnification of
400X.
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6.2.4. Fluorescence methods for detection of apoptosis
6.2.4.1. Tetramethylrhodamine ethyl ester perchlorate (TMRE) staining of
cultured cells
Mitochondrial function in buttermilk-treated cells was analysed by staining
with TMRE. This is a cell-permeant cationic red-orange fluorescent dye that is readily
sequestered by active mitochondria. SW480 cells were seeded in 24-well plate at
density 6x104 cells/well. After 24h they were treated with buttermilk at concentrations
between 0.1-0.6 mg total solids/ml and incubated at 37°C for another 24h or 48h.
Media was removed, cells were washed with PBS and incubated with 0.1 μM TMRE
solution (Sigma-Aldrich, Ireland) for 30 minutes at 37°C, cells were harvested by
scraping and analyzed on flow cytometer at excitation 540 nm and max. emission 595
nm (BD FACSCanto™ II, BD Biosciences, San Jose, California, USA).
6.2.4.2. Apoptosis and cell cycle analysis using propidium iodide by flow
cytometry
DNA fragmentation is a hallmark of apoptosis and provides a basis for the
development of flow cytometry assays to identify apoptotic cells. Low molecular
weight DNA is extracted prior to staining and measurement of cellular DNA. Flow
cytometry was used to analyse DNA content of cells in the presence and absence of
buttermilk. In this method, ethanol was used to fix and permeabilise SW480 cells
aiding access of propidium iodide to nuclear DNA. Propidium iodide is a DNA-
fluorochrome used to stain DNA in fixed cells. Because it reacts with both DNA and
RNA, the staining procedure requires incubation with RNAse. SW480 cells were
seeded in T-25 flasks at density 1x106 cells/flask. After 24h they were treated with
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buttermilk at concentration of 0.4 mg total solids/ml or 5 mM sodium butyrate as a
positive control. After 48h attached and detached cells were collected together and
counted, 1x106 cells were pelleted and resuspended in 1 ml cold PBS. Next, 3 ml of
cold (-20°C) 100% ethanol was gently added while gently swirling tube with cells.
The cells were then frozen at -20°C for few days. On the day of analysis cells were
thawed at room temperature and centrifuged at 3000 rpm for 5 min. Supernatant was
discarded and the cell pellets were washed in 1 ml of PBS following centrifugation at
2000 rpm for 5 min. Supernatant was discarded and cell pellets were resuspended in
100 μl of 200 μg/ml DNAse free RNAse A solution and incubated at 37°C. After 30
min propidium iodine solution was added to cells (part of Annexin-V-FLUOS
Staining Kit, Roche Diagnostics GmbH, Germany) at concentration 15 μl per 1 ml of
cell suspension, incubated at room temperature for 15-20 min. Cell fluorescence was
measured on flow cytometer (BD FACSCanto™ II, BD Biosciences, San Jose,
California, USA).
6.2.4.3. Apoptosis detection using Annexin-V-FLUOS staining
Externalisation of phosphatidylserine was determined by staining with
Annexin-V-FLUOS. SW480 cells were seeded in T-25 flasks at density 1x106
cells/flask. After 24h they were treated with buttermilk at concentration 0.4 mg total
solids/ml or 5 mM sodium butyrate as a positive control. After 48h attached and
detached cells were collected separately and 1x106 cells were counted, washed with
PBS and centrifuged at 1000 rpm for 5 min. The cell pellet was resuspended in 100 μl
of Annexin-V-FLUOS labeling solution (Roche Diagnostics GmbH, Germany),
containing 20 μl/ml of Annexin-V-Fluorescein labelling reagent and 20 μl/ml of
propidium iodide solution. Cells in labelling solution were incubated for 15 min at
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room temperature in the dark and analysed on flow cytometer (BD FACSCanto™ II,
BD Biosciences, San Jose, California, USA) at excitation 488 nm and max. emission
519 nm for Annexin-V- Fluorescein and exc. 532 nm and max. emission 578 nm for
propidium iodide.
Samples were also analysed under a fluorescence microscope. For microscopy
analysis SW480 cells were seeded in Lab-Tek Chamber Slides (Sigma-Aldrich,
Ireland) at density 0.2x106 cells/chamber. After 0.4 mg total solids/ml buttermilk
incubation medium, chambers and silicon borders were removed from chamber slides
and cells were covered with Annexin-V-FLUOS labeling solution, incubated for 15
min at room temperature in the dark and analyzed by fluorescence microscopy
(Olympus BX51; Olympus America Inc, Center Valley, Pennsylvania, USA) using
488nm excitation wavelength and green channel for detection.
6.2.5. Determination of Akt using fast activated cell-based ELISA (FACE)
Determination of phosphorylated and total Akt in SW480 human colon cancer
cells before and after buttermilk treatment was performed using colorimetric Fast
Activated Cell-based ELISA (FACE) Kit (Active Motif, Belgium) according to
manufacture’s instruction manual. In short, SW480 cells were seeded in 96-well
plates at density 8x103 cells/well. After 48h they were treated with buttermilk at
concentration between 0-1 mg total solids/ml and incubated at 37°C. After 24h media
was removed and cells were fixed with 4% formaldehyde in PBS and incubated at
room temperature. After 20 min cells were washed 3 times with wash buffer (0.1%
Triton X-100 in PBS) and incubated for another 20 min with quenching buffer (10%
H2O2 and 10% sodium azide in wash buffer) to inactivate cells’ endogenous
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peroxidase activity. Cells were then washed 2 times with wash buffer, incubated for
1h at room temperature with antibody blocking buffer and washed 2 times with wash
buffer. Next, cells were incubated overnight at 4°C with primary antibody (against
phosphorylated Akt or total Akt) diluted in antibody dilution buffer. Next day primary
antibody was removed, cells were washed with wash buffer and incubated with
secondary antibody diluted in antibody dilution buffer for 1h at room temperature.
Cells were then washed 3 times with wash buffer and 5 times with PBS and incubated
with developing solution for 10-20 min at room temperature protected from direct
light. After the blue colour being developed reaction was stopped with stop solution
and absorbance was read on Multi-Detection Microplate Reader SynergyTM HT
(supplied by BioTek® Instruments, Inc) at 450nm. To normalize readings to cell
number cells were washed with wash buffer and with PBS, followed by incubation
with Crystal Violet for 30 min at room temperature. Cells were then washed with
wash buffer and incubated with 1% SDS solution for 1 h on shaker. Absorbance was
read at 595 nm. The measured OD450 readings were corrected for cell number by
dividing the OD450 reading for a given well by the OD595 reading for that well.
6.2.6. Analysis of β-catenin, ERK2, phosphorylated-ERK 1/2, c-myc,
phosphorylated p38 and phosphorylated JNK using In-Cell Western Assay
In-Cell Western Assay was performed using LI-COR Biosciences In-Cell
Western™ Assay Kit I containing IRDye 800CW-labeled anti-rabbit and anti-mouse
antibodies, Odyssey Blocking Buffer and DRAQ5™ and Sapphire700™ reagents for
cell number normalization. Assay was performed according to manufacturer’s
instruction; briefly SW480 cells were seeded in 96-well plates at density 8x103
cells/well. After 48h they were treated with buttermilk at concentration ranging
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between 0-1 mg total solids/ml and incubated for another 24h or 48h. Cells were then
fixed with 3.7% paraformaldehyde in PBS for 20 min at room temperature. To allow
permeabilization, cells were washed 5 times with wash buffer (0.1% Triton X-100 in
PBS). Next, 150 µl of Odyssey Blocking Buffer was carefully added to each well and
incubated for 1.5h at room temperature with moderate shaking. Blocking buffer was
removed and cells were incubated with primary antibody, diluted in Odyssey
Blocking Buffer overnight at 4ºC with gentle shaking. Next day, plates with cells
were washed 5 times with 0.1% Tween-20 wash buffer and incubated with
fluorescently labeled secondary antibody (1:800), DRAQ5™ (1:2000) and
Sapphire700™ (1:1000) solution diluted in Odyssey Blocking Buffer and incubated in
dark for 1h at room temperature with gentle shaking. Next, cells were washed 5 times
with 0.1% Tween-20 wash buffer and read on the Odyssey Imager using 800 nm
channel for IRDye 800CW detection and 700 nm channel for normalization stains.
Data was processed using Odyssey Application Software version 3.0.
6.2.7. Western Blot analysis of caspase-9 and caspase-3
6.2.7.1 Harvesting the cells
After 48h following buttermilk treatment SW480 human colon cancer cells in
T-25 flasks were placed on ice, washed with cold PBS, scraped and centrifuged at
1000 rpm for 5 min. Supernatant was then removed, the pellets were resuspended in
0.5 ml ice-cold PBS, transferred into eppendorf tubes and centrifuged at 1000 rpm for
5 min. Supernatant was then removed and the appropriate volume of lysis buffer was
added. Lysis buffer contained the following protease inhibitors: 2 μg/ml aprotinin, 1
μg/ml leupeptin, 1 mM PMSF and phosphatase inhibitors: 5 mM NaF and 1 mM
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Na3VO4 (all supplemented by Sigma-Aldrich, Ireland). The cells were then sonicated
(3 times for 5 sec) on MSE Soniprep150 sonicator (MSE (UK) Ltd, Wolf
Laboratories, London, UK) and spun at 14 000 rpm for 15 min at 4°C. The
supernatant was transferred into new tubes and stored at -70°C until analyzed.
6.2.7.2. Protein estimation
To estimate the protein concentration in each sample the Bicinchoninic Acid
Protein assay (Sigma-Aldrich, Ireland) was carried out. Standards for the standard
curve were prepared using bovine serum albumin (BSA) solutions at concentration
range 0-2 mg/ml in lysis buffer. The volume required to load 30 μg protein was
calculated before loading the SDS-PAGE gel.
6.2.7.3. SDS-PAGE
Acrylamide gel (12%) for electrophoresis was prepared for protein separation.
The prestained protein marker (Cell Signaling Technology, Inc; Danvers,
Massachusetss, USA) and the samples mixed with 4X sample buffer containing β-
mercatoethanol were put into the boiling water for 5 minutes. The samples and the
markers were loaded onto gels and run in a chamber with running buffer at 120V for
about 100 min.
6.2.7.4. Blotting and detection
After electrophoresis, each gel was placed in a cassette along with PVDF
membrane, between 4 sheets of filter paper and 2 sponges. Transfer of the proteins to
the membrane was carried out in the chamber with the transfer buffer for 45 minutes
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at 100V. The membranes were then washed using TBS-Tween and the non-specific
binding sites were blocked with 5% milk-TBS-Tween solution for 1 hour at room
temperature with gentle shaking. Primary antibodies were then diluted in 5% milk-
TBS-Tween solution and incubated overnight at 4°C with gentle shaking. Next, the
membranes were washed 4 times in TBS, for 7 minutes each time. Next, the
membranes were incubated with secondary antibody in 3% milk-TBS-Tween for 1
hour and washed in TBS, 3 times for 10 minutes each time. The membranes were
incubated in Pierce® ECL detection solution (Thermo Scientific, Rockford, Illinois,
USA) for 5 minutes, exposed to autoradiography film (Kodak™, Sigma-Aldrich,
Ireland) and developed in D-19 Developer (Kodak™, Sigma-Aldrich, Ireland).
6.2.8. Immunofluorescence analysis of cleaved PARP, apoptosis-inducing factor
(AIF) and endonuclease G
SW480 cells were seeded on Lab-Tek Chamber Slides (Sigma-Aldrich,
Ireland) at density of 0.2x106 cells/chamber. After 24h they were treated with
buttermilk at concentration 0.4 mg total solids/ml and incubated at 37°C for 48h.
Media was then removed and cells were fixed with 3.7% paraformaldehyde in PBS
and left for 15 minutes at room temperature. Next, fixative was removed and
following washing cells three times in PBS for 5 min each, with gentle shaking, they
were blocked in Blocking Buffer (PBS containing 5% normal goat serum and 0.3 %
Triton X-100). After 1 h blocking cells were incubated overnight at 4°C with primary
antibody diluted in Antibody Dilution Buffer (PBS containing 1% BSA and 0.3 %
Triton X-100). Next day cells were rinsed three times in PBS for 5 minutes each, with
gentle shaking and incubated in FITC-conjugated anti-rabbit IgG developed in goat
(Sigma-Aldich, Ireland) and DRAQ5™ (LI-COR Biosciences; Lincoln, Nebraska
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USA) diluted in Antibody Dilution Buffer for 2 hours in dark at room temperature,
with gentle shaking. Cells were then rinsed three times in PBS for 5 minutes each and
examined under Leica DM TCS SP5 confocal scanning laser microscope (Leica
Microsystems, Wetzler, Germany) and using Leica LAS AF Lite program.
6.2.9. Statistical analysis
Three independent experiments were performed in quadruplicate for each
treatment and the Student’s t-test (Microsoft Office Excel) was used to determine
significant difference between treatments or comparing to the control.
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6.3. Results
6.3.1. Haematoxylin and eosin staining of cultured cells
Haematoxylin and eosin staining, method commonly used in histology and
cytology, was carried out to determine if cells undergo apoptosis after buttermilk
treatment. (Fig. 6.1 a-f). This stain can display a broad range of cytoplasmic, nuclear
and extracellular matrix features. Haematoxylin stained nuclear chromatin deep blue,
whereas eosin stained cytoplasmic structures and extracellular matrix with varying
degrees of pink. Compared to untreated healthy cells (Fig. 6.1 a) we observed
condensation of chromatin and shrinkage of nuclei of some cells (Fig. 6.1 d-f) after
buttermilk treatment indicating activation of apoptosis (black arrows). However, we
could not detect characteristic apoptotic bodies after buttermilk treatment and necrotic
cells were also observed.
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a)  C- b)  C+ early
c)  C+ late d)  BM early
e)  BM late f)  BM late
Fig. 6.1. Light microscopy images (400X) following haematoxylin and eosin staining
of SW480 cells in Leibovitz-15 medium: a) negative control, C- b) positive control
(sodium butyrate), C+, early stages of apoptosis, c) positive control (sodium butyrate),
C+, late stages of apoptosis, d) cells after buttermilk treatment (BM), early stages of
apoptosis, e) & f) cells after buttermilk treatment (BM), late stages of apoptosis. The
arrows indicate the apoptotic cells.
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6.3.2. Apoptosis detection using Annexin-V-FLUOS by FACS
We also investigated other apoptotic biomarkers in colon cancer cells after
buttermilk treatment. In all stages of apoptosis phosphatidylserine is translocated from
the inner part of the membrane to the outer layer. Flow cytometry is a technique for
counting and examining microscopic particles by suspending them in a stream of fluid
and passing them by an electronic detection apparatus. It allows simultaneous
multiparametric analysis of the physical and/or chemical characteristics of up to
thousands of particles per second. Fluorescence-activated cell sorting (FACS) is a
specialized type of flow cytometry. It provides a method for sorting a heterogeneous
mixture of biological cells into two or more containers, one cell at a time, based upon
the specific light scattering and fluorescent characteristics of each cell. It is a useful
scientific instrument, as it provides fast, objective and quantitative recording of
fluorescent signals from individual cells as well as physical separation of cells of
particular interest. The acronym FACS is trademarked and owned by Becton,
Dickinson and Company (BD). Annexin-V-Fluorescein binds in a Ca2+-dependent
manner to negatively charged phospholipid surfaces and shows high specificity to
phosphatidylserine. It does not bind normal intact cells. This protein can be used as a
sensitive probe for phosphatidylserine exposure upon the outer leaflet of the cell
membrane and is therefore suited to detect apoptotic cells in cell populations. Since
necrotic cells also expose phosphatidylserine as they lose membrane integrity,
propidium iodide is used as a DNA stain to distinguish between necrotic cells and
Annexin-V labelled cells. Excitation and emission wavelengths for Annexin-V-
Fluorescein detection were 488 nm and 518 nm, respectively; hence FITC filter was
used. For identification of propidium iodide we used APC filter, which detects
fluorescence signal at excitation 595 nm and emission 660 nm, which was the closest
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to fluorescence characteristics of this dye. Using FACS method we observed an
increase in % of green staining suggesting that phosphatidylserine was externalised in
buttermilk-treated cells (Fig. 6.2 d). Analysis showed that 91.1% of control cells were
viable and that the remainder (8.9%) were apoptotic (Fig. 6.2 a). Following treatment
with buttermilk 57.5% of cells were viable and 42.5% of cells were apoptotic (Fig.
6.2 d). Treatment with the positive control (5 mM sodium butyrate) yielded 62.9%
viable cells and 36.6% apoptotic cells (Fig. 6.2 c).
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a) b)
c) d)
Fig. 6.2. FACS examination of phosphatidylserine exposure to the outer membrane
with Annexin-V-FITC and counterstaining with propidium iodide, performed 48h
after exposure of the SW480 cells in Leibovitz-15 medium to buttermilk in order to
detect early apoptotic cells (green population) and late apoptotic/dead cells (blue
population), respectively. A) control with untreated, healthy cells, b) dead, necrotic
cells, c) positive control (5 mM NaBut), d) cells after 48h buttermilk treatment.
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6.3.3. Apoptosis detection using Anexin-V-FLUOS by fluorescence microscopy
Fluorescent imaging using the same Annexin-V-FLUOS dyes and green filter
(excitation wavelength in the range 450-500 nm, emission wavelength in the range
515-565 nm) confirmed results from flow cytometry (Fig. 6.3 a-e). Apoptotic cells
bind to fluorescein, hence are visible in green and can be differentiated from necrotic
cells because they exclude propidium iodide. Necrotic cells took up propidium iodide
and stained orange/green while apoptotic cells stained green only.
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a) b)
c) d)
e)
Fig. 6.3. Fluorescent microscopic examination of phosphatidylserine exposure to the
outer membrane with Annexin-V-FITC and counterstaining with propidium iodide,
performed 48h after exposure of the SW480 cells in Leibovitz-15 medium to
buttermilk. Light (a) and fluorescent (b) microscopic images of untreated, healthy
cells; light (c) and fluorescent (d, e) microscopic images of cells after 48 h buttermilk
treatment.
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6.3.4. Apoptosis and cell cycle analysis by FACS
DNA analysis is, after immunofluorescence, the second most important
application of flow cytometry. Propidium iodide is used to bind to DNA. The amount
of propidium iodide bound correlates with the content of DNA within a given cell.
Once cells are stained they may be analysed on a flow cytometer. Apoptotic cells are
detected as cells having degraded DNA (hypodiploid DNA) content due to the fact
that cells loose DNA by shedding apoptotic bodies. Additionally, rinsing and staining
extracts DNA resulting in apoptotic cells manifesting reduced DNA content. They are
recognised following staining of cellular DNA as cells with decreased stainability
(sub-G1 cells) located to left of a peak representing G1 cells on DNA content
frequency histograms. Our studies using FACS showed apoptotic cells with fractional
DNA content after buttermilk treatment (Fig. 6.4 c). The number of apoptotic SW480
cells was found to be significantly greater (P ≤ 0.001) when cells were treated with
sodium butyrate (36.8%) or with buttermilk (34.85%) compared to control (9.15%).
The cell cycle position of non-apoptotic cells was also estimated. Percentage of
G1/G0 non-apoptotic cells was 50.2, 44.4 and 30.55% in control, sodium butyrate and
buttermilk treatments, respectively. Together the data suggest that buttermilk
triggered apoptosis in SW480 cells and affected progression of non-apoptotic cells
through the cell cycle.
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a)  untreated b)  NaBut c)  buttermilk
Fig. 6.4. Induction of apoptosis in SW480 cells by buttermilk treatment. SW480 cells in Leibovitz-15 medium were treated with buttermilk (0.4
mg total solids/ml) and NaBut (5mM) for 48 h. Subsequently, nuclei were isolated by hypotonic lysis, stained with propidium iodide and
analysed by flow cytometry for hypodiploid DNA content as indicator of apoptosis. Figure shows representative histograms of: a) untreated cells,
b) 5 mM NaBut (positive control), c) cells after 48h of buttermilk treatment. A total of 10 000 nuclei were counted per data point. The rate of
nuclei with hypodiploid DNA content is expressed as % total nuclei. The values represent the mean of triplicate experiments.
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6.3.5. Analysis of mitochondrial membrane depolarization
Dissipation of mitochondrial membrane potential () is a critical event in
the process of cell death. To examine whether antiproliferative activity of
buttermilk in SW480 cells was associated with changes in , we measured
uptake and retention by mitochondria of tetramethylrhodamine ethyl ester
perchlorate (TMRE). This is a fluorescent probe whose accumulation and
subsequent retention in healthy non-apoptotic cells is dependent on . In
apoptotic cells, a trans-membrane electrical potential gradient collapses and
TMRE dye no longer accumulates inside the mitochondria and becomes more
evenly distributed throughout the cytosol; hence overall cellular fluorescence
levels drop. Fig 6.5 a-f shows representative histograms from cells treated with
varying concentrations of buttermilk solids and subjected to FACS analysis.
Beyond an arbitrary threshold of 5x103, buttermilk decreased TMRE fluorescence
in a concentration-dependent manner and shifted the distribution curve leftward,
indicating depolarisation of  relative to untreated cells. Approximately 76.6%
of control cells retained high levels of fluorescence as compared to 16.8% of cells
treated with buttermilk (0.15 mg total solids/ml) for 48h (P ≤ 0.001).
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a) b)
c) d)
e) f)
Fig.6.5. Loss of the mitochondrial membrane potential . The histograms are
representative of experiments with SW480 cells in Leibovitz-15 medium that
were either left untreated (a) or treated with buttermilk at concentrations: 0.1 mg
total solids/ml for 24h (b); 0.15 mg total solids/ml for 24h (c); 0.2 mg total
solids/ml for 24h (d); 0.25 mg total solids/ml for 24h (e); 0.15 mg total solids/ml
for 48h (f). The mitochondrial membrane potential was determined by staining of
23.8%
43.6%
31.0%
51.0%
53.4% 83.8%
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cells with the fluorescent dye, TMRE (tetramethylrhodamine ethyl ester
perchlorate), which migrates and accumulates inside mitochondria in healthy
cells. In apoptotic cells, a trans-membrane electrical potential gradient collapses
and TMRE dye becomes more evenly distributed throughout the cytosol, hence
shifting the distribution curve leftward. The control values were obtained with
untreated SW480 cells. The rate of cells with collapsed mitochondrial membrane
potential is expressed as % of total cell counts. The values represent the mean of
triplicate experiments.
6.3.6. Analysis of cleavage of apoptotic biomarkers: caspase-3 , caspase-9 and
PARP
Apoptotic cell death is orchestrated by activation of death proteases known
as caspases which target an array of cellular proteins for degradation, resulting in
controlled disassembly of the cell. Caspases are present in cells as inactive
precursors that require limited proteolysis to become activated. The activation
status of an initiator caspase (caspase-9) and an executioner caspase (caspase-3)
was analysed by SDS-PAGE/immunoblotting. Immunoblotting with antibodies
raised against caspase-9 (Fig. 6.6 a)  and caspase-3 (Fig. 6.6 b) revealed
appearance of processed subunits (MW 17kDa) of these enzymes in cells treated
with 5 mM sodium butyrate (positive control). However processed forms of these
caspases were not detected in cells treated with buttermilk (Fig. 6.6 a and b).
Western Blot analysis (Fig. 6.6 a) showed a very weak band (MW 17kDa) of
cleaved caspase-9 in detached/dead (S) cells after 48h of buttermilk treatment at
concentration of 0.3 mg total solids/ml. However, no band was observed in
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attached (A) cells from the same experimental flask, which was a predictable
result, as some small population of cells is highly likely to enter apoptosis
pathway while dying. Other methods, such as In-Cell Western analysis of cleaved
caspase-3 in cells treated with increasing amounts of buttermilk (Fig. 6.7),
incubation of treated cells with Rhodamine 110-based derivative of bis-L-aspartic
acid amide (Molecular Probes, Inc; Eugene, Oregon, USA) (data not shown) and
ApoToxGlo™ Triplex Assay (Promega Corporation, Madison, WI, USA) (data
not shown) also did not show cleavage of caspases, whereas cleaved caspase was
observed in the positive control, (cells treated with 5 mM sodium butyrate) (Fig.
6.7).
a)
b)
Fig. 6.6. Western blot analysis for the status of caspase-9 and caspase-3. SW480
cells in Leibovitz-15 medium were treated with buttermilk for 48 h. Then, cell
lysates were prepared and subjected to immunoblot analysis. Abbreviations: A,
cells attached to the bottom of flask during harvesting cells for analysis; S, cells
detached (in suspension) from the bottom of the flask during harvesting cells for
analysis; C, negative control; NaBut, cells treated with 5 mM sodium butyrate,
positive control; B2, cells treated with buttermilk at concentration 0.2 mg total
solids/ml; B3, cells treated with buttermilk at concentration 0.3 mg total solids/ml.
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Fig. 6.7. Expression of cleaved caspase-3. SW480 cells in Leibovitz-15 medium
were either left untreated or exposed to buttermilk at indicated times and
concentrations. SW480 cells were additionally treated with 5 mM NaBut, which
served as positive control. After the indicated times, treatment was removed, cells
were washed and subjected to In-Cell Western analysis using specific antibody
against cleaved caspase-3. Results are shown as mean ± S.D. of three independent
experiments. Changes in caspase-3 were considered significantly different than
control when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
Immunostaining for cleaved PARP was carried out as an alternative
indirect method for detecting caspase activity. PARP is a 116kDa nuclear poly
(ADP-ribose) polymerase that is involved in DNA repair. Cleavage of PARP by
caspase-3 into 89 kDa and 24 kDa fragments facilitates cellular disassembly and
is a valuable marker of apoptosis. The effect of buttermilk on PARP cleavage was
examined by immunofluorescence analysis of cells using a cleaved PARP
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antibody that recognises the large fragment (89 kDa) of mouse PARP1. It does not
recognise full length PARP1 or other isoforms. Apoptosis evaluation induced in
vitro by sodium butyrate in SW480 cells yielded green-labeled cleaved PARP
positive cells (Fig. 6.8). Neither control cells nor buttermilk-treated cells yielded
green-labelled cells, indicating that cleavage of PARP did not contribute to the
commitment to apoptosis by buttermilk (Fig. 6.8).
a)
control
b)
NaBut
(positive
control)
c)
buttermilk
0.4 mg
total
solids/ml;
48h
Fig. 6.8. Immunofluorescent detection of cleaved PARP. SW480 cells in
Leibovitz-15 medium were either untreated (a) or treated with buttermilk at
concentration 0.4 mg total solids/ml (c). SW480 cells were also treated with 5mM
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NaBut, which served as positive control (b). After 48h cells were labelled with
antibody against cleaved PARP and examined under immunofluorescent and light
microscope. Green signal of cleaved PARP was observed only in positive control.
6.3.7. Efect of buttermilk on signalling molecules: Akt, ERK 1/2, β-catenin
and c-myc
Protein phosphorylation is the principal regulatory mechanism of cell
signalling pathways. Protein kinases including Akt and ERK1/2 become activated
by phosphorylation before activating nuclear targets including c-myc transcription
factor. Fast activated cell-based ELISA (also termed In-Cell Western)
methodology was used to evaluate the activation state of signalling pathways in
SW480 cells after treatment with buttermilk. The relative amounts of
phosphorylated Akt and ERK1/2 were determined using antibodies to
phosphorylated and native proteins. We detected a decrease in phosphorylated
Akt protein in SW480 cells after 24h of buttermilk treatment, while total Akt
remained unchanged compared to the control (Fig. 6.9). Interestingly, at very low
buttermilk concentration, 0.1 mg total solids/ml, we could observe an increase in
phosphorylated Akt, as well as total Akt (P ≤ 0.01). A dose-dependent decrease in
β-catenin protein levels, which is overexpressed in colon cancer and plays a
significant role in Wnt signalling pathway, was also seen after 24 h of buttermilk
treatment (Fig. 6.10). Furthermore, we also observed a time-dependent decrease
in ERK2 (Fig. 6.11) and a dose-dependent decrease in phosphorylated ERK 1/2
(Fig. 6.12) proteins, as well as c-myc (Fig. 6.13) protein; however using the same
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method, we could not see any changes in other MAPK proteins, such as
phosphorylated p38 (Fig. 6.14) and phosphorylated JNK (Fig. 6.15).
Fig. 6.9. Changes in total Akt (white bars) and phosphorylated Akt (black bars) in
SW480 cells in Leibovitz-15 medium after 24h of buttermilk treatment. SW480
cells were either left untreated or exposed to buttermilk at indicated
concentrations. After 24h buttermilk was removed and cells were subjected to
colorimetric Fast Activated Cell-based ELISA assay based on total Akt or
phosphorylated Akt as primary antibodies. Results are shown as mean ± S.D. of
three independent experiments. Changes in Akt and phosphorylated Akt were
considered significantly different than their controls when: * = P ≤ 0.05, ** = P ≤
0.01, *** = P ≤ 0.001.
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Fig. 6.10. Changes in β-catenin protein in SW480 colon cancer cells after 24h of
buttermilk treatment. SW480 cells in Leibovitz-15 medium were either left
untreated or exposed to buttermilk at indicated concentrations. After 24h
treatment was removed, cells were washed and subjected to In-Cell Western
analysis using specific antibody against β-catenin. Results are shown as mean ±
S.D. of three independent experiments. Changes in β-catenin were considered
significantly different than control when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤
0.001.
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Fig. 6.11. Changes in ERK2 protein in SW480 colon cancer cells after 24h and
48h (as indicated) of buttermilk. SW480 cells in Leibovitz-15 medium were either
left untreated or exposed to buttermilk at indicated times and concentrations.
SW480 cells were additionally treated with 5 mM NaBut, which served as
positive control. After the indicated times, treatment was removed, cells were
washed and subjected to In-Cell Western analysis using specific antibody against
ERK2 protein. Results are shown as mean ± S.D. of three independent
experiments. Changes in ERK2 were considered significantly different than
control when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
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Fig. 6.12. Changes in phosphorylated ERK1/2 protein in SW480 colon cancer
cells in Leibovitz-15 medium after 24h of buttermilk treatment at different
concentrations. SW480 cells were either left untreated or exposed to buttermilk at
indicated times and concentrations. After 24h treatment was removed, cells were
washed and subjected to In-Cell Western analysis using specific antibody against
phosphorylated ERK1/2 protein. Results are shown as mean ± S.D. of three
independent experiments. Changes in phosphorylated ERK1/2 were considered
significantly different than control when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤
0.001.
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Fig. 6.13. Changes in c-myc protein in SW480 colon cancer cells after 24h and
48h (as indicated) of buttermilk treatment at different concentrations. SW480 cells
in Leibovitz-15 medium were either left untreated or exposed to buttermilk at
indicated times and concentrations. SW480 cells were additionally treated with 5
mM NaBut, which served as positive control. After the indicated times, treatment
was removed, cells were washed and subjected to In-Cell Western analysis using
specific antibody against c-myc protein. Results are shown as mean ± S.D. of
three independent experiments. Changes in c-myc protein were considered
significantly different than control when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤
0.001.
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Fig. 6.14. Expression of phosphorylated p38 protein in SW480 colon cancer cells
after 24h and 48h (as indicated) of buttermilk treatment at different
concentrations. SW480 cells in Leibovitz-15 medium were either left untreated or
exposed to buttermilk at indicated times and concentrations. SW480 cells were
additionally treated with 5 mM NaBut, which served as positive control. After the
indicated times, treatment was removed, cells were washed and subjected to In-
Cell Western analysis using specific antibody against phosphorylated p38 protein.
Results are shown as mean ± S.D. of three independent experiments. Changes in
phosphorylated p38 protein were considered significantly different than control
when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
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Fig. 6.15. Expression of phosphorylated JNK protein in SW480 colon cancer cells
after 24h and 48h (as indicated) of buttermilk treatment at different
concentrations. SW480 cells in Leibovitz-15 medium were either left untreated or
exposed to buttermilk at indicated times and concentrations. SW480 cells were
additionally treated with 5 mM NaBut, which served as positive control. After the
indicated times, treatment was removed, cells were washed and subjected to In-
Cell Western analysis using specific antibody against phosphorylated JNK
protein. Results are shown as mean ± S.D. of three independent experiments.
Changes in phosphorylated JNK protein were considered significantly different
than control when: * = P ≤ 0.05, ** = P ≤ 0.01, *** = P ≤ 0.001.
6.3.8. Analysis of endonuclease G and AIF by immunofluorescence
Knowing that buttermilk induced apoptosis in SW480 colon cancer cells,
but did  not trigger cleavage of either caspases or PARP protein, we investigated
further if it led to release of AIF and endonuclease G from depolarized
mitochondria, as these molecules can lead to suicidal cell death in a caspase-
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independent manner. Endonuclease G is a mitochondrial specific nuclease that
translocates to the nucleus and cleaves chromatin DNA during apoptosis. Using
immunofluorescence, we observed that endonuclease G was prominent after
treatment with buttermilk and sodium butyrate but was not detected in control
cells. It relocated to the nucleus upon treatment with buttermilk for 48h and with
sodium butyrate (positive control) (Fig. 6.16). Similar results were observed in
cells labelled with AIF antibody (Fig. 6.17), however more cells showed AIF
signal from the inside of cells nuclei than in the case of endonuclease G. Staining
with DRAQ5 dye, which stains nuclei of cells, showed that nuclei of buttermilk-
treated cells were more condensed than those of healthy cells; however, as with
H&E staining, apoptotic bodies could not be observed.
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Fig. 6.16. Confocal immunofluorescent examination of endonuclease G in SW480 cells. SW480 cells were either untreated (control, C-) and
treated with 0.2 mg total solids/ml (B2). SW480 cells in Leibovitz-15 medium were also treated with 5 mM sodium butyrate (NaBut, C+), which
served as positive control. After 48h cells were washed and labelled with endonuclease G antibody (green) (a). SW480 cells were also
counterstained with DRAG5 (b), which is fluorescent DNA dye to detect cells’ nuclei (blue). Merged images (c) show nuclei of SW480 cells
(blue) and endonuclease G (green). Figure shows representative images of duplicate experiments.
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Fig. 6.17. Confocal immunofluorescent examination of AIF in SW480 cells. SW480 cells were either untreated (control, C-) and treated with 0.2
mg total solids/ml (B2). SW480 cells in Leibovitz-15 medium were also treated with 5 mM sodium butyrate (NaBut, C+), which served as
positive control. After 48h cells were washed and labelled with AIF antibody (green) (a). SW480 cells were also counterstained with DRAG5
(b), which is fluorescent DNA dye to detect cells’ nuclei (blue). Merged images (c) show nuclei of SW480 cells (blue) and AIF (green). Figure
shows representative images of duplicate experiments.
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6.4. Discussion
To determine the mode of action of buttermilk’s components on SW480 colon
cancer cells we investigated different key components of cell survival and death
pathways using variety of biochemical techniques. First of all, we observed a decrease
in phosphorylated (active) Akt in SW480 colon cancer cells after buttermilk treatment
(Fig. 6.10). We hypothesise that the sensitivity of SW480 cell growth to buttermilk
derives in part from down regulation of an Akt-induced bioenergetics program in
these cells, possibly by disrupting mitochondrial integrity. Enzyme activity of
phosphorylated Akt is essential for cell survival. Its contribution to cellular
bioenergetics appears to be a key factor in cell survival. Elstrom et al. (2004)
observed that Akt stimulated glucose consumption in Akt-transfected blood cancer
cells without affecting the rate of oxidative phosphorylation. Akt stimulates glycolysis
and increases protein and lipid synthesis while blocking -oxidation and autophagy,
an evolutionarily conserved response to starvation by which cells catabolise their
components to create an internal supply of essential nutrients. Such metabolic changes
render cells with constitutively active Akt unable to activate quiescence. The role of
Akt in cancer cell bioenergetics may account for the effect of culture conditions in
determining the cellular response to buttermilk as reported in Chapter 4. Growing Akt
expressing SW480 cells in Leibovitz-15 medium containing galactose may have
rendered them more susceptible to mitochondrial-mediated cell death by buttermilk
than growing cells in DMEM medium containing glucose. Two Akt isoforms (Akt1
and Akt2) were reported to be upregulated in human colon cancers compared with
normal mucosa (Bellacosa et al., 2005). It is tempting to speculate that suppression of
Akt expression by buttermilk components would render Akt and apoptosis likely
targets for chemosensitisation.
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FACS analysis of TMRE loading in buttermilk-treated cells revealed poor
mitochondrial retention of TMRE and provided evidence that buttermilk decreased
the mitochondrial membrane potential of SW480 cells in a dose and time-dependent
manner. Mitochondrial membrane potential (is a measure of cellular viability, as it
reflects the pumping of protons across the inner membrane during electron transport
and oxidative phosphorylation, the driving force behind ATP production.
Permeabilization of outer mitochondrial membrane by buttermilk may allow release
of proteins such as the apoptosome and possibly endonuclease G and AIF may
account for the presence of apoptotic cells as shown by flow cytometry in Fig. 6.5.
Apart from Akt, the MAPK signaling pathway is a second critical pathway
involved in cell survival, proliferation, differentiation and tumor growth (Wang et al.,
2010) Three major subfamilies of enzymes make up MAPK. They are extracellular
signal-regulated protein kinase 1/2 (ERK1/2), C-Jun N-terminal kinase (JNK) and p38
MAPK (p38). The former, ERK MAPK is one of the most important enzyme families
driving cell proliferation in human colorectal cancer. It was found that buttermilk
treatment significantly (P ≤ 0.001) reduced activation levels of ERK1/2 in SW480
cells compared with untreated control cells, which suggests that buttermilk is an
important source of bioactive components that can potentially disrupt transduction of
growth stimulatory signals in colorectal cancer. ERK enzymes phosphorylate
cytoplasmic targets or migrate to the nucleus where they phosphorylate transcription
factors that upregulate proliferation genes and protect cell against apoptosis.
Inhibition of ERK1/2 phosphorylation is sufficient to induce apoptotic cell death in
human colon cancer cells (Rice et al., 2003). The other MAPK subfamilies, JNK and
p38 are involved in growth arrest and apoptosis (Fang and Richardson, 2005).
However, neither of these signalling molecules were targeted by buttermilk in our
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studies. Butyrate may have induced apoptosis through JNK and p38 activation in
colon cancer cells (Zhang et al., 2010). Although buttermilk treatment failed to
activate JNK and p38 in SW480 cells, other studies have shown that pure
sphingolipids including sphinganine and ceramide are capable of activating JNK/p38
MAPK and play critical roles in triggering apoptosis in HT-29 human colon cancer
cells (Ahn and Schroeder, 2006).
We also investigated the effect of buttermilk on β-catenin, a key component of
Wnt signalling pathway in SW480 colon cancer cells. In our studies, we found using
the In-Cell Western method, that buttermilk treatment decreased the level of β-catenin
and its target, c-myc after 24 (P ≤ 0.001) and 48h (P ≤ 0.001), respectively in SW480
colon cancer cells. β-catenin is an essential component of the Wnt signalling pathway
which is dysfunctional in up to 60% of sporadic human colon cancers (Powell et al.,
1992) and is thought to predispose cells to additional mutations that proceed to colon
cancer (Polakis, 1999). Most Wnt signalling dysfunctions lead to the nuclear
accumulation of β-catenin where it associates with transcription factors to drive the
transcription of multiple target genes, such as c-myc implicated in proliferation
(Martensson et al., 2007). Our findings, that buttermilk treatment reduced β-catenin,
corroborates similar observations by other workers studying the apoptotic effects of
sphingolipids. Schmelz and co-workers (2001) found that sphingosine reduced
cytosolic and nuclear β-catenin in SW480 and T84 human colon cancer cells.
Sphingolipid components appear to regulate β-catenin levels at the post transcriptional
level rather than at transcription level, possibly at level of protein degradation or
reduced stabilization. Simon et al., (2009) found that SM-rich diet did not
significantly alter mRNA levels of β-catenin and connexin-43 (member of the gap
junction proteins) in CF1 mice, but it downregulated levels of protein β-catenin and
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increased protein levels of connexin-43, which are both early biomarkers of colon
cancer development.
Using H&E staining, Annexin-V-FLUOS and PI staining, FACS analysis and
cell cycle analysis, we determined that buttermilk induced apoptosis in SW480 colon
cancer cells (Fig. 6.1-6.5). However, we did not detect typical biomarkers of
apoptosis, such as cleavage of caspases and PARP. Buttermilk components triggered
mitochondria membrane depolarization in colon cancer cells. The important role of
mitochondria in promoting caspase activation has been a major focus of apoptosis
research; however, mitochondria may also contribute to cell death by a caspase-
independent mechanism (Pradelli et al., 2010). One of the possibilities is that pro-
apoptotic Bcl-2 family members, such as Bax and Bak permeabilize the mitochondrial
outer membrane allowing release of apoptotic molecules, such as cytochrome c or
apoptosis-inducing factor (Lindsten et al., 2000); however, the exact mechanism is
not known. Other models of mitochondrial membrane permeabilization (which leads
to its depolarization) include opening of the voltage-dependent anion channel
(VDAC), opening of the mitochondrial permeability transition pore (PTP), opening of
ceramide channels, swelling of matrix and disruption of  the inner membrane or
formation of pores in the outer membrane (Pradelli et al., 2010, Kroemer et al., 2007,
Roy et al., 2009). Evidence for caspase-independent cell death has come from in vivo
and in vitro studies in which cell death occurred following mitochondrial outer
membrane permeabilization but without caspase activation (Kroemer et al., 2007).
Among the cytochrome c and other proteins, which are released from mitochondria,
endonuclease G (EndoG) was identified as a mitochondrial endonuclease that could
relocate to the nucleus and induce caspase-independent nucleosomal DNA
fragmentation (Li et al., 2001). Another protein released from the mitochondrial inner
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membrane is AIF, a flavoprotein, which translocates to the nucleus where it
cooperates with EndoG and/or cyclophilin A in DNA degradation complex (Niikura et
al., 2007, Cande et al., 2004). In our studies we could see labelled EndoG and AIF in
some of the nuclei of colon cancer cells after buttermilk treatment, indicating that in
some cells these molecules translocate from mitochondria to nuclei.
In addition to caspase-independent cell death, autophagic cell death has
emerged as another mechanism of non-apoptotic cell death. Autophagy occurs at
basal levels in most tissues, contributing to the routine turnover of cytoplasmic
components and promoting cell adaptation and survival during stress, such as
starvation. It is downregulated in most cancer cells. Oncogenic signalling molecules
(e.g. class 1 PI3K/Akt and mTor) suppress autophagy and tumour suppressors (e.g.
PTEN , p53, beclin 1) stimulate autophagy. An increasing number of studies propose
that activation of autophagy is how cancer cells resist cytotoxic drug treatments
because it allows cancer cells to recoup essential building blocks when they are
exposed to chemotherapy agents or irradiation (Bijnsdorp et al., 2010). The balance
between survival-related autophagy and death-related autophagy appears to be
critically dependent on the type of cellular stress and particular cellular settings. A
growing number of studies now suggest that in certain conditions, aberrant ERK
activation can promote cell death (reviewed in Cagnol and Chambard, 2010).
Sustained ERK activity during amino acid depletion or following treatment of HT-29
and HCT15 colon cancer cells with aurintricarboxylic acid or soyasaponins signalled
autophagic cell death (Ogier-Denis et al., 2000, Pattingre et al., 2003 and Ellington et
al., 2006). Reactive oxygen species have been identified as the critical mediators of
ERK-induced cell death (Cagnol and Chambard, 2010), promoting sustained ERK
activation and inhibiting ERK phosphatases. Morphological characteristics of
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autophagy, as detected using transmission electron microscopy and immunoelectron
microscopy include sequestration of cytoplasm and organelles such as mitochondria
and endoplasmic reticulum in double or multiple-membraned vesicles (Blank and
Shiloh, 2007). Biochemically, autophagy is associated with induction of microtubule-
associated protein 1 light chain 3 (LC3) and conversion of LC3-I to LC3-II, induction
of beclin 1 (Cheng et al., 2008), BNIP-3 (An et al., 2006) and phosphorylation of Gα-
interacting protein (GAIP) (Ogier-Denis et al., 2000) and p53 (Cheng et al., 2008).
Other biochemical markers include cytosolic sequestration of lactate dehydrogenase
activity (Blank and Shiloh, 2007). An investigation of the effect of buttermilk on
specific autophagic markers is required to determine if caspase-independent cell death
might also be accompanied by autophagic activity.
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6.5. Conclusions
Summarizing our observations, buttermilk’s components initiate suicidal death
of SW480 colon cancer cells; however the whole pathway could not be established.
Using immunofluorescence and flow cytometry, we could detect some of the
apoptotic hallmarks, such as phosphatidylserine translocation to the outer membrane,
mitochondrial outer membrane depolarization, condensation of chromatin (observed
by flow cytometry analysis of cell cycle, haematoxylin and eosin staining of cells and
DRAQ5 staining with confocal microscopy detection), but we could not detect
apoptotic bodies as well as biochemical markers of caspase-dependent apoptosis, such
as cleavage of caspases and PARP. However, downregulation of Akt and ERK 1/2 in
SW480 colon cancer cells after buttermilk treatment indicated possible activation of
autophagy. Not all details are yet fully understood in different types of suicidal cell
deaths; however, to farther investigate buttermilk components’ mode of action on
colon cancer cells, it is necessary to take in the consideration wider range of cell
signalling pathways. High levels of sphingolipids present in buttermilk indicate a
potential role for sphingolipids in mediating anticancer activity of buttermilk; thus far,
pure sphingosine and C2 ceramide  have been shown to trigger cancer cell death; it
remains unclear if fatty acyl chain length modulates anticancer activity of ceramide. It
is also unclear whether other buttermilk components may modulate the activity of
sphingolipids. While it could not be established which buttermilk components possess
antiproliferative activity, our results indicate that buttermilk, a by-product in
buttermaking process possesses anticancer activity against a colon cancer cell line. A
combination of lipidomics and phosphoproteomic analyses of cancer cells will be
required to identify a) biomarkers of exposure to buttermilks enriched in unique
sphingolipids and b) molecular targets responsible for anticancer activity. Their
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validation in appropriate in vitro and in vivo models will be critical to determining
whether buttermilk holds promise to be a novel functional beverage with health-
promoting properties for the human gastrointestinal tract.
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Final discussion
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This project investigated the anticancer activity of traditional buttermilk, a
dairy-based beverage which formed the main part of the staple diet in Ireland up to the
middle of the last century. It is naturally rich in disrupted MFGM material and its
polar lipid content is relatively high compared with most other dairy products.
Sphingolipids and phospholipids which comprise the bulk of polar lipids in MFGM
are of interest because they define the structural properties of biological membranes
and they also function as intracellular signalling molecules regulating cell growth,
development, adhesion and cell death.
No work to date has evaluated the relative effects of modern cream separation
techniques, washing or heating on the antiproliferative effects of buttermilk. In this
project we evaluated the potential health benefits of buttermilks produced under
different technological conditions. Using an indirect cytotoxicity assay, based on
activity of acid phosphatase, we found that buttermilk produced in laboratory scale
significantly (P ≤ 0.001) inhibited growth of SW480 colon cancer cells, but not FHC
normal human epithelial cells, indicating that it targeted antiproliferative pathways in
cancer cells, which was also confirmed using Caco-2 cells. After scaling up
buttermilk production, it was apparent that it did not lose antiproliferative activity;
moreover, it significantly (P ≤ 0.001) inhibited growth of another colon cancer cell
line, HT-29 as well as the hepatocellular carcinoma cell line HepG2.
We also studied influence of cream separation techniques, gravitational versus
centrifugal, on antiproliferative activity of buttermilk. Buttermilk produced from
gravitationally separated cream had a significantly lower (P ≤ 0.05) antiproliferative
activity and also higher MFGM protein content than buttermilks produced from
commercial cream and from centrifugally separated cream. The latter contained
higher phospholipids content compared with buttermilk produced from gravitationally
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separated cream, suggesting that antiproliferative activity may be more associated
with polar lipid components of the buttermilks than with protein components.
Moreover, we also found that high heat (95°C, 30 min) treatment did not alter
antiproliferative activity of buttermilk. This suggests that β-lactoglobulin interactions
with MFGM as a result of heat treatment had negligible effects on the cellular
signalling circuitry that regulates cell growth and death. This is in accordance with an
earlier study of the comparative cytotoxic activity of dairy derived ingredients in
human cancer cells which demonstrated that β-lactoglobulin had only mild cytotoxic
activity (Chan-Remillard & Ozimek, 2008).
We also found that at concentration 0.3 mg total solids/ml buttermilks
produced from washed creams showed the same antiproliferative activity against
colon cancer cells as buttermilks produced from unwashed creams. Washing of cream
before churning showed higher lipids content in washed fractions compared to
unwashed fractions, as expected (Lamothe et al., 2008, Morin et al., 2007). This
suggests that buttermilk fractions from washed cream may offer potential for the
production of phospholipids concentrates that have antiproliferative activity against
cancer cells.
Spray-dried retentate and permeate samples showed much lower
antiproliferative activity than their corresponding liquid samples, suggesting
temperature and/or pressure-induced impairment of bioactive components responsible
for antiproliferative activity. Morin et al., (2007) showed that spray drying affected
the composition of buttermilk and its MFGM, in particular, it significantly lowered
phospholipid content when compared with initial buttermilks. Gaiani et al. (2010) also
found that spray drying influenced dairy powder surface composition. According to
Kim et al., (2010) non-thermal treatments including freeze drying may be more
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effective at overcoming the loss of nutrients during spray drying process. In our
studies, we found that freeze and spin drying of feed, retentate and permeate fractions
maintained their antiproliferative activity.
Dairy products fermented with lactic acid bacteria have been shown to inhibit
colon cancer cell growth (Baricault et al.,1995, Macdonald et al., 1994, Ganjam et al.,
1997, Jan et al., 2002, Kumar et al., 2010). In this study, fermented buttermilks also
inhibited colon cancer cell growth, though to a lesser extent than buttermilks produced
from unfermented creams.
We also studied hallmarks of selected signalling pathways inside cancer cells
to better understand biochemical mechanisms underlying buttermilk’s
antiproliferative activity. Using immunofluorescence and flow cytometry, we could
detect some apoptotic hallmarks, such as phosphatidylserine translocation to the outer
membrane, mitochondrial outer membrane depolarization, condensation of chromatin
(observed by flow cytometry analysis of cell cycle, haematoxylin and eosin staining
of cells and DRAQ5 staining with confocal microscopy detection), but we did not
detect apoptotic bodies nor biochemical markers of caspase-dependent apoptosis, such
as cleavage of caspases and PARP. Downregulation of Akt and ERK 1/2 in SW480
colon cancer cells after buttermilk treatment may underlie the antiproliferative activity
of buttermilk. Not all details of different types of suicidal cell deaths are yet fully
understood; however, to further investigate buttermilk components’ mode of action on
colon cancer cells, it is necessary to take into consideration a wider range of cell death
pathways.
The use of in vitro models to study hydrolysis of exogenous sources of
sphingolipids, i.e. buttermilk, is limited to cell lines that express alkaline
sphingomyelinase. By contrast an in vivo model would permit evaluation of
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hydrolysis by endogenous and microflora-derived alkaline sphingomyelinase which is
specifically stimulated by bile salts. Recently, MFGM was shown to confer protection
against colon carcinogenesis in an animal model of experimental carcinogenesis. Rats
fed a diet containing MFGM had significantly fewer aberrant crypt foci (ACF)
compared to rats fed corn oil or anhydrous milkfat (Snow et al., 2010). Further studies
should be conducted in vivo to establish the modulatory effect of attainable dietary
buttermilk treatments in the azomethane-treated rats and to identify the number of
mucin-depleted foci (MDF). The latter are postulated to be a subgroup of ACF that
predict tumour outcome better than ACF as their number and multiplicity correlated
with tumour number and incidence (Caderni, 2007, Femia and Caderni, 2008). MDF
were shown to be decreased by dietary treatments with synbiotics comprising a
prebiotic derivative of inulin and two probiotics, lactobacilli and bifidobacteria and
increased by a high corn oil cancer-promoting diet. Its usefulness as a biomarker of an
early pathological alteration in human colon was recently confirmed when they
identified MDF-like lesions in familial adenomatous polyposis (FAP) subjects who
are at high risk of developing colorectal cancer. Research is required to address
whether ceramide and sphingosine metabolites formed from buttermilk sphingolipids
by the combined action of alkaline sphingomyelinase and ceramidase influence the
cellular kinetics of the gut epithelium under normal and tumourigenic conditions. This
would involve determining effects of buttermilk samples on proliferation, apoptosis,
autophagy and differentiation of crypt cells at an early step in the process of
carcinogenesis. An investigation of chemopreventive activity of buttermilk in a rodent
model can significantly improve our knowledge about its mode of action and provide
an opportunity for development of a new functional beverage with widely demanded
chemopreventive activity.
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